BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 995889 COc1nc(ccc1C1=NCCN1)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CNC[C@@H](O)CC(O)=O)c(OC(F)F)c1 InChI=1S/C35H36F2N4O5/c1-20-25(22-10-11-23(31(16-22)46-35(36)37)18-38-19-24(42)17-32(43)44)6-4-7-26(20)27-8-5-9-28(21(27)2)30-13-12-29(34(41-30)45-3)33-39-14-15-40-33/h4-13,16,24,35,38,42H,14-15,17-19H2,1-3H3,(H,39,40)(H,43,44)/t24-/m0/s1 FTKZKJUFQAWNBE-DEOSSOPVSA-N 479542 US10899735, No. 1 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479542&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995890 COc1ccc(\C=C\c2cc(ccc2CNC[C@@H]2CCC(=O)N2)-c2cccc(c2Cl)-c2cccc(c2Cl)-c2ccc(CNC[C@@H]3CCC(=O)N3)c(OC)n2)cc1 InChI=1S/C45H45Cl2N5O4/c1-55-35-18-10-28(11-19-35)9-12-29-23-30(13-14-31(29)24-48-26-33-16-21-41(53)50-33)36-5-3-6-37(43(36)46)38-7-4-8-39(44(38)47)40-20-15-32(45(52-40)56-2)25-49-27-34-17-22-42(54)51-34/h3-15,18-20,23,33-34,48-49H,16-17,21-22,24-27H2,1-2H3,(H,50,53)(H,51,54)/b12-9+/t33-,34-/m0/s1 IWJSLOQICUPCIV-ZEZHIJEESA-N 479543 US10899735, No. 2 Programmed cell death 1 ligand 1/2 Human 6343 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479543&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995891 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(CCc2ccccc2)c1 InChI=1S/C44H45Cl2N5O3/c1-54-44-32(25-48-27-34-19-22-41(53)50-34)17-20-39(51-44)38-12-6-11-37(43(38)46)36-10-5-9-35(42(36)45)30-15-16-31(24-47-26-33-18-21-40(52)49-33)29(23-30)14-13-28-7-3-2-4-8-28/h2-12,15-17,20,23,33-34,47-48H,13-14,18-19,21-22,24-27H2,1H3,(H,49,52)(H,50,53)/t33-,34-/m0/s1 FTUDOIJDMURHCM-HEVIKAOCSA-N 479544 US10899735, No. 3 Programmed cell death 1 ligand 1/2 Human 10467 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479544&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995892 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1O)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H39ClN6O5/c1-47-35-21(17-38-19-23-11-15-31(44)40-23)9-13-29(42-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)46)30-14-10-22(36(43-30)48-2)18-39-20-24-12-16-32(45)41-24/h3-10,13-14,23-24,38-39,46H,11-12,15-20H2,1-2H3,(H,40,44)(H,41,45)/t23-,24-/m0/s1 YXZUBNZJVLDEHD-ZEQRLZLVSA-N 479545 US10899735, No. 4 Programmed cell death 1 ligand 1/2 Human 595 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479545&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995893 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cc(C)cc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C37H40Cl2N6O4/c1-21-15-28(35(39)29(16-21)31-12-8-23(37(45-31)49-3)18-41-20-25-10-14-33(47)43-25)26-5-4-6-27(34(26)38)30-11-7-22(36(44-30)48-2)17-40-19-24-9-13-32(46)42-24/h4-8,11-12,15-16,24-25,40-41H,9-10,13-14,17-20H2,1-3H3,(H,42,46)(H,43,47)/t24-,25-/m0/s1 ODZPURMPQQHAFA-DQEYMECFSA-N 479546 US10899735, No. 5 Programmed cell death 1 ligand 1/2 Human 447 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479546 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479546&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995894 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cc(F)cc(c1F)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H37ClF2N6O4/c1-48-35-20(16-40-18-23-8-12-31(46)42-23)6-10-29(44-35)26-5-3-4-25(33(26)37)27-14-22(38)15-28(34(27)39)30-11-7-21(36(45-30)49-2)17-41-19-24-9-13-32(47)43-24/h3-7,10-11,14-15,23-24,40-41H,8-9,12-13,16-19H2,1-2H3,(H,42,46)(H,43,47)/t23-,24-/m0/s1 OOUVJEARUBVBNN-ZEQRLZLVSA-N 479547 US10899735, No. 6 Programmed cell death 1 ligand 1/2 Human 370 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479547&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995895 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1F)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38ClFN6O4/c1-47-35-21(17-39-19-23-11-15-31(45)41-23)9-13-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-20-24-12-16-32(46)42-24/h3-10,13-14,23-24,39-40H,11-12,15-20H2,1-2H3,(H,41,45)(H,42,46)/t23-,24-/m0/s1 OIRWCTPMCCYZIH-ZEQRLZLVSA-N 479548 US10899735, No. 7 Programmed cell death 1 ligand 1/2 Human 100.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479548 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479548&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995896 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1C)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C37H41ClN6O4/c1-22-27(6-4-7-28(22)31-14-10-23(36(43-31)47-2)18-39-20-25-12-16-33(45)41-25)29-8-5-9-30(35(29)38)32-15-11-24(37(44-32)48-3)19-40-21-26-13-17-34(46)42-26/h4-11,14-15,25-26,39-40H,12-13,16-21H2,1-3H3,(H,41,45)(H,42,46)/t25-,26-/m0/s1 XJSVXUJLNVRJSX-UIOOFZCWSA-N 479549 US10899735, No. 8 Programmed cell death 1 ligand 1/2 Human 363 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479549&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995897 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC(F)F)c1 InChI=1S/C39H37Cl2F2N5O4/c1-51-36-25(18-48-21-39(22-48)15-13-33(50)46-39)10-11-30(44-36)29-7-3-6-28(35(29)41)27-5-2-4-26(34(27)40)23-8-9-24(31(16-23)52-37(42)43)17-47-19-38(20-47)14-12-32(49)45-38/h2-11,16,37H,12-15,17-22H2,1H3,(H,45,49)(H,46,50) IETMXFUVPUWGJX-UHFFFAOYSA-N 479550 US10899735, No. 9 Programmed cell death 1 ligand 1/2 Human 263 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479550&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995898 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC(F)F)c1 InChI=1S/C37H37Cl2F2N5O4/c1-49-36-23(18-43-20-25-12-15-33(48)45-25)10-13-30(46-36)29-7-3-6-28(35(29)39)27-5-2-4-26(34(27)38)21-8-9-22(31(16-21)50-37(40)41)17-42-19-24-11-14-32(47)44-24/h2-10,13,16,24-25,37,42-43H,11-12,14-15,17-20H2,1H3,(H,44,47)(H,45,48)/t24-,25-/m0/s1 CJKOLTKRSNVEBI-DQEYMECFSA-N 479551 US10899735, No. 10 Programmed cell death 1 ligand 1/2 Human 806 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479551&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995899 COc1nc(ccc1C1=NCCN1)-c1cccc(c1Cl)-c1cccc(-c2ccc(cc2)C2=NCCN2)c1Cl InChI=1S/C30H25Cl2N5O/c1-38-30-24(29-35-16-17-36-29)12-13-25(37-30)23-7-3-6-22(27(23)32)21-5-2-4-20(26(21)31)18-8-10-19(11-9-18)28-33-14-15-34-28/h2-13H,14-17H2,1H3,(H,33,34)(H,35,36) WGHKQBCVJNDKJH-UHFFFAOYSA-N 479552 US10899735, No. 11 Programmed cell death 1 ligand 1/2 Human 146 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479552&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995900 Clc1c(cccc1-c1cccc(c1Cl)-c1ccc(C2=NCCN2)c(OCCCC#N)n1)-c1ccc(C2=NCCN2)c(OCCCC#N)n1 InChI=1S/C36H32Cl2N8O2/c37-31-23(7-5-9-25(31)29-13-11-27(33-41-17-18-42-33)35(45-29)47-21-3-1-15-39)24-8-6-10-26(32(24)38)30-14-12-28(34-43-19-20-44-34)36(46-30)48-22-4-2-16-40/h5-14H,1-4,17-22H2,(H,41,42)(H,43,44) GFAGLLQHURSVID-UHFFFAOYSA-N 479553 US10899735, No. 12 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479553&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995901 COc1cc(ccc1NC1=NCCN1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C34H34Cl2N6O3/c1-44-29-17-20(9-13-28(29)42-34-38-15-16-39-34)23-5-3-6-24(31(23)35)25-7-4-8-26(32(25)36)27-12-10-21(33(41-27)45-2)18-37-19-22-11-14-30(43)40-22/h3-10,12-13,17,22,37H,11,14-16,18-19H2,1-2H3,(H,40,43)(H2,38,39,42)/t22-/m0/s1 MIVXMQRAYYYHGD-QFIPXVFZSA-N 479554 US10899735, No. 13 Programmed cell death 1 ligand 1/2 Human 391 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479554&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995902 CNC(=N)Nc1ccc(cc1OC)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C33H34Cl2N6O3/c1-37-33(36)41-27-14-10-19(16-28(27)43-2)22-6-4-7-23(30(22)34)24-8-5-9-25(31(24)35)26-13-11-20(32(40-26)44-3)17-38-18-21-12-15-29(42)39-21/h4-11,13-14,16,21,38H,12,15,17-18H2,1-3H3,(H,39,42)(H3,36,37,41)/t21-/m0/s1 RBNUZCHNQAHDBM-NRFANRHFSA-N 479555 US10899735, No. 14 Programmed cell death 1 ligand 1/2 Human 570 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479555&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995903 COc1nc(ccc1CNCCOC(N)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCOC(N)=O)c(OC)n1 InChI=1S/C32H34Cl2N6O6/c1-43-29-19(17-37-13-15-45-31(35)41)9-11-25(39-29)23-7-3-5-21(27(23)33)22-6-4-8-24(28(22)34)26-12-10-20(30(40-26)44-2)18-38-14-16-46-32(36)42/h3-12,37-38H,13-18H2,1-2H3,(H2,35,41)(H2,36,42) NHJPGDADKFKDCO-UHFFFAOYSA-N 479556 US10899735, No. 15 Programmed cell death 1 ligand 1/2 Human 374 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479556&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995904 COc1nc(ccc1CNCCn1cn[nH]c1=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCn2cn[nH]c2=O)c(OC)n1 InChI=1S/C34H34Cl2N10O4/c1-49-31-21(17-37-13-15-45-19-39-43-33(45)47)9-11-27(41-31)25-7-3-5-23(29(25)35)24-6-4-8-26(30(24)36)28-12-10-22(32(42-28)50-2)18-38-14-16-46-20-40-44-34(46)48/h3-12,19-20,37-38H,13-18H2,1-2H3,(H,43,47)(H,44,48) MIDAPYUZZVHCHV-UHFFFAOYSA-N 479557 US10899735, No. 16 Programmed cell death 1 ligand 1/2 Human 465 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479557&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995905 COc1nc(ccc1CN1C[C@@H]2CNC[C@H]12)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2C[C@@H]3CNC[C@H]23)c(OC)n1 InChI=1S/C36H38Cl2N6O2/c1-45-35-21(17-43-19-23-13-39-15-31(23)43)9-11-29(41-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-12-10-22(36(42-30)46-2)18-44-20-24-14-40-16-32(24)44/h3-12,23-24,31-32,39-40H,13-20H2,1-2H3/t23-,24-,31-,32-/m0/s1 OJXGRVAZNCTODT-UDRQUUIHSA-N 479558 US10899735, No. 17 Programmed cell death 1 ligand 1/2 Human 3678 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479558&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995906 COc1nc(ccc1CN1CC2(C1)CCCO2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCCO3)c(OC)n1 InChI=1S/C38H40Cl2N4O4/c1-45-35-25(19-43-21-37(22-43)15-5-17-47-37)11-13-31(41-35)29-9-3-7-27(33(29)39)28-8-4-10-30(34(28)40)32-14-12-26(36(42-32)46-2)20-44-23-38(24-44)16-6-18-48-38/h3-4,7-14H,5-6,15-24H2,1-2H3 ZGKDIQBIKAAPRY-UHFFFAOYSA-N 479559 US10899735, No. 18 Programmed cell death 1 ligand 1/2 Human 2800 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479559&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995907 COc1nc(ccc1CNCc1c[nH]nn1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCc2c[nH]nn2)c(OC)n1 InChI=1S/C32H30Cl2N10O2/c1-45-31-19(13-35-15-21-17-37-43-41-21)9-11-27(39-31)25-7-3-5-23(29(25)33)24-6-4-8-26(30(24)34)28-12-10-20(32(40-28)46-2)14-36-16-22-18-38-44-42-22/h3-12,17-18,35-36H,13-16H2,1-2H3,(H,37,41,43)(H,38,42,44) FBEQEONWICZTME-UHFFFAOYSA-N 479560 US10899735, No. 19 Programmed cell death 1 ligand 1/2 Human 1613 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479560&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995908 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCc2nnc3COCCn23)c(OC)n1 InChI=1S/C37H38Cl2N8O4/c1-49-36-22(17-40-19-24-11-14-33(48)42-24)9-12-29(43-36)27-7-3-5-25(34(27)38)26-6-4-8-28(35(26)39)30-13-10-23(37(44-30)50-2)18-41-20-31-45-46-32-21-51-16-15-47(31)32/h3-10,12-13,24,40-41H,11,14-21H2,1-2H3,(H,42,48)/t24-/m0/s1 IQCSMWHHEBZHSL-DEOSSOPVSA-N 479561 US10899735, No. 20 Programmed cell death 1 ligand 1/2 Human 205 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479561&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995909 COc1nc(ccc1CN1CC2(C1)CCOCC2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCOCC3)c(OC)n1 InChI=1S/C40H44Cl2N4O4/c1-47-37-27(21-45-23-39(24-45)13-17-49-18-14-39)9-11-33(43-37)31-7-3-5-29(35(31)41)30-6-4-8-32(36(30)42)34-12-10-28(38(44-34)48-2)22-46-25-40(26-46)15-19-50-20-16-40/h3-12H,13-26H2,1-2H3 ULEQFAIXXLLDAG-UHFFFAOYSA-N 479562 US10899735, No. 21 Programmed cell death 1 ligand 1/2 Human 784 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479562&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995910 COc1nc(ccc1CNCc1cnn(C)c1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCc2cnn(C)c2)c(OC)n1 InChI=1S/C36H36Cl2N8O2/c1-45-21-23(17-41-45)15-39-19-25-11-13-31(43-35(25)47-3)29-9-5-7-27(33(29)37)28-8-6-10-30(34(28)38)32-14-12-26(36(44-32)48-4)20-40-16-24-18-42-46(2)22-24/h5-14,17-18,21-22,39-40H,15-16,19-20H2,1-4H3 YOFFQFCTMDRALM-UHFFFAOYSA-N 479563 US10899735, No. 22 Programmed cell death 1 ligand 1/2 Human 752 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479563&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995911 COc1cc(nc(Cl)c1CN1CC2(C1)CNC(=O)C2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C37H37Cl3N6O4/c1-49-30-13-29(44-35(40)27(30)17-46-19-37(20-46)14-32(48)42-18-37)26-8-4-6-24(34(26)39)23-5-3-7-25(33(23)38)28-11-9-21(36(45-28)50-2)15-41-16-22-10-12-31(47)43-22/h3-9,11,13,22,41H,10,12,14-20H2,1-2H3,(H,42,48)(H,43,47)/t22-/m0/s1 CXYRRMQBPACTKO-QFIPXVFZSA-N 479564 US10899735, No. 23 Programmed cell death 1 ligand 1/2 Human 180 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479564&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995912 COc1cc(nc(Cl)c1CN1CC2(C1)CNC(=O)C2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CNC(=O)C3)c(OC)n1 InChI=1S/C38H37Cl3N6O4/c1-50-30-11-29(44-35(41)27(30)15-47-20-38(21-47)13-32(49)43-17-38)26-8-4-6-24(34(26)40)23-5-3-7-25(33(23)39)28-10-9-22(36(45-28)51-2)14-46-18-37(19-46)12-31(48)42-16-37/h3-11H,12-21H2,1-2H3,(H,42,48)(H,43,49) MMOIGGPDIFTJMI-UHFFFAOYSA-N 479565 US10899735, No. 24 Programmed cell death 1 ligand 1/2 Human 118 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479565&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995913 COc1cc(nc(Cl)c1CN1CC2(C1)CNC(=O)C2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(OC)c(CN2CC3(C2)CNC(=O)C3)c(Cl)n1 InChI=1S/C38H36Cl4N6O4/c1-51-29-9-27(45-35(41)25(29)13-47-17-37(18-47)11-31(49)43-15-37)23-7-3-5-21(33(23)39)22-6-4-8-24(34(22)40)28-10-30(52-2)26(36(42)46-28)14-48-19-38(20-48)12-32(50)44-16-38/h3-10H,11-20H2,1-2H3,(H,43,49)(H,44,50) PPLCZUNWWOUBET-UHFFFAOYSA-N 479566 US10899735, No. 25 Programmed cell death 1 ligand 1/2 Human 384 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479566&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995914 Cc1cc(nc(Cl)c1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(C)c(CN2CC3(C2)CCC(=O)N3)c(Cl)n1 InChI=1S/C38H36Cl4N6O2/c1-21-13-29(43-35(41)27(21)15-47-17-37(18-47)11-9-31(49)45-37)25-7-3-5-23(33(25)39)24-6-4-8-26(34(24)40)30-14-22(2)28(36(42)44-30)16-48-19-38(20-48)12-10-32(50)46-38/h3-8,13-14H,9-12,15-20H2,1-2H3,(H,45,49)(H,46,50) VNJHAPCUOXGRNH-UHFFFAOYSA-N 479567 US10899735, No. 26 Programmed cell death 1 ligand 1/2 Human 4116 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479567&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995915 Cc1cc(nc(Cl)c1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(C)c(CNC[C@@H]2CCC(=O)N2)c(Cl)n1 InChI=1S/C36H36Cl4N6O2/c1-19-13-29(45-35(39)27(19)17-41-15-21-9-11-31(47)43-21)25-7-3-5-23(33(25)37)24-6-4-8-26(34(24)38)30-14-20(2)28(36(40)46-30)18-42-16-22-10-12-32(48)44-22/h3-8,13-14,21-22,41-42H,9-12,15-18H2,1-2H3,(H,43,47)(H,44,48)/t21-,22-/m0/s1 FOUXQUGLJVCJPY-VXKWHMMOSA-N 479568 US10899735, No. 27 Programmed cell death 1 ligand 1/2 Human 258 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479568&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995916 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CCN)cc1 InChI=1S/C33H32Cl2N4O2/c1-41-32-23(18-39-19-33(20-39)16-14-29(40)38-33)12-13-28(37-32)27-7-3-6-26(31(27)35)25-5-2-4-24(30(25)34)22-10-8-21(9-11-22)15-17-36/h2-13H,14-20,36H2,1H3,(H,38,40) QIPQIGNDTUMZQI-UHFFFAOYSA-N 479569 US10899735, No. 28 Programmed cell death 1 ligand 1/2 Human 2054 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479569&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995917 COc1cc(ccc1CCCN)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C35H36Cl2N4O3/c1-43-30-18-23(12-11-22(30)6-5-17-38)25-7-3-8-26(32(25)36)27-9-4-10-28(33(27)37)29-14-13-24(34(39-29)44-2)19-41-20-35(21-41)16-15-31(42)40-35/h3-4,7-14,18H,5-6,15-17,19-21,38H2,1-2H3,(H,40,42) LEUBLAGLIGGDBR-UHFFFAOYSA-N 479570 US10899735, No. 29 Programmed cell death 1 ligand 1/2 Human 2164 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479570&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995918 COc1nc(ccc1CNCC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C38H40Cl2N6O4/c1-49-36-23(19-41-18-16-25-11-14-32(47)42-25)9-12-30(43-36)28-7-3-5-26(34(28)39)27-6-4-8-29(35(27)40)31-13-10-24(37(44-31)50-2)20-46-21-38(22-46)17-15-33(48)45-38/h3-10,12-13,25,41H,11,14-22H2,1-2H3,(H,42,47)(H,45,48)/t25-/m0/s1 AOOIRGJTWJCDCG-VWLOTQADSA-N 479571 US10899735, No. 30 Programmed cell death 1 ligand 1/2 Human 163 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479571&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995919 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NC[C@@H](CO)N2O)c(OC)n1 InChI=1S/C35H34Cl2N6O5/c1-47-33-20(16-42-18-35(19-42)14-13-29(45)41-35)9-11-27(39-33)24-7-3-5-22(30(24)36)23-6-4-8-25(31(23)37)28-12-10-26(34(40-28)48-2)32-38-15-21(17-44)43(32)46/h3-12,21,44,46H,13-19H2,1-2H3,(H,41,45)/t21-/m0/s1 LZCYVOLUEIIRKQ-NRFANRHFSA-N 479572 US10899735, No. 31 Programmed cell death 1 ligand 1/2 Human 203 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479572&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995920 COc1nc(ccc1CN[C@H]1CCNC1=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN[C@H]2CCNC2=O)c(OC)n1 InChI=1S/C34H34Cl2N6O4/c1-45-33-19(17-39-27-13-15-37-31(27)43)9-11-25(41-33)23-7-3-5-21(29(23)35)22-6-4-8-24(30(22)36)26-12-10-20(34(42-26)46-2)18-40-28-14-16-38-32(28)44/h3-12,27-28,39-40H,13-18H2,1-2H3,(H,37,43)(H,38,44)/t27-,28-/m0/s1 WEZOTIDJKGONJG-NSOVKSMOSA-N 479573 US10899735, No. 32 Programmed cell death 1 ligand 1/2 Human 1183 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479573&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995921 COc1nc(ccc1CN[C@H]1CCNC1=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C36H36Cl2N6O4/c1-47-34-21(17-40-29-14-16-39-33(29)46)9-11-27(41-34)25-7-3-5-23(31(25)37)24-6-4-8-26(32(24)38)28-12-10-22(35(42-28)48-2)18-44-19-36(20-44)15-13-30(45)43-36/h3-12,29,40H,13-20H2,1-2H3,(H,39,46)(H,43,45)/t29-/m0/s1 ZAMHMPYBKXPVBB-LJAQVGFWSA-N 479574 US10899735, No. 33 Programmed cell death 1 ligand 1/2 Human 597 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479574&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995922 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(cc1)C1CCCN1C InChI=1S/C36H36Cl2N4O2/c1-41-19-5-10-31(41)24-13-11-23(12-14-24)26-6-3-7-27(33(26)37)28-8-4-9-29(34(28)38)30-16-15-25(35(39-30)44-2)20-42-21-36(22-42)18-17-32(43)40-36/h3-4,6-9,11-16,31H,5,10,17-22H2,1-2H3,(H,40,43) KQUHMBANNDLTPA-UHFFFAOYSA-N 479575 US10899735, No. 34 Programmed cell death 1 ligand 1/2 Human 872 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479575&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995923 CC(C)Oc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC(C)C)n1 InChI=1S/C42H46Cl2N6O4/c1-25(2)53-39-27(19-49-21-41(22-49)17-15-35(51)47-41)11-13-33(45-39)31-9-5-7-29(37(31)43)30-8-6-10-32(38(30)44)34-14-12-28(40(46-34)54-26(3)4)20-50-23-42(24-50)18-16-36(52)48-42/h5-14,25-26H,15-24H2,1-4H3,(H,47,51)(H,48,52) JRNUTLVRDPHGTF-UHFFFAOYSA-N 479576 US10899735, No. 35 Programmed cell death 1 ligand 1/2 Human 9133 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479576&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995924 CC(C)Oc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC(C)C)n1 InChI=1S/C40H46Cl2N6O4/c1-23(2)51-39-25(19-43-21-27-13-17-35(49)45-27)11-15-33(47-39)31-9-5-7-29(37(31)41)30-8-6-10-32(38(30)42)34-16-12-26(40(48-34)52-24(3)4)20-44-22-28-14-18-36(50)46-28/h5-12,15-16,23-24,27-28,43-44H,13-14,17-22H2,1-4H3,(H,45,49)(H,46,50)/t27-,28-/m0/s1 IRQARKBWVPVPOE-NSOVKSMOSA-N 479577 US10899735, No. 36 Programmed cell death 1 ligand 1/2 Human 4029 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479577&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995925 CCOc1nc(ccc1C1=NCCN1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NCCN2)c(OCC)n1 InChI=1S/C32H30Cl2N6O2/c1-3-41-31-23(29-35-15-16-36-29)11-13-25(39-31)21-9-5-7-19(27(21)33)20-8-6-10-22(28(20)34)26-14-12-24(30-37-17-18-38-30)32(40-26)42-4-2/h5-14H,3-4,15-18H2,1-2H3,(H,35,36)(H,37,38) CTAABOZZLQLDHD-UHFFFAOYSA-N 479578 US10899735, No. 37 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479578&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995926 CCOc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OCC)n1 InChI=1S/C40H42Cl2N6O4/c1-3-51-37-25(19-47-21-39(22-47)17-15-33(49)45-39)11-13-31(43-37)29-9-5-7-27(35(29)41)28-8-6-10-30(36(28)42)32-14-12-26(38(44-32)52-4-2)20-48-23-40(24-48)18-16-34(50)46-40/h5-14H,3-4,15-24H2,1-2H3,(H,45,49)(H,46,50) LLYYYWQGOSEWOO-UHFFFAOYSA-N 479579 US10899735, No. 38 Programmed cell death 1 ligand 1/2 Human 1060 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479579&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995927 CCOc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OCC)n1 InChI=1S/C38H42Cl2N6O4/c1-3-49-37-23(19-41-21-25-13-17-33(47)43-25)11-15-31(45-37)29-9-5-7-27(35(29)39)28-8-6-10-30(36(28)40)32-16-12-24(38(46-32)50-4-2)20-42-22-26-14-18-34(48)44-26/h5-12,15-16,25-26,41-42H,3-4,13-14,17-22H2,1-2H3,(H,43,47)(H,44,48)/t25-,26-/m0/s1 QWWDZESMFWIFIZ-UIOOFZCWSA-N 479580 US10899735, No. 39 Programmed cell death 1 ligand 1/2 Human 339 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479580&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995928 COc1nc(ccc1CNC1(C)CNC1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC2(C)CNC2)c(OC)n1 InChI=1S/C34H38Cl2N6O2/c1-33(17-37-18-33)39-15-21-11-13-27(41-31(21)43-3)25-9-5-7-23(29(25)35)24-8-6-10-26(30(24)36)28-14-12-22(32(42-28)44-4)16-40-34(2)19-38-20-34/h5-14,37-40H,15-20H2,1-4H3 HCNMIKASMVJGFL-UHFFFAOYSA-N 479581 US10899735, No. 40 Programmed cell death 1 ligand 1/2 Human 1156 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479581&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995929 Fc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(F)n1 InChI=1S/C36H32Cl2F2N6O2/c37-31-23(3-1-5-25(31)27-9-7-21(33(39)41-27)15-45-17-35(18-45)13-11-29(47)43-35)24-4-2-6-26(32(24)38)28-10-8-22(34(40)42-28)16-46-19-36(20-46)14-12-30(48)44-36/h1-10H,11-20H2,(H,43,47)(H,44,48) UIAPXMIGDHYZKN-UHFFFAOYSA-N 479582 US10899735, No. 41 Programmed cell death 1 ligand 1/2 Human 855 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479582&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995930 Fc1nc(ccc1C1=NCCN1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NCCN2)c(F)n1 InChI=1S/C28H20Cl2F2N6/c29-23-15(3-1-5-17(23)21-9-7-19(25(31)37-21)27-33-11-12-34-27)16-4-2-6-18(24(16)30)22-10-8-20(26(32)38-22)28-35-13-14-36-28/h1-10H,11-14H2,(H,33,34)(H,35,36) APHFLVCRCZSIKH-UHFFFAOYSA-N 479583 US10899735, No. 42 Programmed cell death 1 ligand 1/2 Human 278 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479583&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995931 CCOc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCO)c(F)n1 InChI=1S/C30H31Cl2FN4O3/c1-2-40-30-20(18-35-14-16-39)10-12-26(37-30)24-8-4-6-22(28(24)32)21-5-3-7-23(27(21)31)25-11-9-19(29(33)36-25)17-34-13-15-38/h3-12,34-35,38-39H,2,13-18H2,1H3 HQEWYTIEKLGOTQ-UHFFFAOYSA-N 479584 US10899735, No. 43 Programmed cell death 1 ligand 1/2 Human 343 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479584&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995932 Fc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(F)n1 InChI=1S/C34H32Cl2F2N6O2/c35-31-23(3-1-5-25(31)27-11-7-19(33(37)43-27)15-39-17-21-9-13-29(45)41-21)24-4-2-6-26(32(24)36)28-12-8-20(34(38)44-28)16-40-18-22-10-14-30(46)42-22/h1-8,11-12,21-22,39-40H,9-10,13-18H2,(H,41,45)(H,42,46)/t21-,22-/m0/s1 YNMVBNXUIKVIAV-VXKWHMMOSA-N 479585 US10899735, No. 44 Programmed cell death 1 ligand 1/2 Human 507 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479585&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995933 O[C@H](CNCc1ccc(nc1F)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H](O)CC(O)=O)c(F)n1)CC(O)=O InChI=1S/C32H30Cl2F2N4O6/c33-29-21(3-1-5-23(29)25-9-7-17(31(35)39-25)13-37-15-19(41)11-27(43)44)22-4-2-6-24(30(22)34)26-10-8-18(32(36)40-26)14-38-16-20(42)12-28(45)46/h1-10,19-20,37-38,41-42H,11-16H2,(H,43,44)(H,45,46)/t19-,20-/m0/s1 BKZDVHBGKZNICX-PMACEKPBSA-N 479586 US10899735, No. 45 Programmed cell death 1 ligand 1/2 Human 1981 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479586&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995934 COc1nc(ccc1CN[C@@](C)(CO)C(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN[C@@](C)(CO)C(O)=O)c(OC)n1 InChI=1S/C34H36Cl2N4O8/c1-33(17-41,31(43)44)37-15-19-11-13-25(39-29(19)47-3)23-9-5-7-21(27(23)35)22-8-6-10-24(28(22)36)26-14-12-20(30(40-26)48-4)16-38-34(2,18-42)32(45)46/h5-14,37-38,41-42H,15-18H2,1-4H3,(H,43,44)(H,45,46)/t33-,34-/m0/s1 UBUPCWVSCFUXNA-HEVIKAOCSA-N 479587 US10899735, No. 46 Programmed cell death 1 ligand 1/2 Human 388 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479587&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995935 COc1nc(ccc1CN[C@H]1CNC1=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN[C@H]2CNC2=O)c(OC)n1 InChI=1S/C32H30Cl2N6O4/c1-43-31-17(13-35-25-15-37-29(25)41)9-11-23(39-31)21-7-3-5-19(27(21)33)20-6-4-8-22(28(20)34)24-12-10-18(32(40-24)44-2)14-36-26-16-38-30(26)42/h3-12,25-26,35-36H,13-16H2,1-2H3,(H,37,41)(H,38,42)/t25-,26-/m0/s1 YVQAQZNWROMRFJ-UIOOFZCWSA-N 479588 US10899735, No. 47 Programmed cell death 1 ligand 1/2 Human 540 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479588&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995936 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN[C@@](C)(CO)C(O)=O)c(OC)n1 InChI=1S/C32H34Cl2N4O6/c1-32(18-40,31(41)42)36-17-20-11-13-26(38-30(20)44-3)24-9-5-7-22(28(24)34)21-6-4-8-23(27(21)33)25-12-10-19(16-35-14-15-39)29(37-25)43-2/h4-13,35-36,39-40H,14-18H2,1-3H3,(H,41,42)/t32-/m0/s1 UKBGYCKXCRPECC-YTTGMZPUSA-N 479589 US10899735, No. 48 Programmed cell death 1 ligand 1/2 Human 614 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479589&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995937 CCNCc1ccc(nc1OC)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCC)c(OC)n1 InChI=1S/C30H32Cl2N4O2/c1-5-33-17-19-13-15-25(35-29(19)37-3)23-11-7-9-21(27(23)31)22-10-8-12-24(28(22)32)26-16-14-20(18-34-6-2)30(36-26)38-4/h7-16,33-34H,5-6,17-18H2,1-4H3 OJFCZNLKTYEFQH-UHFFFAOYSA-N 479590 US10899735, No. 49 Programmed cell death 1 ligand 1/2 Human 408 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479590&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995938 CCNCc1ccc(nc1OC)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CN(CC)CC)c(OC)n1 InChI=1S/C34H42N4O2/c1-8-35-21-25-17-19-31(36-33(25)39-6)29-15-11-13-27(23(29)4)28-14-12-16-30(24(28)5)32-20-18-26(34(37-32)40-7)22-38(9-2)10-3/h11-20,35H,8-10,21-22H2,1-7H3 CMNGAYJQCQNPQH-UHFFFAOYSA-N 479591 US10899735, No. 50 Programmed cell death 1 ligand 1/2 Human 5558 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479591&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995939 CCNCc1ccc(nc1OC)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CNCC)c(OC)n1 InChI=1S/C32H38N4O2/c1-7-33-19-23-15-17-29(35-31(23)37-5)27-13-9-11-25(21(27)3)26-12-10-14-28(22(26)4)30-18-16-24(20-34-8-2)32(36-30)38-6/h9-18,33-34H,7-8,19-20H2,1-6H3 ARJCRPVWVACYAP-UHFFFAOYSA-N 479592 US10899735, No. 51 Programmed cell death 1 ligand 1/2 Human 577 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479592&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995940 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(NC(=O)C2CNC2)cc1 InChI=1S/C34H33Cl2N5O3/c1-44-34-21(16-38-19-24-13-15-30(42)39-24)10-14-29(41-34)28-7-3-6-27(32(28)36)26-5-2-4-25(31(26)35)20-8-11-23(12-9-20)40-33(43)22-17-37-18-22/h2-12,14,22,24,37-38H,13,15-19H2,1H3,(H,39,42)(H,40,43)/t24-/m0/s1 FDIXGCQEVSYIJF-DEOSSOPVSA-N 479593 US10899735, No. 52 Programmed cell death 1 ligand 1/2 Human 549 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479593&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995941 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(NC(=O)[C@@H]2CCN2)cc1 InChI=1S/C34H33Cl2N5O3/c1-44-34-21(18-37-19-23-13-15-30(42)39-23)10-14-28(41-34)27-7-3-6-26(32(27)36)25-5-2-4-24(31(25)35)20-8-11-22(12-9-20)40-33(43)29-16-17-38-29/h2-12,14,23,29,37-38H,13,15-19H2,1H3,(H,39,42)(H,40,43)/t23-,29-/m0/s1 OTIRVJXWGANMBK-IADCTJSHSA-N 479594 US10899735, No. 53 Programmed cell death 1 ligand 1/2 Human 270 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479594&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995942 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(NC(=O)[C@H]2CCN2)cc1 InChI=1S/C34H33Cl2N5O3/c1-44-34-21(18-37-19-23-13-15-30(42)39-23)10-14-28(41-34)27-7-3-6-26(32(27)36)25-5-2-4-24(31(25)35)20-8-11-22(12-9-20)40-33(43)29-16-17-38-29/h2-12,14,23,29,37-38H,13,15-19H2,1H3,(H,39,42)(H,40,43)/t23-,29+/m0/s1 OTIRVJXWGANMBK-MUAVYFROSA-N 479595 US10899735, No. 54 Programmed cell death 1 ligand 1/2 Human 1700 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479595&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995943 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(NC(=O)C2CCNCC2)cc1 InChI=1S/C36H37Cl2N5O3/c1-46-36-24(20-40-21-26-13-15-32(44)41-26)10-14-31(43-36)30-7-3-6-29(34(30)38)28-5-2-4-27(33(28)37)22-8-11-25(12-9-22)42-35(45)23-16-18-39-19-17-23/h2-12,14,23,26,39-40H,13,15-21H2,1H3,(H,41,44)(H,42,45)/t26-/m0/s1 XBSNZGVNEMYJMM-SANMLTNESA-N 479596 US10899735, No. 55 Programmed cell death 1 ligand 1/2 Human 1742 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479596&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995944 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(NC(=O)CCCN)cc1 InChI=1S/C34H35Cl2N5O3/c1-44-34-22(19-38-20-24-15-17-31(43)40-24)12-16-29(41-34)28-8-3-7-27(33(28)36)26-6-2-5-25(32(26)35)21-10-13-23(14-11-21)39-30(42)9-4-18-37/h2-3,5-8,10-14,16,24,38H,4,9,15,17-20,37H2,1H3,(H,39,42)(H,40,43)/t24-/m0/s1 UAADGASPTVLOON-DEOSSOPVSA-N 479597 US10899735, No. 56 Programmed cell death 1 ligand 1/2 Human 1108 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479597&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995945 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(N)cc1 InChI=1S/C30H28Cl2N4O2/c1-38-30-19(16-34-17-21-13-15-27(37)35-21)10-14-26(36-30)25-7-3-6-24(29(25)32)23-5-2-4-22(28(23)31)18-8-11-20(33)12-9-18/h2-12,14,21,34H,13,15-17,33H2,1H3,(H,35,37)/t21-/m0/s1 ZFKWCDAOXLMXKN-NRFANRHFSA-N 479598 US10899735, No. 57 Programmed cell death 1 ligand 1/2 Human 1675 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479598&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995946 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(NC(=O)CCN)cc1 InChI=1S/C33H33Cl2N5O3/c1-43-33-21(18-37-19-23-13-15-29(41)39-23)10-14-28(40-33)27-7-3-6-26(32(27)35)25-5-2-4-24(31(25)34)20-8-11-22(12-9-20)38-30(42)16-17-36/h2-12,14,23,37H,13,15-19,36H2,1H3,(H,38,42)(H,39,41)/t23-/m0/s1 CNUAVZRVDRAHAV-QHCPKHFHSA-N 479599 US10899735, No. 58 Programmed cell death 1 ligand 1/2 Human 2213 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479599&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995947 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(NC(=O)CN)cc1 InChI=1S/C32H31Cl2N5O3/c1-42-32-20(17-36-18-22-13-15-28(40)38-22)10-14-27(39-32)26-7-3-6-25(31(26)34)24-5-2-4-23(30(24)33)19-8-11-21(12-9-19)37-29(41)16-35/h2-12,14,22,36H,13,15-18,35H2,1H3,(H,37,41)(H,38,40)/t22-/m0/s1 LMXGDNJUYYIBLS-QFIPXVFZSA-N 479600 US10899735, No. 59 Programmed cell death 1 ligand 1/2 Human 2320 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479600&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995948 COc1nc(ccc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1Cl)-c1ccc(F)c(c1F)-c1ccc(CNC[C@@H](O)CC(O)=O)c(OC)n1 InChI=1S/C34H35ClF2N4O8/c1-48-33-18(14-38-16-20(42)12-28(44)45)6-10-26(40-33)24-5-3-4-22(31(24)35)23-8-9-25(36)30(32(23)37)27-11-7-19(34(41-27)49-2)15-39-17-21(43)13-29(46)47/h3-11,20-21,38-39,42-43H,12-17H2,1-2H3,(H,44,45)(H,46,47)/t20-,21-/m0/s1 MSOYMHFXTNNABS-SFTDATJTSA-N 479601 US10899735, No. 60 Programmed cell death 1 ligand 1/2 Human 604 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479601&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995949 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1ccc(F)c(c1F)-c1ccc(CNCCO)c(OC)n1 InChI=1S/C30H31ClF2N4O4/c1-40-29-18(16-34-12-14-38)6-10-24(36-29)22-5-3-4-20(27(22)31)21-8-9-23(32)26(28(21)33)25-11-7-19(17-35-13-15-39)30(37-25)41-2/h3-11,34-35,38-39H,12-17H2,1-2H3 BUXBQAGBVJOMLG-UHFFFAOYSA-N 479602 US10899735, No. 61 Programmed cell death 1 ligand 1/2 Human 1440 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479602&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995950 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1ccc(F)c(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H37Cl2FN6O4/c1-48-35-20(16-40-18-22-8-14-30(46)42-22)6-12-28(44-35)26-5-3-4-24(33(26)37)25-10-11-27(39)32(34(25)38)29-13-7-21(36(45-29)49-2)17-41-19-23-9-15-31(47)43-23/h3-7,10-13,22-23,40-41H,8-9,14-19H2,1-2H3,(H,42,46)(H,43,47)/t22-,23-/m0/s1 FPBQXANQKWEFDO-GOTSBHOMSA-N 479603 US10899735, No. 62 Programmed cell death 1 ligand 1/2 Human 719 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479603&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995951 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1ccc(F)c(c1F)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H37ClF2N6O4/c1-48-35-20(16-40-18-22-8-14-30(46)42-22)6-12-28(44-35)26-5-3-4-24(33(26)37)25-10-11-27(38)32(34(25)39)29-13-7-21(36(45-29)49-2)17-41-19-23-9-15-31(47)43-23/h3-7,10-13,22-23,40-41H,8-9,14-19H2,1-2H3,(H,42,46)(H,43,47)/t22-,23-/m0/s1 BOLGOKIESDVLSO-GOTSBHOMSA-N 479604 US10899735, No. 63 Programmed cell death 1 ligand 1/2 Human 919 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479604&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995952 CNCCNS(=O)(=O)c1ccc(cc1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C30H29Cl2N5O3S/c1-33-15-18-36-41(38,39)20-11-9-19(10-12-20)21-5-3-6-22(27(21)31)23-7-4-8-24(28(23)32)26-14-13-25(30(37-26)40-2)29-34-16-17-35-29/h3-14,33,36H,15-18H2,1-2H3,(H,34,35) YCJAPBCZUBJKSV-UHFFFAOYSA-N 479605 US10899735, No. 64 Programmed cell death 1 ligand 1/2 Human 407 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479605&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995953 CNCCNS(=O)(=O)c1ccc(cc1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C33H35Cl2N5O4S/c1-36-17-18-38-45(42,43)24-13-9-21(10-14-24)25-5-3-6-26(31(25)34)27-7-4-8-28(32(27)35)29-15-11-22(33(40-29)44-2)19-37-20-23-12-16-30(41)39-23/h3-11,13-15,23,36-38H,12,16-20H2,1-2H3,(H,39,41)/t23-/m0/s1 PZTJDCRXVSHNLX-QHCPKHFHSA-N 479606 US10899735, No. 65 Programmed cell death 1 ligand 1/2 Human 495 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479606&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995954 COc1nc(ccc1CNCCS(N)(=O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCS(N)(=O)=O)c(OC)n1 InChI=1S/C30H34Cl2N6O6S2/c1-43-29-19(17-35-13-15-45(33,39)40)9-11-25(37-29)23-7-3-5-21(27(23)31)22-6-4-8-24(28(22)32)26-12-10-20(30(38-26)44-2)18-36-14-16-46(34,41)42/h3-12,35-36H,13-18H2,1-2H3,(H2,33,39,40)(H2,34,41,42) DLJYJNBNRHIUCQ-UHFFFAOYSA-N 479607 US10899735, No. 66 Programmed cell death 1 ligand 1/2 Human 2299 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479607&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995955 COc1nc(ccc1CNCCS(C)(=O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCS(C)(=O)=O)c(OC)n1 InChI=1S/C32H36Cl2N4O6S2/c1-43-31-21(19-35-15-17-45(3,39)40)11-13-27(37-31)25-9-5-7-23(29(25)33)24-8-6-10-26(30(24)34)28-14-12-22(32(38-28)44-2)20-36-16-18-46(4,41)42/h5-14,35-36H,15-20H2,1-4H3 OZRYEBRROOKIRT-UHFFFAOYSA-N 479608 US10899735, No. 67 Programmed cell death 1 ligand 1/2 Human 919 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479608&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995956 COc1nc(ccc1CN1CC[C@@H](C1)C(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@@H](C2)C(O)=O)c(OC)n1 InChI=1S/C36H36Cl2N4O6/c1-47-33-21(17-41-15-13-23(19-41)35(43)44)9-11-29(39-33)27-7-3-5-25(31(27)37)26-6-4-8-28(32(26)38)30-12-10-22(34(40-30)48-2)18-42-16-14-24(20-42)36(45)46/h3-12,23-24H,13-20H2,1-2H3,(H,43,44)(H,45,46)/t23-,24-/m0/s1 OFHBDJBLETUPJQ-ZEQRLZLVSA-N 479609 US10899735, No. 68 Programmed cell death 1 ligand 1/2 Human 108 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479609&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995957 COc1nc(ccc1CN1CC[C@H](C1)C(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@H](C2)C(O)=O)c(OC)n1 InChI=1S/C36H36Cl2N4O6/c1-47-33-21(17-41-15-13-23(19-41)35(43)44)9-11-29(39-33)27-7-3-5-25(31(27)37)26-6-4-8-28(32(26)38)30-12-10-22(34(40-30)48-2)18-42-16-14-24(20-42)36(45)46/h3-12,23-24H,13-20H2,1-2H3,(H,43,44)(H,45,46)/t23-,24-/m1/s1 OFHBDJBLETUPJQ-DNQXCXABSA-N 479610 US10899735, No. 69 Programmed cell death 1 ligand 1/2 Human 137 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479610&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995958 COc1nc(ccc1CN1CCCC1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCCC2)c(OC)n1 InChI=1S/C34H36Cl2N4O2/c1-41-33-23(21-39-17-3-4-18-39)13-15-29(37-33)27-11-7-9-25(31(27)35)26-10-8-12-28(32(26)36)30-16-14-24(34(38-30)42-2)22-40-19-5-6-20-40/h7-16H,3-6,17-22H2,1-2H3 QQIPUTYOTPMHOF-UHFFFAOYSA-N 479611 US10899735, No. 70 Programmed cell death 1 ligand 1/2 Human 241 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479611&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995959 COc1nc(ccc1CN1CC2(C1)CN(C2)C(C)=O)-c1cccc(c1Br)-c1cccc(-c2ccc(CN3CC4(C3)CN(C4)C(C)=O)c(OC)n2)c1SC InChI=1S/C41H45BrN6O4S/c1-26(49)47-22-40(23-47)18-45(19-40)16-28-12-14-34(43-38(28)51-3)32-10-6-8-30(36(32)42)31-9-7-11-33(37(31)53-5)35-15-13-29(39(44-35)52-4)17-46-20-41(21-46)24-48(25-41)27(2)50/h6-15H,16-25H2,1-5H3 HGFVWZBHDZWNOY-UHFFFAOYSA-N 479612 US10899735, No. 71 Programmed cell death 1 ligand 1/2 Human 430 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479612&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995960 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Br)-c1cccc(c1SC)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C39H41BrN6O4S/c1-49-36-24(18-45-20-38(21-45)16-14-32(47)43-38)10-12-30(41-36)28-8-4-6-26(34(28)40)27-7-5-9-29(35(27)51-3)31-13-11-25(37(42-31)50-2)19-46-22-39(23-46)17-15-33(48)44-39/h4-13H,14-23H2,1-3H3,(H,43,47)(H,44,48) XNQUOQCFUABPAC-UHFFFAOYSA-N 479613 US10899735, No. 72 Programmed cell death 1 ligand 1/2 Human 150 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479613&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995961 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Br)-c1cccc(c1SC)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C37H41BrN6O4S/c1-47-36-22(18-39-20-24-12-16-32(45)41-24)10-14-30(43-36)28-8-4-6-26(34(28)38)27-7-5-9-29(35(27)49-3)31-15-11-23(37(44-31)48-2)19-40-21-25-13-17-33(46)42-25/h4-11,14-15,24-25,39-40H,12-13,16-21H2,1-3H3,(H,41,45)(H,42,46)/t24-,25-/m0/s1 VAVWLNOQNWONTK-DQEYMECFSA-N 479614 US10899735, No. 73 Programmed cell death 1 ligand 1/2 Human 1170 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479614&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995962 COc1nc(ccc1CN1CC2(C1)CN(C2)C(C)=O)-c1cccc(c1Cl)-c1cccc(-c2ccc(CN3CC4(C3)CN(C4)C(C)=O)c(OC)n2)c1SC InChI=1S/C41H45ClN6O4S/c1-26(49)47-22-40(23-47)18-45(19-40)16-28-12-14-34(43-38(28)51-3)32-10-6-8-30(36(32)42)31-9-7-11-33(37(31)53-5)35-15-13-29(39(44-35)52-4)17-46-20-41(21-46)24-48(25-41)27(2)50/h6-15H,16-25H2,1-5H3 CTVIVADPZSMHAR-UHFFFAOYSA-N 479615 US10899735, No. 74 Programmed cell death 1 ligand 1/2 Human 135 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479615&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995963 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1SC)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C39H41ClN6O4S/c1-49-36-24(18-45-20-38(21-45)16-14-32(47)43-38)10-12-30(41-36)28-8-4-6-26(34(28)40)27-7-5-9-29(35(27)51-3)31-13-11-25(37(42-31)50-2)19-46-22-39(23-46)17-15-33(48)44-39/h4-13H,14-23H2,1-3H3,(H,43,47)(H,44,48) SNDMXQNTLCXFRX-UHFFFAOYSA-N 479616 US10899735, No. 75 Programmed cell death 1 ligand 1/2 Human 289 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479616&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995964 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1SC)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C37H41ClN6O4S/c1-47-36-22(18-39-20-24-12-16-32(45)41-24)10-14-30(43-36)28-8-4-6-26(34(28)38)27-7-5-9-29(35(27)49-3)31-15-11-23(37(44-31)48-2)19-40-21-25-13-17-33(46)42-25/h4-11,14-15,24-25,39-40H,12-13,16-21H2,1-3H3,(H,41,45)(H,42,46)/t24-,25-/m0/s1 VMVLPCIBCSOMLG-DQEYMECFSA-N 479617 US10899735, No. 76 Programmed cell death 1 ligand 1/2 Human 127 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479617&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995965 COc1nc(ccc1CN1CC(O)C1)-c1cccc(c1Br)-c1ccnc(c1F)-c1ccc(CN2CC(O)C2)c(OC)n1 InChI=1S/C31H31BrFN5O4/c1-41-30-18(12-37-14-20(39)15-37)6-8-25(35-30)24-5-3-4-22(27(24)32)23-10-11-34-29(28(23)33)26-9-7-19(31(36-26)42-2)13-38-16-21(40)17-38/h3-11,20-21,39-40H,12-17H2,1-2H3 VZUQNYDQGMLAMG-UHFFFAOYSA-N 479618 US10899735, No. 77 Programmed cell death 1 ligand 1/2 Human 3169 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479618&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995966 COc1nc(ccc1CN1CC2(C1)CNC(=O)C2)-c1cccc(c1Br)-c1ccnc(c1F)-c1ccc(CN2CC3(C2)CNC(=O)C3)c(OC)n1 InChI=1S/C37H37BrFN7O4/c1-49-34-22(14-45-18-36(19-45)12-29(47)41-16-36)6-8-27(43-34)26-5-3-4-24(31(26)38)25-10-11-40-33(32(25)39)28-9-7-23(35(44-28)50-2)15-46-20-37(21-46)13-30(48)42-17-37/h3-11H,12-21H2,1-2H3,(H,41,47)(H,42,48) HNSOGXDGECKTCX-UHFFFAOYSA-N 479619 US10899735, No. 78 Programmed cell death 1 ligand 1/2 Human 8184 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479619&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995967 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Br)-c1ccnc(c1F)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C37H37BrFN7O4/c1-49-34-22(16-45-18-36(19-45)13-10-29(47)43-36)6-8-27(41-34)26-5-3-4-24(31(26)38)25-12-15-40-33(32(25)39)28-9-7-23(35(42-28)50-2)17-46-20-37(21-46)14-11-30(48)44-37/h3-9,12,15H,10-11,13-14,16-21H2,1-2H3,(H,43,47)(H,44,48) VVMUHTGCRIRNLU-UHFFFAOYSA-N 479620 US10899735, No. 79 Programmed cell death 1 ligand 1/2 Human 3262 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479620 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479620&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995968 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Br)-c1ccnc(c1F)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C35H37BrFN7O4/c1-47-34-20(16-38-18-22-8-12-29(45)41-22)6-10-27(43-34)26-5-3-4-24(31(26)36)25-14-15-40-33(32(25)37)28-11-7-21(35(44-28)48-2)17-39-19-23-9-13-30(46)42-23/h3-7,10-11,14-15,22-23,38-39H,8-9,12-13,16-19H2,1-2H3,(H,41,45)(H,42,46)/t22-,23-/m0/s1 ZQAWRUXADWECRW-GOTSBHOMSA-N 479621 US10899735, No. 80 Programmed cell death 1 ligand 1/2 Human 2162 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479621&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995969 COc1nc(ccc1CN1CC(F)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC(F)C2)c(OC)n1 InChI=1S/C32H30Cl2F2N4O2/c1-41-31-19(13-39-15-21(35)16-39)9-11-27(37-31)25-7-3-5-23(29(25)33)24-6-4-8-26(30(24)34)28-12-10-20(32(38-28)42-2)14-40-17-22(36)18-40/h3-12,21-22H,13-18H2,1-2H3 MNCHKFAMZMWNLJ-UHFFFAOYSA-N 479622 US10899735, No. 81 Programmed cell death 1 ligand 1/2 Human 8808 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479622&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995970 COc1nc(ccc1CN)-c1ccc(F)c(c1Cl)-c1cccc(-c2ccc(CN)c(OC)n2)c1C#N InChI=1S/C27H23ClFN5O2/c1-35-26-15(12-30)6-10-22(33-26)17-4-3-5-18(20(17)14-32)24-21(29)9-8-19(25(24)28)23-11-7-16(13-31)27(34-23)36-2/h3-11H,12-13,30-31H2,1-2H3 FGNFXBMUNFPNRT-UHFFFAOYSA-N 479623 US10899735, No. 82 Programmed cell death 1 ligand 1/2 Human 2152 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479623&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995971 COc1nc(ccc1CNCCO)-c1ccc(F)c(c1Cl)-c1cccc(-c2ccc(CNCCO)c(OC)n2)c1C#N InChI=1S/C31H31ClFN5O4/c1-41-30-19(17-35-12-14-39)6-10-26(37-30)21-4-3-5-22(24(21)16-34)28-25(33)9-8-23(29(28)32)27-11-7-20(18-36-13-15-40)31(38-27)42-2/h3-11,35-36,39-40H,12-15,17-18H2,1-2H3 VHFAUKQADHTWOK-UHFFFAOYSA-N 479624 US10899735, No. 83 Programmed cell death 1 ligand 1/2 Human 1218 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479624&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995972 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1ccc(F)c(c1Cl)-c1cccc(-c2ccc(CNC[C@@H]3CCC(=O)N3)c(OC)n2)c1C#N InChI=1S/C37H37ClFN7O4/c1-49-36-21(17-41-19-23-8-14-32(47)43-23)6-12-30(45-36)25-4-3-5-26(28(25)16-40)34-29(39)11-10-27(35(34)38)31-13-7-22(37(46-31)50-2)18-42-20-24-9-15-33(48)44-24/h3-7,10-13,23-24,41-42H,8-9,14-15,17-20H2,1-2H3,(H,43,47)(H,44,48)/t23-,24-/m0/s1 NHZRJAMHUSGJFS-ZEQRLZLVSA-N 479625 US10899735, No. 84 Programmed cell death 1 ligand 1/2 Human 227 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479625&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995973 COc1nc(ccc1C1=NCCN1)-c1ccc(F)c(c1Cl)-c1cccc(-c2ccc(C3=NCCN3)c(OC)n2)c1C#N InChI=1S/C31H25ClFN7O2/c1-41-30-20(28-35-12-13-36-28)7-10-24(39-30)17-4-3-5-18(22(17)16-34)26-23(33)9-6-19(27(26)32)25-11-8-21(31(40-25)42-2)29-37-14-15-38-29/h3-11H,12-15H2,1-2H3,(H,35,36)(H,37,38) QBMIBRCFSIGVHU-UHFFFAOYSA-N 479626 US10899735, No. 85 Programmed cell death 1 ligand 1/2 Human 156 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479626&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995974 COc1nc(ccc1CN)-c1cccc(c1F)-c1c(F)ccc(c1Cl)-c1ccc(CN)c(OC)n1 InChI=1S/C26H23ClF2N4O2/c1-34-25-14(12-30)6-10-20(32-25)16-8-9-19(28)22(23(16)27)18-5-3-4-17(24(18)29)21-11-7-15(13-31)26(33-21)35-2/h3-11H,12-13,30-31H2,1-2H3 HJVBDDSYWMJEJV-UHFFFAOYSA-N 479627 US10899735, No. 86 Programmed cell death 1 ligand 1/2 Human 1364 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479627&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995975 COc1nc(ccc1C1=NCCN1)-c1cccc(c1F)-c1c(F)ccc(c1Cl)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C30H25ClF2N6O2/c1-40-29-19(27-34-12-13-35-27)7-10-22(38-29)16-6-9-21(32)24(25(16)31)18-5-3-4-17(26(18)33)23-11-8-20(30(39-23)41-2)28-36-14-15-37-28/h3-11H,12-15H2,1-2H3,(H,34,35)(H,36,37) BTPCELFYUQPYQP-UHFFFAOYSA-N 479628 US10899735, No. 87 Programmed cell death 1 ligand 1/2 Human 192 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479628&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995976 COc1nc(ccc1CN)-c1ccc(F)c(c1Cl)-c1c(F)ccc(c1Cl)-c1ccc(CN)c(OC)n1 InChI=1S/C26H22Cl2F2N4O2/c1-35-25-13(11-31)3-9-19(33-25)15-5-7-17(29)21(23(15)27)22-18(30)8-6-16(24(22)28)20-10-4-14(12-32)26(34-20)36-2/h3-10H,11-12,31-32H2,1-2H3 WQKWTQZRQKRURW-UHFFFAOYSA-N 479629 US10899735, No. 88 Programmed cell death 1 ligand 1/2 Human 1485 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479629&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995977 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1ccc(F)c(c1Cl)-c1c(F)ccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C38H36Cl2F2N6O4/c1-51-35-21(15-47-17-37(18-47)13-11-29(49)45-37)3-9-27(43-35)23-5-7-25(41)31(33(23)39)32-26(42)8-6-24(34(32)40)28-10-4-22(36(44-28)52-2)16-48-19-38(20-48)14-12-30(50)46-38/h3-10H,11-20H2,1-2H3,(H,45,49)(H,46,50) RAUZXBRSHBKKLL-UHFFFAOYSA-N 479630 US10899735, No. 89 Programmed cell death 1 ligand 1/2 Human 2342 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479630&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995978 COc1nc(ccc1C1=NCCN1)-c1ccc(F)c(c1Cl)-c1c(F)ccc(c1Cl)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C30H24Cl2F2N6O2/c1-41-29-17(27-35-11-12-36-27)5-9-21(39-29)15-3-7-19(33)23(25(15)31)24-20(34)8-4-16(26(24)32)22-10-6-18(30(40-22)42-2)28-37-13-14-38-28/h3-10H,11-14H2,1-2H3,(H,35,36)(H,37,38) CAFRXZJYNDZXAS-UHFFFAOYSA-N 479631 US10899735, No. 90 Programmed cell death 1 ligand 1/2 Human 614 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479631&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995979 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1ccc(F)c(c1Cl)-c1c(F)ccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H36Cl2F2N6O4/c1-49-35-19(15-41-17-21-5-13-29(47)43-21)3-11-27(45-35)23-7-9-25(39)31(33(23)37)32-26(40)10-8-24(34(32)38)28-12-4-20(36(46-28)50-2)16-42-18-22-6-14-30(48)44-22/h3-4,7-12,21-22,41-42H,5-6,13-18H2,1-2H3,(H,43,47)(H,44,48)/t21-,22-/m0/s1 VXZITRVWOSSWLX-VXKWHMMOSA-N 479632 US10899735, No. 91 Programmed cell death 1 ligand 1/2 Human 2959 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479632&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995980 COc1nc(ccc1CNCCO)-c1ccc(F)c(c1Cl)-c1c(F)ccc(c1Cl)-c1ccc(CNCCO)c(OC)n1 InChI=1S/C30H30Cl2F2N4O4/c1-41-29-17(15-35-11-13-39)3-9-23(37-29)19-5-7-21(33)25(27(19)31)26-22(34)8-6-20(28(26)32)24-10-4-18(16-36-12-14-40)30(38-24)42-2/h3-10,35-36,39-40H,11-16H2,1-2H3 PISQQPUDFQKLIY-UHFFFAOYSA-N 479633 US10899735, No. 92 Programmed cell death 1 ligand 1/2 Human 4488 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479633 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479633&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995981 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1c(F)ccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C38H37Cl2FN6O4/c1-50-35-22(16-46-18-37(19-46)14-12-30(48)44-37)6-10-28(42-35)24-4-3-5-26(33(24)39)32-27(41)9-8-25(34(32)40)29-11-7-23(36(43-29)51-2)17-47-20-38(21-47)15-13-31(49)45-38/h3-11H,12-21H2,1-2H3,(H,44,48)(H,45,49) ISVGKHCGAKVLKB-UHFFFAOYSA-N 479634 US10899735, No. 93 Programmed cell death 1 ligand 1/2 Human 592 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479634&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995982 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1c(F)ccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H37Cl2FN6O4/c1-48-35-20(16-40-18-22-8-14-30(46)42-22)6-12-28(44-35)24-4-3-5-26(33(24)37)32-27(39)11-10-25(34(32)38)29-13-7-21(36(45-29)49-2)17-41-19-23-9-15-31(47)43-23/h3-7,10-13,22-23,40-41H,8-9,14-19H2,1-2H3,(H,42,46)(H,43,47)/t22-,23-/m0/s1 OPSIEHLKWWJTRP-GOTSBHOMSA-N 479635 US10899735, No. 94 Programmed cell death 1 ligand 1/2 Human 862 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479635&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995983 COc1nc(ccc1C1=NCCN1)-c1cccc(c1Cl)-c1c(F)ccc(c1Cl)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C30H25Cl2FN6O2/c1-40-29-19(27-34-12-13-35-27)7-10-22(38-29)16-4-3-5-18(25(16)31)24-21(33)9-6-17(26(24)32)23-11-8-20(30(39-23)41-2)28-36-14-15-37-28/h3-11H,12-15H2,1-2H3,(H,34,35)(H,36,37) PLJFNDBKLUQCLA-UHFFFAOYSA-N 479636 US10899735, No. 95 Programmed cell death 1 ligand 1/2 Human 94.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479636 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479636&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995984 COc1nc(ccc1CNCCNC(N)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCNC(N)=O)c(OC)n1 InChI=1S/C32H36Cl2N8O4/c1-45-29-19(17-37-13-15-39-31(35)43)9-11-25(41-29)23-7-3-5-21(27(23)33)22-6-4-8-24(28(22)34)26-12-10-20(30(42-26)46-2)18-38-14-16-40-32(36)44/h3-12,37-38H,13-18H2,1-2H3,(H3,35,39,43)(H3,36,40,44) AIWKYMDQTKNNOX-UHFFFAOYSA-N 479637 US10899735, No. 96 Programmed cell death 1 ligand 1/2 Human 593 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479637&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995985 COc1nc(c(Cl)cc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1nc(OC)c(CNC[C@@H](O)CC(O)=O)cc1Cl InChI=1S/C34H34Cl4N4O8/c1-49-33-17(13-39-15-19(43)11-27(45)46)9-25(35)31(41-33)23-7-3-5-21(29(23)37)22-6-4-8-24(30(22)38)32-26(36)10-18(34(42-32)50-2)14-40-16-20(44)12-28(47)48/h3-10,19-20,39-40,43-44H,11-16H2,1-2H3,(H,45,46)(H,47,48)/t19-,20-/m0/s1 QJRGYCFATXJDKB-PMACEKPBSA-N 479638 US10899735, No. 97 Programmed cell death 1 ligand 1/2 Human 9824 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479638&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995986 COc1nc(c(Cl)cc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1nc(OC)c(CNC[C@@H]2CCC(=O)N2)cc1Cl InChI=1S/C36H36Cl4N6O4/c1-49-35-19(15-41-17-21-9-11-29(47)43-21)13-27(37)33(45-35)25-7-3-5-23(31(25)39)24-6-4-8-26(32(24)40)34-28(38)14-20(36(46-34)50-2)16-42-18-22-10-12-30(48)44-22/h3-8,13-14,21-22,41-42H,9-12,15-18H2,1-2H3,(H,43,47)(H,44,48)/t21-,22-/m0/s1 VAXSAQSMBKUGBM-VXKWHMMOSA-N 479639 US10899735, No. 98 Programmed cell death 1 ligand 1/2 Human 9573 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479639&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995987 COc1nc(ccc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1F)-c1cccc(c1Br)-c1ccc(CNC[C@@H](O)CC(O)=O)c(OC)n1 InChI=1S/C34H36BrFN4O8/c1-47-33-19(15-37-17-21(41)13-29(43)44)9-11-27(39-33)25-7-3-5-23(31(25)35)24-6-4-8-26(32(24)36)28-12-10-20(34(40-28)48-2)16-38-18-22(42)14-30(45)46/h3-12,21-22,37-38,41-42H,13-18H2,1-2H3,(H,43,44)(H,45,46)/t21-,22-/m0/s1 KQEBELBPLFBHNU-VXKWHMMOSA-N 479640 US10899735, No. 99 Programmed cell death 1 ligand 1/2 Human 179 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479640 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479640&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995988 COc1nc(ccc1CNC[C@H]1CCC(=O)N1)-c1cccc(c1F)-c1cccc(c1Br)-c1ccc(CNC[C@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38BrFN6O4/c1-47-35-21(17-39-19-23-11-15-31(45)41-23)9-13-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-20-24-12-16-32(46)42-24/h3-10,13-14,23-24,39-40H,11-12,15-20H2,1-2H3,(H,41,45)(H,42,46)/t23-,24-/m1/s1 ONIJWVUKLLFEHQ-DNQXCXABSA-N 479641 US10899735, No. 100 Programmed cell death 1 ligand 1/2 Human 266 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479641&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995989 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1F)-c1cccc(c1Br)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38BrFN6O4/c1-47-35-21(17-39-19-23-11-15-31(45)41-23)9-13-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-20-24-12-16-32(46)42-24/h3-10,13-14,23-24,39-40H,11-12,15-20H2,1-2H3,(H,41,45)(H,42,46)/t23-,24-/m0/s1 ONIJWVUKLLFEHQ-ZEQRLZLVSA-N 479642 US10899735, No. 101 Programmed cell death 1 ligand 1/2 Human 326 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479642&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995990 COc1nc(ccc1CNCCO)-c1cccc(c1F)-c1cccc(c1Br)-c1ccc(CNCCO)c(OC)n1 InChI=1S/C30H32BrFN4O4/c1-39-29-19(17-33-13-15-37)9-11-25(35-29)23-7-3-5-21(27(23)31)22-6-4-8-24(28(22)32)26-12-10-20(18-34-14-16-38)30(36-26)40-2/h3-12,33-34,37-38H,13-18H2,1-2H3 AFRVMZDARXKSBC-UHFFFAOYSA-N 479643 US10899735, No. 102 Programmed cell death 1 ligand 1/2 Human 1006 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479643&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995991 COc1nc(ccc1C1=NCCN1)-c1cccc(c1F)-c1cccc(c1Br)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C30H26BrFN6O2/c1-39-29-21(27-33-13-14-34-27)9-11-23(37-29)19-7-3-5-17(25(19)31)18-6-4-8-20(26(18)32)24-12-10-22(30(38-24)40-2)28-35-15-16-36-28/h3-12H,13-16H2,1-2H3,(H,33,34)(H,35,36) OURXBZGKLZJEOT-UHFFFAOYSA-N 479644 US10899735, No. 103 Programmed cell death 1 ligand 1/2 Human 431 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479644&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995992 COc1nc(ccc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1Cl)-c1cccc(c1Br)-c1ccc(CNC[C@@H](O)CC(O)=O)c(OC)n1 InChI=1S/C34H36BrClN4O8/c1-47-33-19(15-37-17-21(41)13-29(43)44)9-11-27(39-33)25-7-3-5-23(31(25)35)24-6-4-8-26(32(24)36)28-12-10-20(34(40-28)48-2)16-38-18-22(42)14-30(45)46/h3-12,21-22,37-38,41-42H,13-18H2,1-2H3,(H,43,44)(H,45,46)/t21-,22-/m0/s1 CFPMBFWTRFMXTO-VXKWHMMOSA-N 479645 US10899735, No. 104 Programmed cell death 1 ligand 1/2 Human 90.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479645 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479645&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995993 COc1nc(ccc1CNC[C@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Br)-c1ccc(CNC[C@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38BrClN6O4/c1-47-35-21(17-39-19-23-11-15-31(45)41-23)9-13-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-20-24-12-16-32(46)42-24/h3-10,13-14,23-24,39-40H,11-12,15-20H2,1-2H3,(H,41,45)(H,42,46)/t23-,24-/m1/s1 NPBLCLDYNBQVEC-DNQXCXABSA-N 479646 US10899735, No. 105 Programmed cell death 1 ligand 1/2 Human 107 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479646&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995994 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Br)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38BrClN6O4/c1-47-35-21(17-39-19-23-11-15-31(45)41-23)9-13-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-20-24-12-16-32(46)42-24/h3-10,13-14,23-24,39-40H,11-12,15-20H2,1-2H3,(H,41,45)(H,42,46)/t23-,24-/m0/s1 NPBLCLDYNBQVEC-ZEQRLZLVSA-N 479647 US10899735, No. 106 Programmed cell death 1 ligand 1/2 Human 79.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479647&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995995 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Br)-c1ccc(CNCCO)c(OC)n1 InChI=1S/C30H32BrClN4O4/c1-39-29-19(17-33-13-15-37)9-11-25(35-29)23-7-3-5-21(27(23)31)22-6-4-8-24(28(22)32)26-12-10-20(18-34-14-16-38)30(36-26)40-2/h3-12,33-34,37-38H,13-18H2,1-2H3 YDBRBJICYCMESF-UHFFFAOYSA-N 479648 US10899735, No. 107 Programmed cell death 1 ligand 1/2 Human 197 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479648 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479648&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995996 COc1nc(ccc1C1=NCCN1)-c1cccc(c1Cl)-c1cccc(c1Br)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C30H26BrClN6O2/c1-39-29-21(27-33-13-14-34-27)9-11-23(37-29)19-7-3-5-17(25(19)31)18-6-4-8-20(26(18)32)24-12-10-22(30(38-24)40-2)28-35-15-16-36-28/h3-12H,13-16H2,1-2H3,(H,33,34)(H,35,36) SANFISVEWAJJPD-UHFFFAOYSA-N 479649 US10899735, No. 108 Programmed cell death 1 ligand 1/2 Human 201 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479649&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995997 COc1nc(ccc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1Br)-c1cccc(c1Br)-c1ccc(CNC[C@@H](O)CC(O)=O)c(OC)n1 InChI=1S/C34H36Br2N4O8/c1-47-33-19(15-37-17-21(41)13-29(43)44)9-11-27(39-33)25-7-3-5-23(31(25)35)24-6-4-8-26(32(24)36)28-12-10-20(34(40-28)48-2)16-38-18-22(42)14-30(45)46/h3-12,21-22,37-38,41-42H,13-18H2,1-2H3,(H,43,44)(H,45,46)/t21-,22-/m0/s1 KCHSURSMFRPRJC-VXKWHMMOSA-N 479650 US10899735, No. 109 Programmed cell death 1 ligand 1/2 Human 196 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479650&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995998 COc1nc(ccc1CNC[C@H]1CCC(=O)N1)-c1cccc(c1Br)-c1cccc(c1Br)-c1ccc(CNC[C@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38Br2N6O4/c1-47-35-21(17-39-19-23-11-15-31(45)41-23)9-13-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-20-24-12-16-32(46)42-24/h3-10,13-14,23-24,39-40H,11-12,15-20H2,1-2H3,(H,41,45)(H,42,46)/t23-,24-/m1/s1 ODKAUONYOBNSDY-DNQXCXABSA-N 479651 US10899735, No. 110 Programmed cell death 1 ligand 1/2 Human 328 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479651&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 995999 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Br)-c1cccc(c1Br)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38Br2N6O4/c1-47-35-21(17-39-19-23-11-15-31(45)41-23)9-13-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-20-24-12-16-32(46)42-24/h3-10,13-14,23-24,39-40H,11-12,15-20H2,1-2H3,(H,41,45)(H,42,46)/t23-,24-/m0/s1 ODKAUONYOBNSDY-ZEQRLZLVSA-N 479652 US10899735, No. 111 Programmed cell death 1 ligand 1/2 Human 220 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479652&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996000 COc1nc(ccc1CNCCO)-c1cccc(c1Br)-c1cccc(c1Br)-c1ccc(CNCCO)c(OC)n1 InChI=1S/C30H32Br2N4O4/c1-39-29-19(17-33-13-15-37)9-11-25(35-29)23-7-3-5-21(27(23)31)22-6-4-8-24(28(22)32)26-12-10-20(18-34-14-16-38)30(36-26)40-2/h3-12,33-34,37-38H,13-18H2,1-2H3 ILQHLODDZWTGPF-UHFFFAOYSA-N 479653 US10899735, No. 112 Programmed cell death 1 ligand 1/2 Human 134 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479653 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479653&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996001 COc1nc(ccc1C1=NCCN1)-c1cccc(c1Br)-c1cccc(c1Br)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C30H26Br2N6O2/c1-39-29-21(27-33-13-14-34-27)9-11-23(37-29)19-7-3-5-17(25(19)31)18-6-4-8-20(26(18)32)24-12-10-22(30(38-24)40-2)28-35-15-16-36-28/h3-12H,13-16H2,1-2H3,(H,33,34)(H,35,36) IUDJHDLROFGLGI-UHFFFAOYSA-N 479654 US10899735, No. 113 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479654&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996002 COc1cc(ccc1OCCN[C@@](C)(CO)C(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C38H40Cl2N4O7/c1-37(22-45,36(47)48)41-16-17-51-30-13-11-23(18-31(30)49-2)25-6-4-7-26(33(25)39)27-8-5-9-28(34(27)40)29-12-10-24(35(42-29)50-3)19-44-20-38(21-44)15-14-32(46)43-38/h4-13,18,41,45H,14-17,19-22H2,1-3H3,(H,43,46)(H,47,48)/t37-/m0/s1 IGHGEXMZNFWXLE-QNGWXLTQSA-N 479655 US10899735, No. 114 Programmed cell death 1 ligand 1/2 Human 88.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479655&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996003 COc1cc(ccc1OCCN1C[C@@H](O)C[C@H]1C(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C39H40Cl2N4O7/c1-50-33-17-23(10-12-32(33)52-16-15-45-20-25(46)18-31(45)38(48)49)26-5-3-6-27(35(26)40)28-7-4-8-29(36(28)41)30-11-9-24(37(42-30)51-2)19-44-21-39(22-44)14-13-34(47)43-39/h3-12,17,25,31,46H,13-16,18-22H2,1-2H3,(H,43,47)(H,48,49)/t25-,31-/m0/s1 DHPKDYZXSGOSQZ-FKAPRUDGSA-N 479656 US10899735, No. 115 Programmed cell death 1 ligand 1/2 Human 84.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479656&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996004 COc1cc(ccc1OCCNC[C@@H](O)CC(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C38H40Cl2N4O7/c1-49-32-17-23(10-12-31(32)51-16-15-41-19-25(45)18-34(47)48)26-5-3-6-27(35(26)39)28-7-4-8-29(36(28)40)30-11-9-24(37(42-30)50-2)20-44-21-38(22-44)14-13-33(46)43-38/h3-12,17,25,41,45H,13-16,18-22H2,1-2H3,(H,43,46)(H,47,48)/t25-/m0/s1 GRFPUMFIILFFHZ-VWLOTQADSA-N 479657 US10899735, No. 116 Programmed cell death 1 ligand 1/2 Human 67.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479657&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996005 COc1cc(ccc1OCCN1CC[C@@H](C1)C(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C39H40Cl2N4O6/c1-49-33-19-24(10-12-32(33)51-18-17-44-16-14-26(21-44)38(47)48)27-5-3-6-28(35(27)40)29-7-4-8-30(36(29)41)31-11-9-25(37(42-31)50-2)20-45-22-39(23-45)15-13-34(46)43-39/h3-12,19,26H,13-18,20-23H2,1-2H3,(H,43,46)(H,47,48)/t26-/m0/s1 NPQJZOGHINQOBL-SANMLTNESA-N 479658 US10899735, No. 117 Programmed cell death 1 ligand 1/2 Human 70.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479658&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996006 COc1cc(ccc1OCCNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C39H41Cl2N5O5/c1-49-33-19-24(10-13-32(33)51-18-17-42-20-26-11-14-34(47)43-26)27-5-3-6-28(36(27)40)29-7-4-8-30(37(29)41)31-12-9-25(38(44-31)50-2)21-46-22-39(23-46)16-15-35(48)45-39/h3-10,12-13,19,26,42H,11,14-18,20-23H2,1-2H3,(H,43,47)(H,45,48)/t26-/m0/s1 VYOCLFSKEDPHGI-SANMLTNESA-N 479659 US10899735, No. 118 Programmed cell death 1 ligand 1/2 Human 439 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479659&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996007 COc1cc(ccc1OCCN1CC(O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C37H38Cl2N4O5/c1-46-32-17-23(10-12-31(32)48-16-15-42-19-25(44)20-42)26-5-3-6-27(34(26)38)28-7-4-8-29(35(28)39)30-11-9-24(36(40-30)47-2)18-43-21-37(22-43)14-13-33(45)41-37/h3-12,17,25,44H,13-16,18-22H2,1-2H3,(H,41,45) WHOGXSJGHSGDTG-UHFFFAOYSA-N 479660 US10899735, No. 119 Programmed cell death 1 ligand 1/2 Human 567 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479660&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996008 COc1cc(ccc1OCCN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C40H41Cl2N5O5/c1-50-33-19-25(10-12-32(33)52-18-17-46-21-39(22-46)15-13-34(48)44-39)27-5-3-6-28(36(27)41)29-7-4-8-30(37(29)42)31-11-9-26(38(43-31)51-2)20-47-23-40(24-47)16-14-35(49)45-40/h3-12,19H,13-18,20-24H2,1-2H3,(H,44,48)(H,45,49) VRMOKRSWVXYERY-UHFFFAOYSA-N 479661 US10899735, No. 120 Programmed cell death 1 ligand 1/2 Human 160 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479661&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996009 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(OCCN2C(=N)NC(C)(C)C2=O)cc1 InChI=1S/C38H38Cl2N6O4/c1-37(2)35(48)46(36(41)44-37)18-19-50-25-13-10-23(11-14-25)26-6-4-7-27(32(26)39)28-8-5-9-29(33(28)40)30-15-12-24(34(42-30)49-3)20-45-21-38(22-45)17-16-31(47)43-38/h4-15H,16-22H2,1-3H3,(H2,41,44)(H,43,47) FVQOUWLRWPNIIH-UHFFFAOYSA-N 479662 US10899735, No. 121 Programmed cell death 1 ligand 1/2 Human 4989 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479662&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996010 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(cc1)N1C(=N)NC(C)(C)C1=O InChI=1S/C36H34Cl2N6O3/c1-35(2)33(46)44(34(39)42-35)23-13-10-21(11-14-23)24-6-4-7-25(30(24)37)26-8-5-9-27(31(26)38)28-15-12-22(32(40-28)47-3)18-43-19-36(20-43)17-16-29(45)41-36/h4-15H,16-20H2,1-3H3,(H2,39,42)(H,41,45) HUMFSRYITLSNOX-UHFFFAOYSA-N 479663 US10899735, No. 122 Programmed cell death 1 ligand 1/2 Human 2245 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479663&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996011 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2C(=N)NC(C)(C)C2=O)cc1 InChI=1S/C37H36Cl2N6O3/c1-36(2)34(47)45(35(40)43-36)18-22-10-12-23(13-11-22)25-6-4-7-26(31(25)38)27-8-5-9-28(32(27)39)29-15-14-24(33(41-29)48-3)19-44-20-37(21-44)17-16-30(46)42-37/h4-15H,16-21H2,1-3H3,(H2,40,43)(H,42,46) VHNRTBSIYGGJLA-UHFFFAOYSA-N 479664 US10899735, No. 123 Programmed cell death 1 ligand 1/2 Human 7514 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479664&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996012 Clc1c(cccc1-c1cccc(c1Cl)-c1ccc(cn1)C1=NCCN1)-c1ccc(cn1)C1=NCCN1 InChI=1S/C28H22Cl2N6/c29-25-19(3-1-5-21(25)23-9-7-17(15-35-23)27-31-11-12-32-27)20-4-2-6-22(26(20)30)24-10-8-18(16-36-24)28-33-13-14-34-28/h1-10,15-16H,11-14H2,(H,31,32)(H,33,34) FGEDYEUUQJEFPN-UHFFFAOYSA-N 479665 US10899735, No. 124 Programmed cell death 1 ligand 1/2 Human 839 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479665&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996013 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@@H](C2)C(O)=O)c(OC)n1 InChI=1S/C36H37Cl2N5O5/c1-47-34-21(17-39-18-24-11-14-31(44)40-24)9-12-29(41-34)27-7-3-5-25(32(27)37)26-6-4-8-28(33(26)38)30-13-10-22(35(42-30)48-2)19-43-16-15-23(20-43)36(45)46/h3-10,12-13,23-24,39H,11,14-20H2,1-2H3,(H,40,44)(H,45,46)/t23-,24-/m0/s1 XTXQIFFYIOQXOP-ZEQRLZLVSA-N 479666 US10899735, No. 125 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479666&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996014 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@H](C2)C(O)=O)c(OC)n1 InChI=1S/C36H37Cl2N5O5/c1-47-34-21(17-39-18-24-11-14-31(44)40-24)9-12-29(41-34)27-7-3-5-25(32(27)37)26-6-4-8-28(33(26)38)30-13-10-22(35(42-30)48-2)19-43-16-15-23(20-43)36(45)46/h3-10,12-13,23-24,39H,11,14-20H2,1-2H3,(H,40,44)(H,45,46)/t23-,24+/m1/s1 XTXQIFFYIOQXOP-RPWUZVMVSA-N 479667 US10899735, No. 126 Programmed cell death 1 ligand 1/2 Human 92.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479667&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996015 COc1nc(ccc1CNCCC(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C34H35Cl2N5O5/c1-45-33-20(17-37-16-15-30(43)44)9-12-27(40-33)25-7-3-5-23(31(25)35)24-6-4-8-26(32(24)36)28-13-10-21(34(41-28)46-2)18-38-19-22-11-14-29(42)39-22/h3-10,12-13,22,37-38H,11,14-19H2,1-2H3,(H,39,42)(H,43,44)/t22-/m0/s1 UEICYSQRGYBSFJ-QFIPXVFZSA-N 479668 US10899735, No. 127 Programmed cell death 1 ligand 1/2 Human 87.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479668&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996016 COc1nc(ccc1[C@@H](C)NC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H](C)NC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-21(41-19-23-11-17-33(47)43-23)25-13-15-31(45-37(25)49-3)29-9-5-7-27(35(29)39)28-8-6-10-30(36(28)40)32-16-14-26(38(46-32)50-4)22(2)42-20-24-12-18-34(48)44-24/h5-10,13-16,21-24,41-42H,11-12,17-20H2,1-4H3,(H,43,47)(H,44,48)/t21-,22-,23+,24+/m1/s1 UZLWRPRQTXDWMQ-LWSSLDFYSA-N 479669 US10899735, No. 128 Programmed cell death 1 ligand 1/2 Human 4211 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479669&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996017 COc1nc(ccc1[C@H](C)NC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)NC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-21(41-19-23-11-17-33(47)43-23)25-13-15-31(45-37(25)49-3)29-9-5-7-27(35(29)39)28-8-6-10-30(36(28)40)32-16-14-26(38(46-32)50-4)22(2)42-20-24-12-18-34(48)44-24/h5-10,13-16,21-24,41-42H,11-12,17-20H2,1-4H3,(H,43,47)(H,44,48)/t21-,22-,23-,24-/m0/s1 UZLWRPRQTXDWMQ-ZJZGAYNASA-N 479670 US10899735, No. 129 Programmed cell death 1 ligand 1/2 Human 1456 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479670&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996018 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H](C)NC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C37H40Cl2N6O4/c1-21(41-20-24-12-17-33(47)43-24)25-13-15-31(45-37(25)49-3)29-9-5-7-27(35(29)39)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-19-23-11-16-32(46)42-23/h4-10,13-15,21,23-24,40-41H,11-12,16-20H2,1-3H3,(H,42,46)(H,43,47)/t21-,23+,24+/m1/s1 FSVKLBFBAWSILR-NHTMILBNSA-N 479671 US10899735, No. 130 Programmed cell death 1 ligand 1/2 Human 277 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479671&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996019 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)NC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C37H40Cl2N6O4/c1-21(41-20-24-12-17-33(47)43-24)25-13-15-31(45-37(25)49-3)29-9-5-7-27(35(29)39)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-19-23-11-16-32(46)42-23/h4-10,13-15,21,23-24,40-41H,11-12,16-20H2,1-3H3,(H,42,46)(H,43,47)/t21-,23-,24-/m0/s1 FSVKLBFBAWSILR-XWGVYQGASA-N 479672 US10899735, No. 131 Programmed cell death 1 ligand 1/2 Human 489 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479672&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996020 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H39ClN6O4/c1-46-35-24(18-38-20-26-11-15-32(44)40-26)9-13-30(42-35)23-6-3-5-22(17-23)28-7-4-8-29(34(28)37)31-14-10-25(36(43-31)47-2)19-39-21-27-12-16-33(45)41-27/h3-10,13-14,17,26-27,38-39H,11-12,15-16,18-21H2,1-2H3,(H,40,44)(H,41,45)/t26-,27-/m0/s1 FSZONJWQGJPZTI-SVBPBHIXSA-N 479673 US10899735, No. 132 Programmed cell death 1 ligand 1/2 Human 568 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479673&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996021 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCC(F)(F)F)c(OC)n1 InChI=1S/C33H32Cl2F3N5O3/c1-45-31-19(15-39-17-21-11-14-28(44)41-21)9-12-26(42-31)24-7-3-5-22(29(24)34)23-6-4-8-25(30(23)35)27-13-10-20(32(43-27)46-2)16-40-18-33(36,37)38/h3-10,12-13,21,39-40H,11,14-18H2,1-2H3,(H,41,44)/t21-/m0/s1 VFWCWZJRWSGONZ-NRFANRHFSA-N 479674 US10899735, No. 133 Programmed cell death 1 ligand 1/2 Human 3786 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479674&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996022 COc1cc(ncc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38Cl2N6O4/c1-47-31-15-30(41-18-22(31)17-40-20-24-11-14-33(46)43-24)28-8-4-6-26(35(28)38)25-5-3-7-27(34(25)37)29-12-9-21(36(44-29)48-2)16-39-19-23-10-13-32(45)42-23/h3-9,12,15,18,23-24,39-40H,10-11,13-14,16-17,19-20H2,1-2H3,(H,42,45)(H,43,46)/t23-,24-/m0/s1 RLTFSJVTNNAEGP-ZEQRLZLVSA-N 479675 US10899735, No. 134 Programmed cell death 1 ligand 1/2 Human 71.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479675&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996023 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(C)n1 InChI=1S/C36H38Cl2N6O3/c1-21-22(17-39-19-24-11-15-32(45)42-24)9-13-30(41-21)28-7-3-5-26(34(28)37)27-6-4-8-29(35(27)38)31-14-10-23(36(44-31)47-2)18-40-20-25-12-16-33(46)43-25/h3-10,13-14,24-25,39-40H,11-12,15-20H2,1-2H3,(H,42,45)(H,43,46)/t24-,25-/m0/s1 IOPPQOQYJGGVKN-DQEYMECFSA-N 479676 US10899735, No. 135 Programmed cell death 1 ligand 1/2 Human 183 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479676&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996024 COc1nc(ccc1C1=NCCN1)-c1cccc(c1F)-c1cccc(c1F)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C30H26F2N6O2/c1-39-29-21(27-33-13-14-34-27)9-11-23(37-29)19-7-3-5-17(25(19)31)18-6-4-8-20(26(18)32)24-12-10-22(30(38-24)40-2)28-35-15-16-36-28/h3-12H,13-16H2,1-2H3,(H,33,34)(H,35,36) UCNHOLJKBDBVCN-UHFFFAOYSA-N 479677 US10899735, No. 136 Programmed cell death 1 ligand 1/2 Human 929 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479677&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996025 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1F)-c1cccc(c1F)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38F2N6O4/c1-47-35-21(17-39-19-23-11-15-31(45)41-23)9-13-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-20-24-12-16-32(46)42-24/h3-10,13-14,23-24,39-40H,11-12,15-20H2,1-2H3,(H,41,45)(H,42,46)/t23-,24-/m0/s1 PZTZHUWWHDHOFE-ZEQRLZLVSA-N 479678 US10899735, No. 137 Programmed cell death 1 ligand 1/2 Human 1961 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479678&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996026 COc1nc(ccc1CN)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN)c(OC)n1 InChI=1S/C26H24Cl2N4O2/c1-33-25-15(13-29)9-11-21(31-25)19-7-3-5-17(23(19)27)18-6-4-8-20(24(18)28)22-12-10-16(14-30)26(32-22)34-2/h3-12H,13-14,29-30H2,1-2H3 QDIFOVNDQSISHL-UHFFFAOYSA-N 479679 US10899735, No. 138 Programmed cell death 1 ligand 1/2 Human 557 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479679&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996027 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(-c2cccc(-c3ccc(CNC[C@@H]4CCC(=O)N4)c(OC)n3)c2C#N)c1C#N InChI=1S/C38H38N8O4/c1-49-37-23(19-41-21-25-11-15-35(47)43-25)9-13-33(45-37)29-7-3-5-27(31(29)17-39)28-6-4-8-30(32(28)18-40)34-14-10-24(38(46-34)50-2)20-42-22-26-12-16-36(48)44-26/h3-10,13-14,25-26,41-42H,11-12,15-16,19-22H2,1-2H3,(H,43,47)(H,44,48)/t25-,26-/m0/s1 VXZRHCPILQCKMA-UIOOFZCWSA-N 479680 US10899735, No. 139 Programmed cell death 1 ligand 1/2 Human 207 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479680&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996028 COc1nc(ccc1C1=NCCN1)-c1cccc(-c2cccc(-c3ccc(C4=NCCN4)c(OC)n3)c2C#N)c1C#N InChI=1S/C32H26N8O2/c1-41-31-23(29-35-13-14-36-29)9-11-27(39-31)21-7-3-5-19(25(21)17-33)20-6-4-8-22(26(20)18-34)28-12-10-24(32(40-28)42-2)30-37-15-16-38-30/h3-12H,13-16H2,1-2H3,(H,35,36)(H,37,38) DUPFSESXFILDGA-UHFFFAOYSA-N 479681 US10899735, No. 140 Programmed cell death 1 ligand 1/2 Human 260 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479681&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996029 COc1cc(ncc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(OC)c(CNC[C@@H]2CCC(=O)N2)cn1 InChI=1S/C36H38Cl2N6O4/c1-47-31-13-29(41-17-21(31)15-39-19-23-9-11-33(45)43-23)27-7-3-5-25(35(27)37)26-6-4-8-28(36(26)38)30-14-32(48-2)22(18-42-30)16-40-20-24-10-12-34(46)44-24/h3-8,13-14,17-18,23-24,39-40H,9-12,15-16,19-20H2,1-2H3,(H,43,45)(H,44,46)/t23-,24-/m0/s1 YQBZRDMJCDEIST-ZEQRLZLVSA-N 479682 US10899735, No. 141 Programmed cell death 1 ligand 1/2 Human 291 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479682&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996030 COc1nc(ccc1C1=NCCN1C)-c1cccc(c1Cl)-c1cccc(-c2ccc(C3=NCCN3C)c(OC)n2)c1Cl InChI=1S/C32H30Cl2N6O2/c1-39-17-15-35-29(39)23-11-13-25(37-31(23)41-3)21-9-5-7-19(27(21)33)20-8-6-10-22(28(20)34)26-14-12-24(32(38-26)42-4)30-36-16-18-40(30)2/h5-14H,15-18H2,1-4H3 GMFOAIUAWAUMRK-UHFFFAOYSA-N 479683 US10899735, No. 142 Programmed cell death 1 ligand 1/2 Human 172 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479683&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996031 COc1nc(ccc1C1=NC[C@H](CO)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NC[C@H](CO)N2)c(OC)n1 InChI=1S/C32H30Cl2N6O4/c1-43-31-23(29-35-13-17(15-41)37-29)9-11-25(39-31)21-7-3-5-19(27(21)33)20-6-4-8-22(28(20)34)26-12-10-24(32(40-26)44-2)30-36-14-18(16-42)38-30/h3-12,17-18,41-42H,13-16H2,1-2H3,(H,35,37)(H,36,38)/t17-,18-/m1/s1 ZZNPMZPXIUMWHT-QZTJIDSGSA-N 479684 US10899735, No. 143 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479684&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996032 Clc1c(cccc1-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)cn1)-c1ccc(CNC[C@@H]2CCC(=O)N2)cn1 InChI=1S/C34H34Cl2N6O2/c35-33-25(3-1-5-27(33)29-11-7-21(17-39-29)15-37-19-23-9-13-31(43)41-23)26-4-2-6-28(34(26)36)30-12-8-22(18-40-30)16-38-20-24-10-14-32(44)42-24/h1-8,11-12,17-18,23-24,37-38H,9-10,13-16,19-20H2,(H,41,43)(H,42,44)/t23-,24-/m0/s1 ZBPZKKOZKCUPDX-ZEQRLZLVSA-N 479685 US10899735, No. 144 Programmed cell death 1 ligand 1/2 Human 755 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479685&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996033 COc1ncc(cc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cnc(OC)c(CNC[C@@H]2CCC(=O)N2)c1 InChI=1S/C36H38Cl2N6O4/c1-47-35-23(15-39-19-25-9-11-31(45)43-25)13-21(17-41-35)27-5-3-7-29(33(27)37)30-8-4-6-28(34(30)38)22-14-24(36(48-2)42-18-22)16-40-20-26-10-12-32(46)44-26/h3-8,13-14,17-18,25-26,39-40H,9-12,15-16,19-20H2,1-2H3,(H,43,45)(H,44,46)/t25-,26-/m0/s1 UQAWIQSWCFAXPI-UIOOFZCWSA-N 479686 US10899735, No. 145 Programmed cell death 1 ligand 1/2 Human 1139 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479686&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996034 FC(F)(F)c1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(n1)C(F)(F)F InChI=1S/C36H32Cl2F6N6O2/c37-31-23(3-1-5-25(31)27-11-7-19(33(49-27)35(39,40)41)15-45-17-21-9-13-29(51)47-21)24-4-2-6-26(32(24)38)28-12-8-20(34(50-28)36(42,43)44)16-46-18-22-10-14-30(52)48-22/h1-8,11-12,21-22,45-46H,9-10,13-18H2,(H,47,51)(H,48,52)/t21-,22-/m0/s1 RELSDIDCUSFZPY-VXKWHMMOSA-N 479687 US10899735, No. 146 Programmed cell death 1 ligand 1/2 Human 2858 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479687&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996035 Cc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(C)n1 InChI=1S/C36H38Cl2N6O2/c1-21-23(17-39-19-25-11-15-33(45)43-25)9-13-31(41-21)29-7-3-5-27(35(29)37)28-6-4-8-30(36(28)38)32-14-10-24(22(2)42-32)18-40-20-26-12-16-34(46)44-26/h3-10,13-14,25-26,39-40H,11-12,15-20H2,1-2H3,(H,43,45)(H,44,46)/t25-,26-/m0/s1 AOHCKGUMXDGJST-UIOOFZCWSA-N 479688 US10899735, No. 147 Programmed cell death 1 ligand 1/2 Human 952 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479688&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996036 COc1nc(ccc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C32H31Cl2N5O5/c1-43-31-18(16-35-17-19(40)15-27(41)42)9-11-25(38-31)22-7-3-5-20(28(22)33)21-6-4-8-23(29(21)34)26-12-10-24(32(39-26)44-2)30-36-13-14-37-30/h3-12,19,35,40H,13-17H2,1-2H3,(H,36,37)(H,41,42)/t19-/m0/s1 XHTQCXYKQWLKSX-IBGZPJMESA-N 479689 US10899735, No. 148 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479689&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996037 COc1nc(ccc1C1=NC[C@@H](CO)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NC[C@@H](CO)N2)c(OC)n1 InChI=1S/C32H30Cl2N6O4/c1-43-31-23(29-35-13-17(15-41)37-29)9-11-25(39-31)21-7-3-5-19(27(21)33)20-6-4-8-22(28(20)34)26-12-10-24(32(40-26)44-2)30-36-14-18(16-42)38-30/h3-12,17-18,41-42H,13-16H2,1-2H3,(H,35,37)(H,36,38)/t17-,18-/m0/s1 ZZNPMZPXIUMWHT-ROUUACIJSA-N 479690 US10899735, No. 149 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479690&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996038 COc1nc(ccc1C1=NCCN1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C30H26Cl2N6O2/c1-39-29-21(27-33-13-14-34-27)9-11-23(37-29)19-7-3-5-17(25(19)31)18-6-4-8-20(26(18)32)24-12-10-22(30(38-24)40-2)28-35-15-16-36-28/h3-12H,13-16H2,1-2H3,(H,33,34)(H,35,36) CSDWEOIKPJNONX-UHFFFAOYSA-N 479691 US10899735, No. 150 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479691&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996039 COc1nc(ccc1CN[C@@H]1CCC[C@@H]1O)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(C2=NCCN2Cc2cncc(c2)C#N)c(OC)n1 InChI=1S/C42H43N7O3/c1-26-31(8-5-10-33(26)36-16-14-30(41(47-36)51-3)24-46-38-12-7-13-39(38)50)32-9-6-11-34(27(32)2)37-17-15-35(42(48-37)52-4)40-45-18-19-49(40)25-29-20-28(21-43)22-44-23-29/h5-6,8-11,14-17,20,22-23,38-39,46,50H,7,12-13,18-19,24-25H2,1-4H3/t38-,39+/m1/s1 JOERBBLRINKZCF-RGULYWFUSA-N 479692 US10899735, No. 151 Programmed cell death 1 ligand 1/2 Human 1196 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479692&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996040 COc1nc(ccc1CN[C@@H]1CCC[C@@H]1O)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(C2=NCCN2C(C)=O)c(OC)n1 InChI=1S/C37H41N5O4/c1-22-26(9-6-11-28(22)31-17-15-25(36(40-31)45-4)21-39-33-13-8-14-34(33)44)27-10-7-12-29(23(27)2)32-18-16-30(37(41-32)46-5)35-38-19-20-42(35)24(3)43/h6-7,9-12,15-18,33-34,39,44H,8,13-14,19-21H2,1-5H3/t33-,34+/m1/s1 CVUIPKVBGJTXNP-NOCHOARKSA-N 479693 US10899735, No. 152 Programmed cell death 1 ligand 1/2 Human 1313 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479693&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996041 COc1nc(ccc1CN[C@@H]1CCC[C@@H]1O)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(C2=NCCN2C(=O)C2CC2)c(OC)n1 InChI=1S/C39H43N5O4/c1-23-27(8-5-10-29(23)32-18-16-26(37(42-32)47-3)22-41-34-12-7-13-35(34)45)28-9-6-11-30(24(28)2)33-19-17-31(38(43-33)48-4)36-40-20-21-44(36)39(46)25-14-15-25/h5-6,8-11,16-19,25,34-35,41,45H,7,12-15,20-22H2,1-4H3/t34-,35+/m1/s1 PLKDLBAIAPPINO-GPOMZPHUSA-N 479694 US10899735, No. 153 Programmed cell death 1 ligand 1/2 Human 1392 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479694&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996042 COc1nc(ccc1CN[C@@H]1CCC[C@@H]1O)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(C2=NCCN2S(C)(=O)=O)c(OC)n1 InChI=1S/C36H41N5O5S/c1-22-25(9-6-11-27(22)30-17-15-24(35(39-30)45-3)21-38-32-13-8-14-33(32)42)26-10-7-12-28(23(26)2)31-18-16-29(36(40-31)46-4)34-37-19-20-41(34)47(5,43)44/h6-7,9-12,15-18,32-33,38,42H,8,13-14,19-21H2,1-5H3/t32-,33+/m1/s1 SMGHCXXUDHUUIG-SAIUNTKASA-N 479695 US10899735, No. 154 Programmed cell death 1 ligand 1/2 Human 1865 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479695&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996043 COc1nc(ccc1CN[C@@H]1CCC[C@@H]1O)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(C2=NC[C@@H](CO)N2)c(OC)n1 InChI=1S/C36H41N5O4/c1-21-25(8-5-10-27(21)30-16-14-23(35(40-30)44-3)18-37-32-12-7-13-33(32)43)26-9-6-11-28(22(26)2)31-17-15-29(36(41-31)45-4)34-38-19-24(20-42)39-34/h5-6,8-11,14-17,24,32-33,37,42-43H,7,12-13,18-20H2,1-4H3,(H,38,39)/t24-,32+,33-/m0/s1 NYJONROGKVHOFF-RZCVILGXSA-N 479696 US10899735, No. 155 Programmed cell death 1 ligand 1/2 Human 725 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479696&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996044 COc1nc(ccc1CNC[C@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38Cl2N6O4/c1-47-35-21(17-39-19-23-11-15-31(45)41-23)9-13-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-20-24-12-16-32(46)42-24/h3-10,13-14,23-24,39-40H,11-12,15-20H2,1-2H3,(H,41,45)(H,42,46)/t23-,24-/m1/s1 CCQYZUWIGMDBQE-DNQXCXABSA-N 479697 US10899735, No. 156::US10899735, No. 306 Programmed cell death 1 ligand 1/2 Human 304 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479697&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996045 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38Cl2N6O4/c1-47-35-21(17-39-19-23-11-15-31(45)41-23)9-13-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-20-24-12-16-32(46)42-24/h3-10,13-14,23-24,39-40H,11-12,15-20H2,1-2H3,(H,41,45)(H,42,46)/t23-,24-/m0/s1 CCQYZUWIGMDBQE-ZEQRLZLVSA-N 479698 US10899735, No. 157 Programmed cell death 1 ligand 1/2 Human 145 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479698&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996046 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCO)c(OC)n1 InChI=1S/C30H32Cl2N4O4/c1-39-29-19(17-33-13-15-37)9-11-25(35-29)23-7-3-5-21(27(23)31)22-6-4-8-24(28(22)32)26-12-10-20(18-34-14-16-38)30(36-26)40-2/h3-12,33-34,37-38H,13-18H2,1-2H3 MOFWLGBOVMXWFS-UHFFFAOYSA-N 479699 US10899735, No. 158 Programmed cell death 1 ligand 1/2 Human 234 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479699&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996047 COc1nc(ccc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C34H37N5O5/c1-20-24(7-5-9-26(20)29-13-11-22(33(38-29)43-3)18-35-19-23(40)17-31(41)42)25-8-6-10-27(21(25)2)30-14-12-28(34(39-30)44-4)32-36-15-16-37-32/h5-14,23,35,40H,15-19H2,1-4H3,(H,36,37)(H,41,42)/t23-/m0/s1 LPEPDTPCJBUUKJ-QHCPKHFHSA-N 479700 US10899735, No. 159 Programmed cell death 1 ligand 1/2 Human 140 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479700&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996048 COc1nc(ccc1CN[C@@H]1CCC[C@@H]1O)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C35H39N5O3/c1-21-24(8-5-10-26(21)29-16-14-23(34(39-29)42-3)20-38-31-12-7-13-32(31)41)25-9-6-11-27(22(25)2)30-17-15-28(35(40-30)43-4)33-36-18-19-37-33/h5-6,8-11,14-17,31-32,38,41H,7,12-13,18-20H2,1-4H3,(H,36,37)/t31-,32+/m1/s1 YQJNTLGVKCDUGJ-ZWXJPIIXSA-N 479701 US10899735, No. 160 Programmed cell death 1 ligand 1/2 Human 495 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479701&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996049 CCOc1nc(ccc1CNCCO)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CNCCO)c(OCC)n1 InChI=1S/C34H42N4O4/c1-5-41-33-25(21-35-17-19-39)13-15-31(37-33)29-11-7-9-27(23(29)3)28-10-8-12-30(24(28)4)32-16-14-26(22-36-18-20-40)34(38-32)42-6-2/h7-16,35-36,39-40H,5-6,17-22H2,1-4H3 KVALIAJZZLREEF-UHFFFAOYSA-N 479702 US10899735, No. 161 Programmed cell death 1 ligand 1/2 Human 3393 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479702&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996050 COc1nc(ccc1CNCCO)-c1cccc(c1F)-c1cccc(c1C)-c1ccc(CNCCO)cc1 InChI=1S/C31H34FN3O3/c1-21-25(23-11-9-22(10-12-23)19-33-15-17-36)5-3-6-26(21)27-7-4-8-28(30(27)32)29-14-13-24(20-34-16-18-37)31(35-29)38-2/h3-14,33-34,36-37H,15-20H2,1-2H3 KBMCZFMKSAVCJH-UHFFFAOYSA-N 479703 US10899735, No. 162 Programmed cell death 1 ligand 1/2 Human 2802 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479703&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996051 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1C)-c1ccc(CNCCO)cc1 InChI=1S/C31H34ClN3O3/c1-21-25(23-11-9-22(10-12-23)19-33-15-17-36)5-3-6-26(21)27-7-4-8-28(30(27)32)29-14-13-24(20-34-16-18-37)31(35-29)38-2/h3-14,33-34,36-37H,15-20H2,1-2H3 ZHTIJBNCJVDUSN-UHFFFAOYSA-N 479704 US10899735, No. 163 Programmed cell death 1 ligand 1/2 Human 1417 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479704&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996052 COc1nc(ccc1CN[C@@H]1CCC[C@@H]1O)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CN[C@@H]2CCC[C@@H]2O)cc1 InChI=1S/C38H45N3O3/c1-24-29(27-18-16-26(17-19-27)22-39-34-12-6-14-36(34)42)8-4-9-30(24)31-10-5-11-32(25(31)2)33-21-20-28(38(41-33)44-3)23-40-35-13-7-15-37(35)43/h4-5,8-11,16-21,34-37,39-40,42-43H,6-7,12-15,22-23H2,1-3H3/t34-,35-,36+,37+/m1/s1 SQQLZSATJANCHI-MDOFDWFASA-N 479705 US10899735, No. 164 Programmed cell death 1 ligand 1/2 Human 7949 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479705&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996053 COc1nc(ccc1CNCCO)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CNCCO)cc1 InChI=1S/C32H37N3O3/c1-22-27(25-12-10-24(11-13-25)20-33-16-18-36)6-4-7-28(22)29-8-5-9-30(23(29)2)31-15-14-26(21-34-17-19-37)32(35-31)38-3/h4-15,33-34,36-37H,16-21H2,1-3H3 NPFZHMXZLUZMGA-UHFFFAOYSA-N 479706 US10899735, No. 165 Programmed cell death 1 ligand 1/2 Human 1333 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479706&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996054 COc1nc(ccc1CN[C@@H]1CCC[C@@H]1O)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CN[C@@H]2CCC[C@@H]2O)c(OC)n1 InChI=1S/C38H46N4O4/c1-23-27(9-5-11-29(23)31-19-17-25(37(41-31)45-3)21-39-33-13-7-15-35(33)43)28-10-6-12-30(24(28)2)32-20-18-26(38(42-32)46-4)22-40-34-14-8-16-36(34)44/h5-6,9-12,17-20,33-36,39-40,43-44H,7-8,13-16,21-22H2,1-4H3/t33-,34-,35+,36+/m1/s1 BBFSDUZZTRVUAO-NWJWHWDBSA-N 479707 US10899735, No. 166 Programmed cell death 1 ligand 1/2 Human 8274 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479707&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996055 COc1nc(ccc1CN1CC[C@@H](O)C1)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CN2CC[C@@H](O)C2)c(OC)n1 InChI=1S/C36H42N4O4/c1-23-29(7-5-9-31(23)33-13-11-25(35(37-33)43-3)19-39-17-15-27(41)21-39)30-8-6-10-32(24(30)2)34-14-12-26(36(38-34)44-4)20-40-18-16-28(42)22-40/h5-14,27-28,41-42H,15-22H2,1-4H3/t27-,28-/m1/s1 MVQINRBJZHKBSQ-VSGBNLITSA-N 479708 US10899735, No. 167 Programmed cell death 1 ligand 1/2 Human 857 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479708&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996056 COc1nc(ccc1CNCC1CCC(=O)N1)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CNCC2CCC(=O)N2)c(OC)n1 InChI=1S/C38H44N6O4/c1-23-29(7-5-9-31(23)33-15-11-25(37(43-33)47-3)19-39-21-27-13-17-35(45)41-27)30-8-6-10-32(24(30)2)34-16-12-26(38(44-34)48-4)20-40-22-28-14-18-36(46)42-28/h5-12,15-16,27-28,39-40H,13-14,17-22H2,1-4H3,(H,41,45)(H,42,46) DHBBWGNAGLFJKF-UHFFFAOYSA-N 479709 US10899735, No. 168 Programmed cell death 1 ligand 1/2 Human 1516 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479709&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996057 COc1nc(ccc1C1=NCCN1)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C32H32N6O2/c1-19-21(7-5-9-23(19)27-13-11-25(31(37-27)39-3)29-33-15-16-34-29)22-8-6-10-24(20(22)2)28-14-12-26(32(38-28)40-4)30-35-17-18-36-30/h5-14H,15-18H2,1-4H3,(H,33,34)(H,35,36) LQHOPSOYZCUWSZ-UHFFFAOYSA-N 479710 US10899735, No. 169 Programmed cell death 1 ligand 1/2 Human 161 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479710&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996058 COc1nc(ccc1CNCCO)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CNC[C@@H](O)CC(O)=O)c(OC)n1 InChI=1S/C34H40N4O6/c1-21-26(7-5-9-28(21)30-13-11-23(18-35-15-16-39)33(37-30)43-3)27-8-6-10-29(22(27)2)31-14-12-24(34(38-31)44-4)19-36-20-25(40)17-32(41)42/h5-14,25,35-36,39-40H,15-20H2,1-4H3,(H,41,42)/t25-/m0/s1 PGXXFPVFGYDEIV-VWLOTQADSA-N 479711 US10899735, No. 170 Programmed cell death 1 ligand 1/2 Human 858 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479711&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996059 COc1nc(ccc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CNC[C@@H](O)CC(O)=O)c(OC)n1 InChI=1S/C36H42N4O8/c1-21-27(7-5-9-29(21)31-13-11-23(35(39-31)47-3)17-37-19-25(41)15-33(43)44)28-8-6-10-30(22(28)2)32-14-12-24(36(40-32)48-4)18-38-20-26(42)16-34(45)46/h5-14,25-26,37-38,41-42H,15-20H2,1-4H3,(H,43,44)(H,45,46)/t25-,26-/m0/s1 FNPSCGBNUYWZRI-UIOOFZCWSA-N 479712 US10899735, No. 171 Programmed cell death 1 ligand 1/2 Human 1115 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479712&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996060 COc1nc(ccc1CNCCO)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CNCCO)c(OC)n1 InChI=1S/C32H38N4O4/c1-21-25(7-5-9-27(21)29-13-11-23(19-33-15-17-37)31(35-29)39-3)26-8-6-10-28(22(26)2)30-14-12-24(20-34-16-18-38)32(36-30)40-4/h5-14,33-34,37-38H,15-20H2,1-4H3 GTZDRCADRXTGQU-UHFFFAOYSA-N 479713 US10899735, No. 172 Programmed cell death 1 ligand 1/2 Human 896 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479713&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996061 COc1cc(ncc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CN2CC[C@@H](O)C2)cc1 InChI=1S/C36H41N3O5/c1-23-30(26-12-10-25(11-13-26)21-39-15-14-28(40)22-39)6-4-7-31(23)32-8-5-9-33(24(32)2)34-17-35(44-3)27(19-38-34)18-37-20-29(41)16-36(42)43/h4-13,17,19,28-29,37,40-41H,14-16,18,20-22H2,1-3H3,(H,42,43)/t28-,29+/m1/s1 ZBPCKBCEUWXMIS-WDYNHAJCSA-N 479714 US10899735, No. 173 Programmed cell death 1 ligand 1/2 Human 1472 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479714 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479714&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996062 COc1nc(ccc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1C)-c1cccc(c1C)-c1ccc(CN2CC[C@@H](O)C2)cc1 InChI=1S/C36H41N3O5/c1-23-30(26-12-10-25(11-13-26)21-39-17-16-28(40)22-39)6-4-7-31(23)32-8-5-9-33(24(32)2)34-15-14-27(36(38-34)44-3)19-37-20-29(41)18-35(42)43/h4-15,28-29,37,40-41H,16-22H2,1-3H3,(H,42,43)/t28-,29+/m1/s1 IIQHZGZATZPJAP-WDYNHAJCSA-N 479715 US10899735, No. 174 Programmed cell death 1 ligand 1/2 Human 421 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479715&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996063 COc1nc(ccc1CN1CC[C@@]2(CCC(=O)N2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@@]3(CCC(=O)N3)C2)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-37-25(21-47-19-17-39(23-47)15-13-33(49)45-39)9-11-31(43-37)29-7-3-5-27(35(29)41)28-6-4-8-30(36(28)42)32-12-10-26(38(44-32)52-2)22-48-20-18-40(24-48)16-14-34(50)46-40/h3-12H,13-24H2,1-2H3,(H,45,49)(H,46,50)/t39-,40-/m0/s1 BAEFCGDHNMNKPE-ZAQUEYBZSA-N 479716 US10899735, No. 175 Programmed cell death 1 ligand 1/2 Human 364 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479716 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479716&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996064 COc1nc(ccc1CN1CC[C@@]2(CCC(=O)N2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@]3(CCC(=O)N3)C2)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-37-25(21-47-19-17-39(23-47)15-13-33(49)45-39)9-11-31(43-37)29-7-3-5-27(35(29)41)28-6-4-8-30(36(28)42)32-12-10-26(38(44-32)52-2)22-48-20-18-40(24-48)16-14-34(50)46-40/h3-12H,13-24H2,1-2H3,(H,45,49)(H,46,50)/t39-,40+ BAEFCGDHNMNKPE-LQDDJWCHSA-N 479717 US10899735, No. 176 Programmed cell death 1 ligand 1/2 Human 238 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479717&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996065 COc1nc(ccc1CN1CC[C@]2(CCC(=O)N2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@]3(CCC(=O)N3)C2)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-37-25(21-47-19-17-39(23-47)15-13-33(49)45-39)9-11-31(43-37)29-7-3-5-27(35(29)41)28-6-4-8-30(36(28)42)32-12-10-26(38(44-32)52-2)22-48-20-18-40(24-48)16-14-34(50)46-40/h3-12H,13-24H2,1-2H3,(H,45,49)(H,46,50)/t39-,40-/m1/s1 BAEFCGDHNMNKPE-XRSDMRJBSA-N 479718 US10899735, No. 177 Programmed cell death 1 ligand 1/2 Human 150 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479718&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996066 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C(C)N2CC3(C2)CN(C3)C(C)=O)c(OC)n1 InChI=1S/C39H42Cl2N6O4/c1-23(46-19-39(20-46)21-47(22-39)24(2)48)27-13-15-33(45-38(27)51-4)31-10-6-8-29(36(31)41)28-7-5-9-30(35(28)40)32-14-11-25(37(44-32)50-3)17-42-18-26-12-16-34(49)43-26/h5-11,13-15,23,26,42H,12,16-22H2,1-4H3,(H,43,49)/t23?,26-/m0/s1 MSDVVDOJAWEWIF-NASUQTAISA-N 479719 US10899735, No. 178 Programmed cell death 1 ligand 1/2 Human 359 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479719 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479719&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996067 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C38H40Cl2N6O4/c1-22(46-20-38(21-46)17-16-33(48)45-38)25-12-14-31(44-37(25)50-3)29-9-5-7-27(35(29)40)26-6-4-8-28(34(26)39)30-13-10-23(36(43-30)49-2)18-41-19-24-11-15-32(47)42-24/h4-10,12-14,22,24,41H,11,15-21H2,1-3H3,(H,42,47)(H,45,48)/t22-,24-/m0/s1 TVXQRECRVCLOJX-UPVQGACJSA-N 479720 US10899735, No. 179 Programmed cell death 1 ligand 1/2 Human 403 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479720&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996068 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H](C)N2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C38H40Cl2N6O4/c1-22(46-20-38(21-46)17-16-33(48)45-38)25-12-14-31(44-37(25)50-3)29-9-5-7-27(35(29)40)26-6-4-8-28(34(26)39)30-13-10-23(36(43-30)49-2)18-41-19-24-11-15-32(47)42-24/h4-10,12-14,22,24,41H,11,15-21H2,1-3H3,(H,42,47)(H,45,48)/t22-,24+/m1/s1 TVXQRECRVCLOJX-VWNXMTODSA-N 479721 US10899735, No. 180 Programmed cell death 1 ligand 1/2 Human 1033 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479721 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479721&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996069 COc1nc(ccc1CNC[C@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C(C)N2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C38H40Cl2N6O4/c1-22(46-20-38(21-46)17-16-33(48)45-38)25-12-14-31(44-37(25)50-3)29-9-5-7-27(35(29)40)26-6-4-8-28(34(26)39)30-13-10-23(36(43-30)49-2)18-41-19-24-11-15-32(47)42-24/h4-10,12-14,22,24,41H,11,15-21H2,1-3H3,(H,42,47)(H,45,48)/t22?,24-/m1/s1 TVXQRECRVCLOJX-SYIFMXBLSA-N 479722 US10899735, No. 181 Programmed cell death 1 ligand 1/2 Human 480 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479722 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479722&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996070 COc1nc(ccc1CNC1CC2(C1)CN(C2)C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC2CC3(C2)CN(C3)C(C)=O)c(OC)n1 InChI=1S/C42H46Cl2N6O4/c1-25(51)49-21-41(22-49)15-29(16-41)45-19-27-11-13-35(47-39(27)53-3)33-9-5-7-31(37(33)43)32-8-6-10-34(38(32)44)36-14-12-28(40(48-36)54-4)20-46-30-17-42(18-30)23-50(24-42)26(2)52/h5-14,29-30,45-46H,15-24H2,1-4H3 UYBOVJDFSBOVKU-UHFFFAOYSA-N 479723 US10899735, No. 182 Programmed cell death 1 ligand 1/2 Human 152 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479723&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996071 COc1nc(ccc1CNCCn1cnnc1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C36H36Cl2N8O3/c1-48-34-23(17-39-15-16-45-21-40-41-22-45)9-11-29(42-34)27-7-3-5-25(32(27)37)26-6-4-8-28(33(26)38)30-12-10-24(35(43-30)49-2)18-46-19-36(20-46)14-13-31(47)44-36/h3-12,21-22,39H,13-20H2,1-2H3,(H,44,47) MJMVOIVZOCEOPK-UHFFFAOYSA-N 479724 US10899735, No. 183 Programmed cell death 1 ligand 1/2 Human 282 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479724&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996072 COc1nc(ccc1CN1CCC2(CN(C2)C(C)=O)CC1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CN(C3)C(C)=O)CC2)c(OC)n1 InChI=1S/C44H50Cl2N6O4/c1-29(53)51-25-43(26-51)15-19-49(20-16-43)23-31-11-13-37(47-41(31)55-3)35-9-5-7-33(39(35)45)34-8-6-10-36(40(34)46)38-14-12-32(42(48-38)56-4)24-50-21-17-44(18-22-50)27-52(28-44)30(2)54/h5-14H,15-28H2,1-4H3 OFUMXDPPJVYFDY-UHFFFAOYSA-N 479725 US10899735, No. 184 Programmed cell death 1 ligand 1/2 Human 239 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479725&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996073 COc1nc(ccc1CN1CCC2(CN(C2)C(C)=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CN(C3)C(C)=O)C2)c(OC)n1 InChI=1S/C42H46Cl2N6O4/c1-27(51)49-23-41(24-49)15-17-47(21-41)19-29-11-13-35(45-39(29)53-3)33-9-5-7-31(37(33)43)32-8-6-10-34(38(32)44)36-14-12-30(40(46-36)54-4)20-48-18-16-42(22-48)25-50(26-42)28(2)52/h5-14H,15-26H2,1-4H3 MHYIJPRKDBTISE-UHFFFAOYSA-N 479726 US10899735, No. 185 Programmed cell death 1 ligand 1/2 Human 182 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479726 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479726&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996074 COc1nc(ccc1CNCC1CCC(F)(F)CN1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C38H40Cl2F2N6O3/c1-50-35-23(17-43-18-25-13-16-38(41,42)20-44-25)9-11-30(45-35)28-7-3-5-26(33(28)39)27-6-4-8-29(34(27)40)31-12-10-24(36(46-31)51-2)19-48-21-37(22-48)15-14-32(49)47-37/h3-12,25,43-44H,13-22H2,1-2H3,(H,47,49) XNDKKYMXENEAJT-UHFFFAOYSA-N 479727 US10899735, No. 186 Programmed cell death 1 ligand 1/2 Human 6188 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479727&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996075 COc1nc(ccc1CNCCc1cc[nH]n1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C37H37Cl2N7O3/c1-48-35-23(19-40-17-14-25-15-18-41-45-25)9-11-30(42-35)28-7-3-5-26(33(28)38)27-6-4-8-29(34(27)39)31-12-10-24(36(43-31)49-2)20-46-21-37(22-46)16-13-32(47)44-37/h3-12,15,18,40H,13-14,16-17,19-22H2,1-2H3,(H,41,45)(H,44,47) KTLIBMYDNRFEQP-UHFFFAOYSA-N 479728 US10899735, No. 187 Programmed cell death 1 ligand 1/2 Human 2157 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479728&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996076 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CCO3)CC2)c(OC)n1 InChI=1S/C39H41Cl2N5O4/c1-48-36-25(21-45-18-15-39(16-19-45)17-20-50-39)9-11-31(42-36)29-7-3-5-27(34(29)40)28-6-4-8-30(35(28)41)32-12-10-26(37(43-32)49-2)22-46-23-38(24-46)14-13-33(47)44-38/h3-12H,13-24H2,1-2H3,(H,44,47) KTQGFDVOBIEVOH-UHFFFAOYSA-N 479729 US10899735, No. 188 Programmed cell death 1 ligand 1/2 Human 448 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479729 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479729&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996077 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CCO3)C2)c(OC)n1 InChI=1S/C38H39Cl2N5O4/c1-47-35-24(19-44-17-15-38(23-44)16-18-49-38)9-11-30(41-35)28-7-3-5-26(33(28)39)27-6-4-8-29(34(27)40)31-12-10-25(36(42-31)48-2)20-45-21-37(22-45)14-13-32(46)43-37/h3-12H,13-23H2,1-2H3,(H,43,46) XLSGXVNQTYORJI-UHFFFAOYSA-N 479730 US10899735, No. 189 Programmed cell death 1 ligand 1/2 Human 304 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479730&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996078 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(C2)OCCO3)c(OC)n1 InChI=1S/C38H39Cl2N5O5/c1-47-35-24(19-44-16-15-38(23-44)49-17-18-50-38)9-11-30(41-35)28-7-3-5-26(33(28)39)27-6-4-8-29(34(27)40)31-12-10-25(36(42-31)48-2)20-45-21-37(22-45)14-13-32(46)43-37/h3-12H,13-23H2,1-2H3,(H,43,46) ZLWKMODMLOJSCG-UHFFFAOYSA-N 479731 US10899735, No. 190 Programmed cell death 1 ligand 1/2 Human 2835 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479731&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996079 COc1nc(ccc1CNCCc1cn[nH]c1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C37H37Cl2N7O3/c1-48-35-24(19-40-16-14-23-17-41-42-18-23)9-11-30(43-35)28-7-3-5-26(33(28)38)27-6-4-8-29(34(27)39)31-12-10-25(36(44-31)49-2)20-46-21-37(22-46)15-13-32(47)45-37/h3-12,17-18,40H,13-16,19-22H2,1-2H3,(H,41,42)(H,45,47) XKITZJUAZFLZRN-UHFFFAOYSA-N 479732 US10899735, No. 191 Programmed cell death 1 ligand 1/2 Human 559 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479732&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996080 COc1nc(ccc1CN1CC2(C1)CNC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CNC(=O)N3)c(OC)n1 InChI=1S/C36H36Cl2N8O4/c1-49-31-21(13-45-17-35(18-45)15-39-33(47)43-35)9-11-27(41-31)25-7-3-5-23(29(25)37)24-6-4-8-26(30(24)38)28-12-10-22(32(42-28)50-2)14-46-19-36(20-46)16-40-34(48)44-36/h3-12H,13-20H2,1-2H3,(H2,39,43,47)(H2,40,44,48) DJJBFMDLAZFVMM-UHFFFAOYSA-N 479733 US10899735, No. 192 Programmed cell death 1 ligand 1/2 Human 513 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479733&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996081 COc1nc(ccc1CN1CC2(C1)CN(C2)C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NC[C@H](CO)N2)c(OC)n1 InChI=1S/C36H36Cl2N6O4/c1-21(46)44-19-36(20-44)17-43(18-36)15-22-10-12-29(41-34(22)47-2)26-8-4-6-24(31(26)37)25-7-5-9-27(32(25)38)30-13-11-28(35(42-30)48-3)33-39-14-23(16-45)40-33/h4-13,23,45H,14-20H2,1-3H3,(H,39,40)/t23-/m1/s1 KLTOTPXWMLDMQU-HSZRJFAPSA-N 479734 US10899735, No. 193 Programmed cell death 1 ligand 1/2 Human 130 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479734 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479734&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996082 COc1nc(ccc1CN1CC2(C1)CN(C2)C(=O)CO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CN(C3)C(=O)CO)c(OC)n1 InChI=1S/C40H42Cl2N6O6/c1-53-37-25(13-45-17-39(18-45)21-47(22-39)33(51)15-49)9-11-31(43-37)29-7-3-5-27(35(29)41)28-6-4-8-30(36(28)42)32-12-10-26(38(44-32)54-2)14-46-19-40(20-46)23-48(24-40)34(52)16-50/h3-12,49-50H,13-24H2,1-2H3 FLLYULQHELOQME-UHFFFAOYSA-N 479735 US10899735, No. 194 Programmed cell death 1 ligand 1/2 Human 91.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479735&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996083 COc1nc(ccc1CN1CC2(C1)CN(C2)C=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CN(C3)C=O)c(OC)n1 InChI=1S/C38H38Cl2N6O4/c1-49-35-25(13-43-15-37(16-43)19-45(20-37)23-47)9-11-31(41-35)29-7-3-5-27(33(29)39)28-6-4-8-30(34(28)40)32-12-10-26(36(42-32)50-2)14-44-17-38(18-44)21-46(22-38)24-48/h3-12,23-24H,13-22H2,1-2H3 KEDQUUGLUQCWBM-UHFFFAOYSA-N 479736 US10899735, No. 195 Programmed cell death 1 ligand 1/2 Human 93.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479736&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996084 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NC[C@H](CO)N2)c(OC)n1 InChI=1S/C35H34Cl2N6O4/c1-46-33-20(16-43-18-35(19-43)14-13-29(45)42-35)9-11-27(40-33)24-7-3-5-22(30(24)36)23-6-4-8-25(31(23)37)28-12-10-26(34(41-28)47-2)32-38-15-21(17-44)39-32/h3-12,21,44H,13-19H2,1-2H3,(H,38,39)(H,42,45)/t21-/m1/s1 BXNRDWMPKFUHKT-OAQYLSRUSA-N 479737 US10899735, No. 196 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479737&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996085 COc1nc(ccc1CN1CC2(CCO2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(CCO3)C2)c(OC)n1 InChI=1S/C36H36Cl2N4O4/c1-43-33-23(17-41-19-35(20-41)13-15-45-35)9-11-29(39-33)27-7-3-5-25(31(27)37)26-6-4-8-28(32(26)38)30-12-10-24(34(40-30)44-2)18-42-21-36(22-42)14-16-46-36/h3-12H,13-22H2,1-2H3 BXSJOIIKRNFYNK-UHFFFAOYSA-N 479738 US10899735, No. 197 Programmed cell death 1 ligand 1/2 Human 736 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479738&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996086 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C34H32Cl2N6O3/c1-44-32-20(17-42-18-34(19-42)14-13-28(43)41-34)9-11-26(39-32)23-7-3-5-21(29(23)35)22-6-4-8-24(30(22)36)27-12-10-25(33(40-27)45-2)31-37-15-16-38-31/h3-12H,13-19H2,1-2H3,(H,37,38)(H,41,43) RZSQRJULGVOKTM-UHFFFAOYSA-N 479739 US10899735, No. 198 Programmed cell death 1 ligand 1/2 Human 151 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479739&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996087 COc1nc(ccc1CN1CC2(C1)CN(C2)C(=O)CC#N)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CN(C3)C(=O)CC#N)c(OC)n1 InChI=1S/C42H40Cl2N8O4/c1-55-39-27(17-49-19-41(20-49)23-51(24-41)35(53)13-15-45)9-11-33(47-39)31-7-3-5-29(37(31)43)30-6-4-8-32(38(30)44)34-12-10-28(40(48-34)56-2)18-50-21-42(22-50)25-52(26-42)36(54)14-16-46/h3-12H,13-14,17-26H2,1-2H3 SKIKMHBTWGXLQN-UHFFFAOYSA-N 479740 US10899735, No. 199 Programmed cell death 1 ligand 1/2 Human 709 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479740&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996088 COc1nc(ccc1CN1CC2(C1)CN(C2)S(C)(=O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CN(C3)S(C)(=O)=O)c(OC)n1 InChI=1S/C38H42Cl2N6O6S2/c1-51-35-25(15-43-17-37(18-43)21-45(22-37)53(3,47)48)11-13-31(41-35)29-9-5-7-27(33(29)39)28-8-6-10-30(34(28)40)32-14-12-26(36(42-32)52-2)16-44-19-38(20-44)23-46(24-38)54(4,49)50/h5-14H,15-24H2,1-4H3 COBCEWDKVWBOSG-UHFFFAOYSA-N 479741 US10899735, No. 200 Programmed cell death 1 ligand 1/2 Human 208 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479741&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996089 COC(=O)N1CC2(CN(Cc3ccc(nc3OC)-c3cccc(c3Cl)-c3cccc(c3Cl)-c3ccc(CN4CC5(C4)CN(C5)C(=O)OC)c(OC)n3)C2)C1 InChI=1S/C40H42Cl2N6O6/c1-51-35-25(15-45-17-39(18-45)21-47(22-39)37(49)53-3)11-13-31(43-35)29-9-5-7-27(33(29)41)28-8-6-10-30(34(28)42)32-14-12-26(36(44-32)52-2)16-46-19-40(20-46)23-48(24-40)38(50)54-4/h5-14H,15-24H2,1-4H3 KNAZBXXUUKXFRJ-UHFFFAOYSA-N 479742 US10899735, No. 201 Programmed cell death 1 ligand 1/2 Human 605 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479742&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996090 COc1nc(ccc1CN1CC2(C1)CCCN2C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCCN3C(C)=O)c(OC)n1 InChI=1S/C42H46Cl2N6O4/c1-27(51)49-19-7-17-41(49)23-47(24-41)21-29-13-15-35(45-39(29)53-3)33-11-5-9-31(37(33)43)32-10-6-12-34(38(32)44)36-16-14-30(40(46-36)54-4)22-48-25-42(26-48)18-8-20-50(42)28(2)52/h5-6,9-16H,7-8,17-26H2,1-4H3 OIFVRXKQJZRZPZ-UHFFFAOYSA-N 479743 US10899735, No. 202 Programmed cell death 1 ligand 1/2 Human 239 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479743&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996091 COc1nc(ccc1CNCCc1c[nH]cn1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C37H37Cl2N7O3/c1-48-35-23(17-40-16-14-25-18-41-22-42-25)9-11-30(43-35)28-7-3-5-26(33(28)38)27-6-4-8-29(34(27)39)31-12-10-24(36(44-31)49-2)19-46-20-37(21-46)15-13-32(47)45-37/h3-12,18,22,40H,13-17,19-21H2,1-2H3,(H,41,42)(H,45,47) WCBLTOIIFSORIC-UHFFFAOYSA-N 479744 US10899735, No. 203 Programmed cell death 1 ligand 1/2 Human 398 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479744&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996092 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC(C2)N2CCOC2=O)c(OC)n1 InChI=1S/C39H40Cl2N6O5/c1-50-36-24(19-45-16-14-26(21-45)47-17-18-52-38(47)49)9-11-31(42-36)29-7-3-5-27(34(29)40)28-6-4-8-30(35(28)41)32-12-10-25(37(43-32)51-2)20-46-22-39(23-46)15-13-33(48)44-39/h3-12,26H,13-23H2,1-2H3,(H,44,48) LGDPWCKGDVPSLY-UHFFFAOYSA-N 479745 US10899735, No. 204 Programmed cell death 1 ligand 1/2 Human 286 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479745&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996093 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC(C2)N2CCCC2=O)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-38-25(20-46-19-16-27(22-46)48-18-5-10-35(48)50)11-13-32(43-38)30-8-3-6-28(36(30)41)29-7-4-9-31(37(29)42)33-14-12-26(39(44-33)52-2)21-47-23-40(24-47)17-15-34(49)45-40/h3-4,6-9,11-14,27H,5,10,15-24H2,1-2H3,(H,45,49) MLKGVCWOXMMRTG-UHFFFAOYSA-N 479746 US10899735, No. 205 Programmed cell death 1 ligand 1/2 Human 177 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479746&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996094 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCCC[C@H]2C(O)=O)c(OC)n1 InChI=1S/C38H39Cl2N5O5/c1-49-35-23(19-44-21-38(22-44)17-16-32(46)43-38)12-14-29(41-35)27-9-5-7-25(33(27)39)26-8-6-10-28(34(26)40)30-15-13-24(36(42-30)50-2)20-45-18-4-3-11-31(45)37(47)48/h5-10,12-15,31H,3-4,11,16-22H2,1-2H3,(H,43,46)(H,47,48)/t31-/m0/s1 DFGWCQRVXXWVOS-HKBQPEDESA-N 479747 US10899735, No. 206 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479747&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996095 COc1nc(ccc1CN1CC2(C1)CCCN2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCCN3)c(OC)n1 InChI=1S/C38H42Cl2N6O2/c1-47-35-25(19-45-21-37(22-45)15-5-17-41-37)11-13-31(43-35)29-9-3-7-27(33(29)39)28-8-4-10-30(34(28)40)32-14-12-26(36(44-32)48-2)20-46-23-38(24-46)16-6-18-42-38/h3-4,7-14,41-42H,5-6,15-24H2,1-2H3 AYVUBXGZDLKBFN-UHFFFAOYSA-N 479748 US10899735, No. 207 Programmed cell death 1 ligand 1/2 Human 1769 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479748&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996096 COc1nc(ccc1CN1CC(C1)N1CCCC1=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC(C2)N2CCCC2=O)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-39-25(19-45-21-27(22-45)47-17-5-11-35(47)49)13-15-33(43-39)31-9-3-7-29(37(31)41)30-8-4-10-32(38(30)42)34-16-14-26(40(44-34)52-2)20-46-23-28(24-46)48-18-6-12-36(48)50/h3-4,7-10,13-16,27-28H,5-6,11-12,17-24H2,1-2H3 LUDZTNMGPDGPJP-UHFFFAOYSA-N 479749 US10899735, No. 208 Programmed cell death 1 ligand 1/2 Human 140 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479749&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996097 COc1nc(ccc1CN1CC2(C1)CCN(C2)C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-25(49)48-17-16-39(22-48)20-46(21-39)18-26-10-12-32(43-37(26)51-2)30-8-4-6-28(35(30)41)29-7-5-9-31(36(29)42)33-13-11-27(38(44-33)52-3)19-47-23-40(24-47)15-14-34(50)45-40/h4-13H,14-24H2,1-3H3,(H,45,50) RZOHRDHYSJOTKK-UHFFFAOYSA-N 479750 US10899735, No. 209 Programmed cell death 1 ligand 1/2 Human 259 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479750&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996098 COc1nc(ccc1CN1CC(CC(O)=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C37H37Cl2N5O5/c1-48-35-23(18-43-16-22(17-43)15-32(46)47)9-11-29(40-35)27-7-3-5-25(33(27)38)26-6-4-8-28(34(26)39)30-12-10-24(36(41-30)49-2)19-44-20-37(21-44)14-13-31(45)42-37/h3-12,22H,13-21H2,1-2H3,(H,42,45)(H,46,47) HLLYQYPAJNHCEG-UHFFFAOYSA-N 479751 US10899735, No. 210 Programmed cell death 1 ligand 1/2 Human 272 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479751&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996099 COc1nc(ccc1CNCCc1cnn[nH]1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C36H36Cl2N8O3/c1-48-34-22(17-39-16-14-24-18-40-45-44-24)9-11-29(41-34)27-7-3-5-25(32(27)37)26-6-4-8-28(33(26)38)30-12-10-23(35(42-30)49-2)19-46-20-36(21-46)15-13-31(47)43-36/h3-12,18,39H,13-17,19-21H2,1-2H3,(H,43,47)(H,40,44,45) AETVHSZSNLXAOC-UHFFFAOYSA-N 479752 US10899735, No. 211 Programmed cell death 1 ligand 1/2 Human 419 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479752&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996100 COc1nc(ccc1CN1CC2(CCN2C(C)=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(CCN3C(C)=O)C2)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-25(49)47-17-15-39(47)21-45(22-39)19-27-11-13-33(43-37(27)51-3)31-9-5-7-29(35(31)41)30-8-6-10-32(36(30)42)34-14-12-28(38(44-34)52-4)20-46-23-40(24-46)16-18-48(40)26(2)50/h5-14H,15-24H2,1-4H3 QOPKRXYUQZXQPK-UHFFFAOYSA-N 479753 US10899735, No. 212 Programmed cell death 1 ligand 1/2 Human 239 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479753&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996101 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2C3CCC2CC(=O)NC3)c(OC)n1 InChI=1S/C39H40Cl2N6O4/c1-50-37-23(19-46-21-39(22-46)16-15-33(48)45-39)9-13-31(43-37)29-7-3-5-27(35(29)40)28-6-4-8-30(36(28)41)32-14-10-24(38(44-32)51-2)20-47-25-11-12-26(47)18-42-34(49)17-25/h3-10,13-14,25-26H,11-12,15-22H2,1-2H3,(H,42,49)(H,45,48) VVCCAEGZUOMVQJ-UHFFFAOYSA-N 479754 US10899735, No. 213 Programmed cell death 1 ligand 1/2 Human 142 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479754&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996102 COc1nc(ccc1CN1CC2(C1)CCNC2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C38H40Cl2N6O3/c1-48-35-24(17-45-20-37(21-45)15-16-41-19-37)9-11-30(42-35)28-7-3-5-26(33(28)39)27-6-4-8-29(34(27)40)31-12-10-25(36(43-31)49-2)18-46-22-38(23-46)14-13-32(47)44-38/h3-12,41H,13-23H2,1-2H3,(H,44,47) HSQXPHRBDKCHLQ-UHFFFAOYSA-N 479755 US10899735, No. 214 Programmed cell death 1 ligand 1/2 Human 231 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479755&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996103 COc1nc(ccc1CN1CC2(CCN2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(CCN3)C2)c(OC)n1 InChI=1S/C36H38Cl2N6O2/c1-45-33-23(17-43-19-35(20-43)13-15-39-35)9-11-29(41-33)27-7-3-5-25(31(27)37)26-6-4-8-28(32(26)38)30-12-10-24(34(42-30)46-2)18-44-21-36(22-44)14-16-40-36/h3-12,39-40H,13-22H2,1-2H3 OVBIBESIMRTATR-UHFFFAOYSA-N 479756 US10899735, No. 215 Programmed cell death 1 ligand 1/2 Human 791 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479756&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996104 COc1nc(ccc1CNCCc1cn[nH]c1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCc2cn[nH]c2)c(OC)n1 InChI=1S/C36H36Cl2N8O2/c1-47-35-25(21-39-15-13-23-17-41-42-18-23)9-11-31(45-35)29-7-3-5-27(33(29)37)28-6-4-8-30(34(28)38)32-12-10-26(36(46-32)48-2)22-40-16-14-24-19-43-44-20-24/h3-12,17-20,39-40H,13-16,21-22H2,1-2H3,(H,41,42)(H,43,44) IPZJOTHICVKZRL-UHFFFAOYSA-N 479757 US10899735, No. 216 Programmed cell death 1 ligand 1/2 Human 1201 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479757&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996105 COc1nc(ccc1CNCCc1ncc[nH]1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCc2ncc[nH]2)c(OC)n1 InChI=1S/C36H36Cl2N8O2/c1-47-35-23(21-39-15-13-31-41-17-18-42-31)9-11-29(45-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-12-10-24(36(46-30)48-2)22-40-16-14-32-43-19-20-44-32/h3-12,17-20,39-40H,13-16,21-22H2,1-2H3,(H,41,42)(H,43,44) WQLFGQSOKLWFRR-UHFFFAOYSA-N 479758 US10899735, No. 217 Programmed cell death 1 ligand 1/2 Human 5473 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479758&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996106 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2C[C@@H](O)C[C@H]2C(O)=O)c(OC)n1 InChI=1S/C37H37Cl2N5O6/c1-49-34-21(16-43-19-37(20-43)14-13-31(46)42-37)9-11-28(40-34)26-7-3-5-24(32(26)38)25-6-4-8-27(33(25)39)29-12-10-22(35(41-29)50-2)17-44-18-23(45)15-30(44)36(47)48/h3-12,23,30,45H,13-20H2,1-2H3,(H,42,46)(H,47,48)/t23-,30-/m0/s1 UYUIBLPWOXWMAP-JHOBJCJYSA-N 479759 US10899735, No. 218 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479759&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996107 COc1nc(ccc1CN1CC2(C1)CNC(=O)O2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CNC(=O)O3)c(OC)n1 InChI=1S/C36H34Cl2N6O6/c1-47-31-21(13-43-17-35(18-43)15-39-33(45)49-35)9-11-27(41-31)25-7-3-5-23(29(25)37)24-6-4-8-26(30(24)38)28-12-10-22(32(42-28)48-2)14-44-19-36(20-44)16-40-34(46)50-36/h3-12H,13-20H2,1-2H3,(H,39,45)(H,40,46) QVPZEBTYEADLOH-UHFFFAOYSA-N 479760 US10899735, No. 219 Programmed cell death 1 ligand 1/2 Human 653 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479760&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996108 COc1nc(ccc1CNCc1nc(=O)o[nH]1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C35H33Cl2N7O5/c1-47-32-20(15-38-16-28-41-34(46)49-43-28)9-11-26(39-32)24-7-3-5-22(30(24)36)23-6-4-8-25(31(23)37)27-12-10-21(33(40-27)48-2)17-44-18-35(19-44)14-13-29(45)42-35/h3-12,38H,13-19H2,1-2H3,(H,42,45)(H,41,43,46) OANZZXVAXUNKQE-UHFFFAOYSA-N 479761 US10899735, No. 220 Programmed cell death 1 ligand 1/2 Human 546 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479761&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996109 COc1nc(ccc1CN1CCC(CC1)NC(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC(CC2)NC(C)=O)c(OC)n1 InChI=1S/C40H46Cl2N6O4/c1-25(49)43-29-15-19-47(20-16-29)23-27-11-13-35(45-39(27)51-3)33-9-5-7-31(37(33)41)32-8-6-10-34(38(32)42)36-14-12-28(40(46-36)52-4)24-48-21-17-30(18-22-48)44-26(2)50/h5-14,29-30H,15-24H2,1-4H3,(H,43,49)(H,44,50) VXRSYVMYUIEHNT-UHFFFAOYSA-N 479762 US10899735, No. 221 Programmed cell death 1 ligand 1/2 Human 347 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479762&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996110 COc1nc(ccc1CN1CC[C@@H](C1)NC(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@@H](C2)NC(C)=O)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-23(47)41-27-15-17-45(21-27)19-25-11-13-33(43-37(25)49-3)31-9-5-7-29(35(31)39)30-8-6-10-32(36(30)40)34-14-12-26(38(44-34)50-4)20-46-18-16-28(22-46)42-24(2)48/h5-14,27-28H,15-22H2,1-4H3,(H,41,47)(H,42,48)/t27-,28-/m0/s1 CSLMAHJGYCVVLZ-NSOVKSMOSA-N 479763 US10899735, No. 222 Programmed cell death 1 ligand 1/2 Human 182 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479763&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996111 COc1nc(ccc1CN1CC[C@H](C1)NC(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@H](C2)NC(C)=O)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-23(47)41-27-15-17-45(21-27)19-25-11-13-33(43-37(25)49-3)31-9-5-7-29(35(31)39)30-8-6-10-32(36(30)40)34-14-12-26(38(44-34)50-4)20-46-18-16-28(22-46)42-24(2)48/h5-14,27-28H,15-22H2,1-4H3,(H,41,47)(H,42,48)/t27-,28-/m1/s1 CSLMAHJGYCVVLZ-VSGBNLITSA-N 479764 US10899735, No. 223 Programmed cell death 1 ligand 1/2 Human 164 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479764&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996112 COc1nc(ccc1CN1CC2(C1)CN(C2)C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CN(C3)C(C)=O)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-25(49)47-21-39(22-47)17-45(18-39)15-27-11-13-33(43-37(27)51-3)31-9-5-7-29(35(31)41)30-8-6-10-32(36(30)42)34-14-12-28(38(44-34)52-4)16-46-19-40(20-46)23-48(24-40)26(2)50/h5-14H,15-24H2,1-4H3 MQDAAJUTAKEGML-UHFFFAOYSA-N 479765 US10899735, No. 224 Programmed cell death 1 ligand 1/2 Human 227 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479765&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996113 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC[C@H]2C(O)=O)c(OC)n1 InChI=1S/C37H37Cl2N5O5/c1-48-34-22(18-43-20-37(21-43)16-15-31(45)42-37)11-13-28(40-34)26-8-3-6-24(32(26)38)25-7-4-9-27(33(25)39)29-14-12-23(35(41-29)49-2)19-44-17-5-10-30(44)36(46)47/h3-4,6-9,11-14,30H,5,10,15-21H2,1-2H3,(H,42,45)(H,46,47)/t30-/m0/s1 BKAMKWFSKIKUGT-PMERELPUSA-N 479766 US10899735, No. 225 Programmed cell death 1 ligand 1/2 Human 65.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479766&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996114 COc1nc(ccc1CNCc1nnn[nH]1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C34H33Cl2N9O3/c1-47-32-20(15-37-16-28-41-43-44-42-28)9-11-26(38-32)24-7-3-5-22(30(24)35)23-6-4-8-25(31(23)36)27-12-10-21(33(39-27)48-2)17-45-18-34(19-45)14-13-29(46)40-34/h3-12,37H,13-19H2,1-2H3,(H,40,46)(H,41,42,43,44) SZEQRMXDVHJMDF-UHFFFAOYSA-N 479767 US10899735, No. 226 Programmed cell death 1 ligand 1/2 Human 273 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479767&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996115 COc1nc(ccc1CNCC(=O)NS(C)(=O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C35H36Cl2N6O6S/c1-48-33-21(16-38-17-30(45)42-50(3,46)47)10-12-27(39-33)25-8-4-6-23(31(25)36)24-7-5-9-26(32(24)37)28-13-11-22(34(40-28)49-2)18-43-19-35(20-43)15-14-29(44)41-35/h4-13,38H,14-20H2,1-3H3,(H,41,44)(H,42,45) YXPRZTFYXMXBSN-UHFFFAOYSA-N 479768 US10899735, No. 227 Programmed cell death 1 ligand 1/2 Human 162 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479768&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996116 COc1nc(ccc1CNCCC(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C35H35Cl2N5O5/c1-46-33-21(17-38-16-14-30(44)45)9-11-27(39-33)25-7-3-5-23(31(25)36)24-6-4-8-26(32(24)37)28-12-10-22(34(40-28)47-2)18-42-19-35(20-42)15-13-29(43)41-35/h3-12,38H,13-20H2,1-2H3,(H,41,43)(H,44,45) YSVADVSBCHZMLA-UHFFFAOYSA-N 479769 US10899735, No. 228 Programmed cell death 1 ligand 1/2 Human 136 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479769&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996117 COc1nc(ccc1CNCCCC(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C36H37Cl2N5O5/c1-47-34-22(18-39-17-5-10-31(45)46)11-13-28(40-34)26-8-3-6-24(32(26)37)25-7-4-9-27(33(25)38)29-14-12-23(35(41-29)48-2)19-43-20-36(21-43)16-15-30(44)42-36/h3-4,6-9,11-14,39H,5,10,15-21H2,1-2H3,(H,42,44)(H,45,46) ZKJDCLYFPQMEEW-UHFFFAOYSA-N 479770 US10899735, No. 229 Programmed cell death 1 ligand 1/2 Human 74.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479770&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996118 COc1nc(ccc1CNC[C@@H](O)C(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C35H35Cl2N5O6/c1-47-32-20(15-38-16-28(43)34(45)46)9-11-26(39-32)24-7-3-5-22(30(24)36)23-6-4-8-25(31(23)37)27-12-10-21(33(40-27)48-2)17-42-18-35(19-42)14-13-29(44)41-35/h3-12,28,38,43H,13-19H2,1-2H3,(H,41,44)(H,45,46)/t28-/m1/s1 QNZPURFWGFOSLI-MUUNZHRXSA-N 479771 US10899735, No. 230 Programmed cell death 1 ligand 1/2 Human 268 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479771&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C02929 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996119 COc1nc(ccc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C36H37Cl2N5O6/c1-48-34-21(16-39-17-23(44)15-31(46)47)9-11-28(40-34)26-7-3-5-24(32(26)37)25-6-4-8-27(33(25)38)29-12-10-22(35(41-29)49-2)18-43-19-36(20-43)14-13-30(45)42-36/h3-12,23,39,44H,13-20H2,1-2H3,(H,42,45)(H,46,47)/t23-/m0/s1 LYDZMNONBACXNL-QHCPKHFHSA-N 479772 US10899735, No. 231 Programmed cell death 1 ligand 1/2 Human 176 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479772&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996120 COc1nc(ccc1CNCC(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C34H33Cl2N5O5/c1-45-32-20(15-37-16-29(43)44)9-11-26(38-32)24-7-3-5-22(30(24)35)23-6-4-8-25(31(23)36)27-12-10-21(33(39-27)46-2)17-41-18-34(19-41)14-13-28(42)40-34/h3-12,37H,13-19H2,1-2H3,(H,40,42)(H,43,44) RNAMENRHUJSNSC-UHFFFAOYSA-N 479773 US10899735, No. 232 Programmed cell death 1 ligand 1/2 Human 121 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479773&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996121 COc1nc(ccc1CN1CCC2(CCC(=O)N2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CCC(=O)N3)C2)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-37-25(21-47-19-17-39(23-47)15-13-33(49)45-39)9-11-31(43-37)29-7-3-5-27(35(29)41)28-6-4-8-30(36(28)42)32-12-10-26(38(44-32)52-2)22-48-20-18-40(24-48)16-14-34(50)46-40/h3-12H,13-24H2,1-2H3,(H,45,49)(H,46,50) BAEFCGDHNMNKPE-UHFFFAOYSA-N 479774 US10899735, No. 233 Programmed cell death 1 ligand 1/2 Human 204 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479774&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996122 COc1nc(ccc1CN1CC2(C1)CCCCN2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCCCN3)c(OC)n1 InChI=1S/C40H46Cl2N6O2/c1-49-37-27(21-47-23-39(24-47)17-3-5-19-43-39)13-15-33(45-37)31-11-7-9-29(35(31)41)30-10-8-12-32(36(30)42)34-16-14-28(38(46-34)50-2)22-48-25-40(26-48)18-4-6-20-44-40/h7-16,43-44H,3-6,17-26H2,1-2H3 FNSTVWICOHREQZ-UHFFFAOYSA-N 479775 US10899735, No. 234 Programmed cell death 1 ligand 1/2 Human 7949 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479775&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996123 COc1nc(ccc1CN[C@@H]1CNC(=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN[C@@H]2CNC(=O)C2)c(OC)n1 InChI=1S/C34H34Cl2N6O4/c1-45-33-19(15-37-21-13-29(43)39-17-21)9-11-27(41-33)25-7-3-5-23(31(25)35)24-6-4-8-26(32(24)36)28-12-10-20(34(42-28)46-2)16-38-22-14-30(44)40-18-22/h3-12,21-22,37-38H,13-18H2,1-2H3,(H,39,43)(H,40,44)/t21-,22-/m0/s1 NSRFYCLSEUPKPP-VXKWHMMOSA-N 479776 US10899735, No. 235 Programmed cell death 1 ligand 1/2 Human 318 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479776&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996124 COc1nc(ccc1CN[C@H]1CNC(=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN[C@H]2CNC(=O)C2)c(OC)n1 InChI=1S/C34H34Cl2N6O4/c1-45-33-19(15-37-21-13-29(43)39-17-21)9-11-27(41-33)25-7-3-5-23(31(25)35)24-6-4-8-26(32(24)36)28-12-10-20(34(42-28)46-2)16-38-22-14-30(44)40-18-22/h3-12,21-22,37-38H,13-18H2,1-2H3,(H,39,43)(H,40,44)/t21-,22-/m1/s1 NSRFYCLSEUPKPP-FGZHOGPDSA-N 479777 US10899735, No. 236 Programmed cell death 1 ligand 1/2 Human 231 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479777&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996125 COc1nc(ccc1CN1CCC2(CNC(=O)O2)CC1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CNC(=O)O3)CC2)c(OC)n1 InChI=1S/C40H42Cl2N6O6/c1-51-35-25(21-47-17-13-39(14-18-47)23-43-37(49)53-39)9-11-31(45-35)29-7-3-5-27(33(29)41)28-6-4-8-30(34(28)42)32-12-10-26(36(46-32)52-2)22-48-19-15-40(16-20-48)24-44-38(50)54-40/h3-12H,13-24H2,1-2H3,(H,43,49)(H,44,50) DLJZIJVKFABKRP-UHFFFAOYSA-N 479778 US10899735, No. 237 Programmed cell death 1 ligand 1/2 Human 1665 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479778&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996126 COc1nc(ccc1CNC1CCC2(CNC(=O)C2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC2CCC3(CNC(=O)C3)C2)c(OC)n1 InChI=1S/C42H46Cl2N6O4/c1-53-39-25(21-45-27-13-15-41(17-27)19-35(51)47-23-41)9-11-33(49-39)31-7-3-5-29(37(31)43)30-6-4-8-32(38(30)44)34-12-10-26(40(50-34)54-2)22-46-28-14-16-42(18-28)20-36(52)48-24-42/h3-12,27-28,45-46H,13-24H2,1-2H3,(H,47,51)(H,48,52) MVQPUMJOXFYRAY-UHFFFAOYSA-N 479779 US10899735, No. 238 Programmed cell death 1 ligand 1/2 Human 279 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479779&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996127 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C33H32Cl2N6O3/c1-43-32-19(17-36-18-20-10-14-28(42)39-20)9-12-26(40-32)23-7-3-5-21(29(23)34)22-6-4-8-24(30(22)35)27-13-11-25(33(41-27)44-2)31-37-15-16-38-31/h3-9,11-13,20,36H,10,14-18H2,1-2H3,(H,37,38)(H,39,42)/t20-/m0/s1 VEOBTOJLTUCYLL-FQEVSTJZSA-N 479780 US10899735, No. 239 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479780&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996128 COc1nc(ccc1CN1CC2(C1)CNC(=O)C2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2=NCCN2)c(OC)n1 InChI=1S/C34H32Cl2N6O3/c1-44-32-20(16-42-18-34(19-42)15-28(43)39-17-34)9-11-26(40-32)23-7-3-5-21(29(23)35)22-6-4-8-24(30(22)36)27-12-10-25(33(41-27)45-2)31-37-13-14-38-31/h3-12H,13-19H2,1-2H3,(H,37,38)(H,39,43) HXGGJUNVDJBAHS-UHFFFAOYSA-N 479781 US10899735, No. 240 Programmed cell death 1 ligand 1/2 Human 75.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479781&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996129 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CCC(=O)N3)CC2)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-37-25(21-47-19-17-39(18-20-47)15-13-33(49)45-39)9-11-31(43-37)29-7-3-5-27(35(29)41)28-6-4-8-30(36(28)42)32-12-10-26(38(44-32)52-2)22-48-23-40(24-48)16-14-34(50)46-40/h3-12H,13-24H2,1-2H3,(H,45,49)(H,46,50) VIKCCNILKDRXIN-UHFFFAOYSA-N 479782 US10899735, No. 241 Programmed cell death 1 ligand 1/2 Human 319 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479782&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996130 COc1nc(ccc1CNC1CCN(CC1)C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C39H42Cl2N6O4/c1-24(48)47-18-15-27(16-19-47)42-20-25-10-12-32(43-37(25)50-2)30-8-4-6-28(35(30)40)29-7-5-9-31(36(29)41)33-13-11-26(38(44-33)51-3)21-46-22-39(23-46)17-14-34(49)45-39/h4-13,27,42H,14-23H2,1-3H3,(H,45,49) HCAARPRUMJZOKM-UHFFFAOYSA-N 479783 US10899735, No. 242 Programmed cell death 1 ligand 1/2 Human 390 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479783&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996131 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC(C2)NC(C)=O)c(OC)n1 InChI=1S/C38H40Cl2N6O4/c1-23(47)41-26-15-17-45(20-26)18-24-10-12-31(42-36(24)49-2)29-8-4-6-27(34(29)39)28-7-5-9-30(35(28)40)32-13-11-25(37(43-32)50-3)19-46-21-38(22-46)16-14-33(48)44-38/h4-13,26H,14-22H2,1-3H3,(H,41,47)(H,44,48) VLADIOYVDMALMP-UHFFFAOYSA-N 479784 US10899735, No. 243 Programmed cell death 1 ligand 1/2 Human 280 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479784&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996132 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C37H38Cl2N6O4/c1-48-35-22(17-40-18-24-11-14-31(46)41-24)9-12-29(42-35)27-7-3-5-25(33(27)38)26-6-4-8-28(34(26)39)30-13-10-23(36(43-30)49-2)19-45-20-37(21-45)16-15-32(47)44-37/h3-10,12-13,24,40H,11,14-21H2,1-2H3,(H,41,46)(H,44,47)/t24-/m0/s1 YGCDYEXNEWEELY-DEOSSOPVSA-N 479785 US10899735, No. 244 Programmed cell death 1 ligand 1/2 Human 95.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479785&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996133 COc1nc(ccc1CN1CC2(C1)CNC(=O)C2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C38H38Cl2N6O4/c1-49-35-23(16-45-19-37(20-45)15-32(48)41-18-37)9-11-29(42-35)27-7-3-5-25(33(27)39)26-6-4-8-28(34(26)40)30-12-10-24(36(43-30)50-2)17-46-21-38(22-46)14-13-31(47)44-38/h3-12H,13-22H2,1-2H3,(H,41,48)(H,44,47) XHBCRURLMGVYLG-UHFFFAOYSA-N 479786 US10899735, No. 245 Programmed cell death 1 ligand 1/2 Human 223 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479786&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996134 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C34H35Cl2N5O4/c1-44-32-21(17-37-15-16-42)9-11-27(38-32)25-7-3-5-23(30(25)35)24-6-4-8-26(31(24)36)28-12-10-22(33(39-28)45-2)18-41-19-34(20-41)14-13-29(43)40-34/h3-12,37,42H,13-20H2,1-2H3,(H,40,43) QKNLVFGSDUOVEK-UHFFFAOYSA-N 479787 US10899735, No. 246 Programmed cell death 1 ligand 1/2 Human 166 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479787&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996135 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CNC(=O)C3)c(OC)n1 InChI=1S/C37H38Cl2N6O4/c1-48-35-22(16-40-17-24-11-14-31(46)42-24)9-12-29(43-35)27-7-3-5-25(33(27)38)26-6-4-8-28(34(26)39)30-13-10-23(36(44-30)49-2)18-45-20-37(21-45)15-32(47)41-19-37/h3-10,12-13,24,40H,11,14-21H2,1-2H3,(H,41,47)(H,42,46)/t24-/m0/s1 FMIPGNMKNVLBDC-DEOSSOPVSA-N 479788 US10899735, No. 247 Programmed cell death 1 ligand 1/2 Human 115 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479788&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996136 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C33H35Cl2N5O4/c1-43-32-20(17-36-15-16-41)9-12-27(39-32)25-7-3-5-23(30(25)34)24-6-4-8-26(31(24)35)28-13-10-21(33(40-28)44-2)18-37-19-22-11-14-29(42)38-22/h3-10,12-13,22,36-37,41H,11,14-19H2,1-2H3,(H,38,42)/t22-/m0/s1 DGQAPZRXFLSBMS-QFIPXVFZSA-N 479789 US10899735, No. 248 Programmed cell death 1 ligand 1/2 Human 131 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479789&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996137 COc1nc(ccc1CNC1CN(C1)c1ncccn1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC2CN(C2)c2ncccn2)c(OC)n1 InChI=1S/C40H38Cl2N10O2/c1-53-37-25(19-47-27-21-51(22-27)39-43-15-5-16-44-39)11-13-33(49-37)31-9-3-7-29(35(31)41)30-8-4-10-32(36(30)42)34-14-12-26(38(50-34)54-2)20-48-28-23-52(24-28)40-45-17-6-18-46-40/h3-18,27-28,47-48H,19-24H2,1-2H3 BJJHUDOOVDSSFX-UHFFFAOYSA-N 479790 US10899735, No. 249 Programmed cell death 1 ligand 1/2 Human 3973 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479790&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996138 COc1nc(ccc1CN1CCC2(CCN(C2)C(C)=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CCN(C3)C(C)=O)C2)c(OC)n1 InChI=1S/C44H50Cl2N6O4/c1-29(53)51-21-17-43(27-51)15-19-49(25-43)23-31-11-13-37(47-41(31)55-3)35-9-5-7-33(39(35)45)34-8-6-10-36(40(34)46)38-14-12-32(42(48-38)56-4)24-50-20-16-44(26-50)18-22-52(28-44)30(2)54/h5-14H,15-28H2,1-4H3 YSPLBBDQRNLAKP-UHFFFAOYSA-N 479791 US10899735, No. 250 Programmed cell death 1 ligand 1/2 Human 283 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479791&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996139 COc1nc(ccc1CN1CCCC2(CCN(C2)C(C)=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCCC3(CCN(C3)C(C)=O)C2)c(OC)n1 InChI=1S/C46H54Cl2N6O4/c1-31(55)53-23-19-45(29-53)17-7-21-51(27-45)25-33-13-15-39(49-43(33)57-3)37-11-5-9-35(41(37)47)36-10-6-12-38(42(36)48)40-16-14-34(44(50-40)58-4)26-52-22-8-18-46(28-52)20-24-54(30-46)32(2)56/h5-6,9-16H,7-8,17-30H2,1-4H3 UMZJJJKNOFGXRX-UHFFFAOYSA-N 479792 US10899735, No. 251 Programmed cell death 1 ligand 1/2 Human 1396 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479792&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996140 COc1nc(ccc1CN1CCC2(CCNC2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CCNC3)C2)c(OC)n1 InChI=1S/C40H46Cl2N6O2/c1-49-37-27(21-47-19-15-39(25-47)13-17-43-23-39)9-11-33(45-37)31-7-3-5-29(35(31)41)30-6-4-8-32(36(30)42)34-12-10-28(38(46-34)50-2)22-48-20-16-40(26-48)14-18-44-24-40/h3-12,43-44H,13-26H2,1-2H3 CZALCOSZTGPYQQ-UHFFFAOYSA-N 479793 US10899735, No. 252 Programmed cell death 1 ligand 1/2 Human 3852 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479793&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996141 COc1nc(ccc1CN1CC2(C1)CCNC2=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCNC3=O)c(OC)n1 InChI=1S/C38H38Cl2N6O4/c1-49-33-23(17-45-19-37(20-45)13-15-41-35(37)47)9-11-29(43-33)27-7-3-5-25(31(27)39)26-6-4-8-28(32(26)40)30-12-10-24(34(44-30)50-2)18-46-21-38(22-46)14-16-42-36(38)48/h3-12H,13-22H2,1-2H3,(H,41,47)(H,42,48) VQIFXUZONHNCOA-UHFFFAOYSA-N 479794 US10899735, No. 253 Programmed cell death 1 ligand 1/2 Human 235 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479794&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996142 COc1nc(ccc1CN1CCC2(C1)CCCN(C2)C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(C2)CCCN(C3)C(C)=O)c(OC)n1 InChI=1S/C46H54Cl2N6O4/c1-31(55)53-21-7-17-45(29-53)19-23-51(27-45)25-33-13-15-39(49-43(33)57-3)37-11-5-9-35(41(37)47)36-10-6-12-38(42(36)48)40-16-14-34(44(50-40)58-4)26-52-24-20-46(28-52)18-8-22-54(30-46)32(2)56/h5-6,9-16H,7-8,17-30H2,1-4H3 ZSWBUVKVTIQHOU-UHFFFAOYSA-N 479795 US10899735, No. 254 Programmed cell death 1 ligand 1/2 Human 647 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479795&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996143 COc1nc(ccc1CN1CCC2(CCN2C(C)=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CCN3C(C)=O)C2)c(OC)n1 InChI=1S/C42H46Cl2N6O4/c1-27(51)49-21-17-41(49)15-19-47(25-41)23-29-11-13-35(45-39(29)53-3)33-9-5-7-31(37(33)43)32-8-6-10-34(38(32)44)36-14-12-30(40(46-36)54-4)24-48-20-16-42(26-48)18-22-50(42)28(2)52/h5-14H,15-26H2,1-4H3 SQIZFJGWLZHTNH-UHFFFAOYSA-N 479796 US10899735, No. 255 Programmed cell death 1 ligand 1/2 Human 245 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479796&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996144 COc1nc(ccc1CN1CCCC2(CCNC2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCCC3(CCNC3)C2)c(OC)n1 InChI=1S/C42H50Cl2N6O2/c1-51-39-29(23-49-21-5-15-41(27-49)17-19-45-25-41)11-13-35(47-39)33-9-3-7-31(37(33)43)32-8-4-10-34(38(32)44)36-14-12-30(40(48-36)52-2)24-50-22-6-16-42(28-50)18-20-46-26-42/h3-4,7-14,45-46H,5-6,15-28H2,1-2H3 IFMJDBKLXPYTQC-UHFFFAOYSA-N 479797 US10899735, No. 256 Programmed cell death 1 ligand 1/2 Human 10175 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479797&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996145 COc1nc(ccc1CN1CCC2(CCN2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CCN3)C2)c(OC)n1 InChI=1S/C38H42Cl2N6O2/c1-47-35-25(21-45-19-15-37(23-45)13-17-41-37)9-11-31(43-35)29-7-3-5-27(33(29)39)28-6-4-8-30(34(28)40)32-12-10-26(36(44-32)48-2)22-46-20-16-38(24-46)14-18-42-38/h3-12,41-42H,13-24H2,1-2H3 RZLBOWUUPWBBQM-UHFFFAOYSA-N 479798 US10899735, No. 257 Programmed cell death 1 ligand 1/2 Human 1033 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479798&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996146 COc1nc(ccc1CN1CC2(C1)CCNC2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCNC3)c(OC)n1 InChI=1S/C38H42Cl2N6O2/c1-47-35-25(17-45-21-37(22-45)13-15-41-19-37)9-11-31(43-35)29-7-3-5-27(33(29)39)28-6-4-8-30(34(28)40)32-12-10-26(36(44-32)48-2)18-46-23-38(24-46)14-16-42-20-38/h3-12,41-42H,13-24H2,1-2H3 OMMPPLVCLXIUDL-UHFFFAOYSA-N 479799 US10899735, No. 258 Programmed cell death 1 ligand 1/2 Human 339 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479799&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996147 COc1nc(ccc1CN1CC2(C1)CCN(C2)C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCN(C3)C(C)=O)c(OC)n1 InChI=1S/C42H46Cl2N6O4/c1-27(51)49-17-15-41(25-49)21-47(22-41)19-29-11-13-35(45-39(29)53-3)33-9-5-7-31(37(33)43)32-8-6-10-34(38(32)44)36-14-12-30(40(46-36)54-4)20-48-23-42(24-48)16-18-50(26-42)28(2)52/h5-14H,15-26H2,1-4H3 AAAYEMCSUKCJJA-UHFFFAOYSA-N 479800 US10899735, No. 259 Programmed cell death 1 ligand 1/2 Human 111 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479800&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996148 COc1nc(ccc1CN1CCCC2(CN(C2)C(C)=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCCC3(CN(C3)C(C)=O)C2)c(OC)n1 InChI=1S/C44H50Cl2N6O4/c1-29(53)51-25-43(26-51)17-7-19-49(23-43)21-31-13-15-37(47-41(31)55-3)35-11-5-9-33(39(35)45)34-10-6-12-36(40(34)46)38-16-14-32(42(48-38)56-4)22-50-20-8-18-44(24-50)27-52(28-44)30(2)54/h5-6,9-16H,7-8,17-28H2,1-4H3 VSYYMJQYWLIAFT-UHFFFAOYSA-N 479801 US10899735, No. 260 Programmed cell death 1 ligand 1/2 Human 2738 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479801&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996149 COc1nc(ccc1CN1CC2(CNC2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(CNC3)C2)c(OC)n1 InChI=1S/C36H38Cl2N6O2/c1-45-33-23(13-43-19-35(20-43)15-39-16-35)9-11-29(41-33)27-7-3-5-25(31(27)37)26-6-4-8-28(32(26)38)30-12-10-24(34(42-30)46-2)14-44-21-36(22-44)17-40-18-36/h3-12,39-40H,13-22H2,1-2H3 DETAUYATJMOSCY-UHFFFAOYSA-N 479802 US10899735, No. 261 Programmed cell death 1 ligand 1/2 Human 2271 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479802&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996150 COc1nc(ccc1CN1CC[C@@H]2CNC(=O)[C@@H]2C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@@H]3CNC(=O)[C@@H]3C2)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-39-25(19-47-15-13-23-17-43-37(49)31(23)21-47)9-11-33(45-39)29-7-3-5-27(35(29)41)28-6-4-8-30(36(28)42)34-12-10-26(40(46-34)52-2)20-48-16-14-24-18-44-38(50)32(24)22-48/h3-12,23-24,31-32H,13-22H2,1-2H3,(H,43,49)(H,44,50)/t23-,24-,31-,32-/m1/s1 KGWBUVUEFZMWIA-MIZPTILZSA-N 479803 US10899735, No. 262 Programmed cell death 1 ligand 1/2 Human 650 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479803&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996151 COc1nc(ccc1CN1CCC2(CNC2=O)CC1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CNC3=O)CC2)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-35-25(21-47-17-13-39(14-18-47)23-43-37(39)49)9-11-31(45-35)29-7-3-5-27(33(29)41)28-6-4-8-30(34(28)42)32-12-10-26(36(46-32)52-2)22-48-19-15-40(16-20-48)24-44-38(40)50/h3-12H,13-24H2,1-2H3,(H,43,49)(H,44,50) LZJLDNOIMFVPCT-UHFFFAOYSA-N 479804 US10899735, No. 263 Programmed cell death 1 ligand 1/2 Human 619 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479804&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996152 COc1nc(ccc1CN1CCC2(CC(=O)N2)CC1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CC(=O)N3)CC2)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-37-25(23-47-17-13-39(14-18-47)21-33(49)45-39)9-11-31(43-37)29-7-3-5-27(35(29)41)28-6-4-8-30(36(28)42)32-12-10-26(38(44-32)52-2)24-48-19-15-40(16-20-48)22-34(50)46-40/h3-12H,13-24H2,1-2H3,(H,45,49)(H,46,50) WYYVOTUVEHFYAY-UHFFFAOYSA-N 479805 US10899735, No. 264 Programmed cell death 1 ligand 1/2 Human 798 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479805&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996153 COc1nc(ccc1CN1CCN(CC1)C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCN(CC2)C(C)=O)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-25(47)45-19-15-43(16-20-45)23-27-11-13-33(41-37(27)49-3)31-9-5-7-29(35(31)39)30-8-6-10-32(36(30)40)34-14-12-28(38(42-34)50-4)24-44-17-21-46(22-18-44)26(2)48/h5-14H,15-24H2,1-4H3 IUGPPLBVFKASIO-UHFFFAOYSA-N 479806 US10899735, No. 265 Programmed cell death 1 ligand 1/2 Human 1395 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479806&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996154 COc1nc(ccc1CN1CCC2(CCCC(=O)N2)CC1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CCCC(=O)N3)CC2)c(OC)n1 InChI=1S/C44H50Cl2N6O4/c1-55-41-29(27-51-23-19-43(20-24-51)17-5-11-37(53)49-43)13-15-35(47-41)33-9-3-7-31(39(33)45)32-8-4-10-34(40(32)46)36-16-14-30(42(48-36)56-2)28-52-25-21-44(22-26-52)18-6-12-38(54)50-44/h3-4,7-10,13-16H,5-6,11-12,17-28H2,1-2H3,(H,49,53)(H,50,54) ZUZKNHSBTZDSFJ-UHFFFAOYSA-N 479807 US10899735, No. 266 Programmed cell death 1 ligand 1/2 Human 568 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479807&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996155 COc1cc(ccc1CNC1CN(C1)c1ccncn1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC2CN(C2)c2ccncn2)c(OC)n1 InChI=1S/C41H39Cl2N9O2/c1-53-36-17-26(9-10-27(36)18-46-29-20-51(21-29)37-13-15-44-24-48-37)31-5-3-6-32(39(31)42)33-7-4-8-34(40(33)43)35-12-11-28(41(50-35)54-2)19-47-30-22-52(23-30)38-14-16-45-25-49-38/h3-17,24-25,29-30,46-47H,18-23H2,1-2H3 OSPLIKHCDWAPGY-UHFFFAOYSA-N 479808 US10899735, No. 267 Programmed cell death 1 ligand 1/2 Human 1003 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479808&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996156 COc1nc(ccc1CNC1CN(C1)c1nncs1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC2CN(C2)c2nncs2)c(OC)n1 InChI=1S/C36H34Cl2N10O2S2/c1-49-33-21(13-39-23-15-47(16-23)35-45-41-19-51-35)9-11-29(43-33)27-7-3-5-25(31(27)37)26-6-4-8-28(32(26)38)30-12-10-22(34(44-30)50-2)14-40-24-17-48(18-24)36-46-42-20-52-36/h3-12,19-20,23-24,39-40H,13-18H2,1-2H3 UWYQHIZZAKEVIR-UHFFFAOYSA-N 479809 US10899735, No. 268 Programmed cell death 1 ligand 1/2 Human 3275 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479809&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996157 COc1nc(ccc1CNC1CCN(CC1)C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC2CCN(CC2)C(C)=O)c(OC)n1 InChI=1S/C40H46Cl2N6O4/c1-25(49)47-19-15-29(16-20-47)43-23-27-11-13-35(45-39(27)51-3)33-9-5-7-31(37(33)41)32-8-6-10-34(38(32)42)36-14-12-28(40(46-36)52-4)24-44-30-17-21-48(22-18-30)26(2)50/h5-14,29-30,43-44H,15-24H2,1-4H3 MUEMGMDUYLHQSB-UHFFFAOYSA-N 479810 US10899735, No. 269 Programmed cell death 1 ligand 1/2 Human 67.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479810&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996158 COc1nc(ccc1CN1CCCC(C1)NC(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCCC(C2)NC(C)=O)c(OC)n1 InChI=1S/C40H46Cl2N6O4/c1-25(49)43-29-9-7-19-47(23-29)21-27-15-17-35(45-39(27)51-3)33-13-5-11-31(37(33)41)32-12-6-14-34(38(32)42)36-18-16-28(40(46-36)52-4)22-48-20-8-10-30(24-48)44-26(2)50/h5-6,11-18,29-30H,7-10,19-24H2,1-4H3,(H,43,49)(H,44,50) KPNHCJFJHDLVJV-UHFFFAOYSA-N 479811 US10899735, No. 270 Programmed cell death 1 ligand 1/2 Human 1259 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479811&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996159 COc1nc(ccc1CN1CCC(C1)NC(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC(C2)NC(C)=O)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-23(47)41-27-15-17-45(21-27)19-25-11-13-33(43-37(25)49-3)31-9-5-7-29(35(31)39)30-8-6-10-32(36(30)40)34-14-12-26(38(44-34)50-4)20-46-18-16-28(22-46)42-24(2)48/h5-14,27-28H,15-22H2,1-4H3,(H,41,47)(H,42,48) CSLMAHJGYCVVLZ-UHFFFAOYSA-N 479812 US10899735, No. 271 Programmed cell death 1 ligand 1/2 Human 398 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479812&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996160 COc1nc(ccc1CN1CC2(C1)CNC(=O)C2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CNC(=O)C3)c(OC)n1 InChI=1S/C38H38Cl2N6O4/c1-49-35-23(15-45-19-37(20-45)13-31(47)41-17-37)9-11-29(43-35)27-7-3-5-25(33(27)39)26-6-4-8-28(34(26)40)30-12-10-24(36(44-30)50-2)16-46-21-38(22-46)14-32(48)42-18-38/h3-12H,13-22H2,1-2H3,(H,41,47)(H,42,48) JAUJTSMIGRNTMW-UHFFFAOYSA-N 479813 US10899735, No. 272 Programmed cell death 1 ligand 1/2 Human 172 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479813&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996161 COc1nc(ccc1CN1CCC2(CNC(=O)C2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CNC(=O)C3)C2)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-37-25(19-47-15-13-39(23-47)17-33(49)43-21-39)9-11-31(45-37)29-7-3-5-27(35(29)41)28-6-4-8-30(36(28)42)32-12-10-26(38(46-32)52-2)20-48-16-14-40(24-48)18-34(50)44-22-40/h3-12H,13-24H2,1-2H3,(H,43,49)(H,44,50) WRUXIJVLAFFEQG-UHFFFAOYSA-N 479814 US10899735, No. 273 Programmed cell death 1 ligand 1/2 Human 433 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479814&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996162 COc1nc(ccc1CNC1CCN(C1)c1ccncn1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC2CCN(C2)c2ccncn2)c(OC)n1 InChI=1S/C42H42Cl2N10O2/c1-55-41-27(21-47-29-15-19-53(23-29)37-13-17-45-25-49-37)9-11-35(51-41)33-7-3-5-31(39(33)43)32-6-4-8-34(40(32)44)36-12-10-28(42(52-36)56-2)22-48-30-16-20-54(24-30)38-14-18-46-26-50-38/h3-14,17-18,25-26,29-30,47-48H,15-16,19-24H2,1-2H3 WWJFXUASWFZVFJ-UHFFFAOYSA-N 479815 US10899735, No. 274 Programmed cell death 1 ligand 1/2 Human 2573 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479815&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996163 COc1nc(ccc1CN1CCCC2(CNC(=O)C2)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCCC3(CNC(=O)C3)C2)c(OC)n1 InChI=1S/C42H46Cl2N6O4/c1-53-39-27(21-49-17-5-15-41(25-49)19-35(51)45-23-41)11-13-33(47-39)31-9-3-7-29(37(31)43)30-8-4-10-32(38(30)44)34-14-12-28(40(48-34)54-2)22-50-18-6-16-42(26-50)20-36(52)46-24-42/h3-4,7-14H,5-6,15-26H2,1-2H3,(H,45,51)(H,46,52) APHQYXSHXGCHGW-UHFFFAOYSA-N 479816 US10899735, No. 275 Programmed cell death 1 ligand 1/2 Human 5867 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479816&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996164 COc1nc(ccc1CN1CCC2(CCC(=O)N2)CC1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CCC(=O)N3)CC2)c(OC)n1 InChI=1S/C42H46Cl2N6O4/c1-53-39-27(25-49-21-17-41(18-22-49)15-13-35(51)47-41)9-11-33(45-39)31-7-3-5-29(37(31)43)30-6-4-8-32(38(30)44)34-12-10-28(40(46-34)54-2)26-50-23-19-42(20-24-50)16-14-36(52)48-42/h3-12H,13-26H2,1-2H3,(H,47,51)(H,48,52) WDUOCZIPAGVGBX-UHFFFAOYSA-N 479817 US10899735, No. 276 Programmed cell death 1 ligand 1/2 Human 165 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479817&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996165 COc1nc(ccc1CNC1CCN(C1)c1cncnc1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC2CCN(C2)c2cncnc2)c(OC)n1 InChI=1S/C42H42Cl2N10O2/c1-55-41-27(17-49-29-13-15-53(23-29)31-19-45-25-46-20-31)9-11-37(51-41)35-7-3-5-33(39(35)43)34-6-4-8-36(40(34)44)38-12-10-28(42(52-38)56-2)18-50-30-14-16-54(24-30)32-21-47-26-48-22-32/h3-12,19-22,25-26,29-30,49-50H,13-18,23-24H2,1-2H3 ISGUYKBQIDOWCK-UHFFFAOYSA-N 479818 US10899735, No. 277 Programmed cell death 1 ligand 1/2 Human 3447 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479818&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996166 COc1nc(ccc1CN1CCC2(CNC(=O)C2)CC1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC3(CNC(=O)C3)CC2)c(OC)n1 InChI=1S/C42H46Cl2N6O4/c1-53-39-27(23-49-17-13-41(14-18-49)21-35(51)45-25-41)9-11-33(47-39)31-7-3-5-29(37(31)43)30-6-4-8-32(38(30)44)34-12-10-28(40(48-34)54-2)24-50-19-15-42(16-20-50)22-36(52)46-26-42/h3-12H,13-26H2,1-2H3,(H,45,51)(H,46,52) ZCBWEMDXSHEQLG-UHFFFAOYSA-N 479819 US10899735, No. 278 Programmed cell death 1 ligand 1/2 Human 390 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479819&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996167 COc1nc(ccc1CNC1CNC(=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC2CNC(=O)C2)c(OC)n1 InChI=1S/C34H34Cl2N6O4/c1-45-33-19(15-37-21-13-29(43)39-17-21)9-11-27(41-33)25-7-3-5-23(31(25)35)24-6-4-8-26(32(24)36)28-12-10-20(34(42-28)46-2)16-38-22-14-30(44)40-18-22/h3-12,21-22,37-38H,13-18H2,1-2H3,(H,39,43)(H,40,44) NSRFYCLSEUPKPP-UHFFFAOYSA-N 479820 US10899735, No. 279 Programmed cell death 1 ligand 1/2 Human 301 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479820&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996168 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C38H38Cl2N6O4/c1-49-35-23(17-45-19-37(20-45)15-13-31(47)43-37)9-11-29(41-35)27-7-3-5-25(33(27)39)26-6-4-8-28(34(26)40)30-12-10-24(36(42-30)50-2)18-46-21-38(22-46)16-14-32(48)44-38/h3-12H,13-22H2,1-2H3,(H,43,47)(H,44,48) KKMDWGJTWMTVPY-UHFFFAOYSA-N 479821 US10899735, No. 280 Programmed cell death 1 ligand 1/2 Human 223 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479821&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996169 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(OCCNC[C@@H]2CCC(=O)N2)cc1 InChI=1S/C37H39Cl2N5O4/c1-47-37-24(20-41-22-26-12-17-34(46)43-26)10-15-32(44-37)31-7-3-6-30(36(31)39)29-5-2-4-28(35(29)38)23-8-13-27(14-9-23)48-19-18-40-21-25-11-16-33(45)42-25/h2-10,13-15,25-26,40-41H,11-12,16-22H2,1H3,(H,42,45)(H,43,46)/t25-,26-/m0/s1 HHLIEAHMQWCJNP-UIOOFZCWSA-N 479822 US10899735, No. 281 Programmed cell death 1 ligand 1/2 Human 827 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479822&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996170 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(OCCN2CC3(C2)CCC(=O)N3)cc1 InChI=1S/C39H39Cl2N5O4/c1-49-37-26(20-46-23-39(24-46)17-15-34(48)44-39)10-13-32(42-37)31-7-3-6-30(36(31)41)29-5-2-4-28(35(29)40)25-8-11-27(12-9-25)50-19-18-45-21-38(22-45)16-14-33(47)43-38/h2-13H,14-24H2,1H3,(H,43,47)(H,44,48) KRYUCPJBROTRRU-UHFFFAOYSA-N 479823 US10899735, No. 282 Programmed cell death 1 ligand 1/2 Human 109 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479823&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996171 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(c1)C#CC InChI=1S/C39H39Cl2N5O3/c1-3-6-24-19-25(11-12-26(24)20-42-22-28-14-17-35(47)44-28)30-7-4-8-31(37(30)40)32-9-5-10-33(38(32)41)34-16-13-27(39(46-34)49-2)21-43-23-29-15-18-36(48)45-29/h4-5,7-13,16,19,28-29,42-43H,14-15,17-18,20-23H2,1-2H3,(H,44,47)(H,45,48)/t28-,29-/m0/s1 VRPDDSDVADXLGF-VMPREFPWSA-N 479824 US10899735, No. 283 Programmed cell death 1 ligand 1/2 Human 360 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479824&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996172 COc1cc(c(F)cc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCO)c(OC)n1 InChI=1S/C31H32Cl2FN3O4/c1-40-28-16-25(26(34)15-20(28)18-36-12-14-39)23-7-3-5-21(29(23)32)22-6-4-8-24(30(22)33)27-10-9-19(17-35-11-13-38)31(37-27)41-2/h3-10,15-16,35-36,38-39H,11-14,17-18H2,1-2H3 VMUCQACJJIPIGX-UHFFFAOYSA-N 479825 US10899735, No. 284 Programmed cell death 1 ligand 1/2 Human 803 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479825&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996173 COc1cc(c(F)cc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C37H38Cl2FN5O4/c1-48-32-16-29(30(40)15-22(32)18-42-20-24-11-14-34(47)44-24)27-7-3-5-25(35(27)38)26-6-4-8-28(36(26)39)31-12-9-21(37(45-31)49-2)17-41-19-23-10-13-33(46)43-23/h3-9,12,15-16,23-24,41-42H,10-11,13-14,17-20H2,1-2H3,(H,43,46)(H,44,47)/t23-,24-/m0/s1 JBCXOINMZFKEDQ-ZEQRLZLVSA-N 479826 US10899735, No. 285 Programmed cell death 1 ligand 1/2 Human 389 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479826&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996174 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCO)c(F)c1F InChI=1S/C30H29Cl2F2N3O3/c1-40-30-19(17-36-13-15-39)9-11-25(37-30)24-7-3-5-21(27(24)32)20-4-2-6-22(26(20)31)23-10-8-18(16-35-12-14-38)28(33)29(23)34/h2-11,35-36,38-39H,12-17H2,1H3 OQZQRJDSPQSCIJ-UHFFFAOYSA-N 479827 US10899735, No. 286 Programmed cell death 1 ligand 1/2 Human 278 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479827&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996175 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCO)c(OC)c1F InChI=1S/C31H32Cl2FN3O4/c1-40-30-19(17-35-13-15-38)9-11-24(29(30)34)23-7-3-5-21(27(23)32)22-6-4-8-25(28(22)33)26-12-10-20(18-36-14-16-39)31(37-26)41-2/h3-12,35-36,38-39H,13-18H2,1-2H3 VWMSTWNCLRKITJ-UHFFFAOYSA-N 479828 US10899735, No. 287 Programmed cell death 1 ligand 1/2 Human 292 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479828&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996176 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)c1F InChI=1S/C37H38Cl2FN5O4/c1-48-36-21(17-41-19-23-11-15-31(46)43-23)9-13-28(35(36)40)27-7-3-5-25(33(27)38)26-6-4-8-29(34(26)39)30-14-10-22(37(45-30)49-2)18-42-20-24-12-16-32(47)44-24/h3-10,13-14,23-24,41-42H,11-12,15-20H2,1-2H3,(H,43,46)(H,44,47)/t23-,24-/m0/s1 ATIYCNSAZLZHEQ-ZEQRLZLVSA-N 479829 US10899735, No. 288 Programmed cell death 1 ligand 1/2 Human 562 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479829&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996177 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(F)c1F InChI=1S/C36H35Cl2F2N5O3/c1-48-36-21(17-42-19-23-11-15-31(47)44-23)9-13-29(45-36)28-7-3-5-25(33(28)38)24-4-2-6-26(32(24)37)27-12-8-20(34(39)35(27)40)16-41-18-22-10-14-30(46)43-22/h2-9,12-13,22-23,41-42H,10-11,14-19H2,1H3,(H,43,46)(H,44,47)/t22-,23-/m0/s1 LRUYVEOHVLDREA-GOTSBHOMSA-N 479830 US10899735, No. 289 Programmed cell death 1 ligand 1/2 Human 281 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479830&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996178 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCO)cc1 InChI=1S/C30H31Cl2N3O3/c1-38-30-22(19-34-15-17-37)12-13-27(35-30)26-7-3-6-25(29(26)32)24-5-2-4-23(28(24)31)21-10-8-20(9-11-21)18-33-14-16-36/h2-13,33-34,36-37H,14-19H2,1H3 VCRDUEZZTKLBPL-UHFFFAOYSA-N 479831 US10899735, No. 290 Programmed cell death 1 ligand 1/2 Human 713 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479831&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996179 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)cc1 InChI=1S/C36H37Cl2N5O3/c1-46-36-24(19-40-21-26-14-17-33(45)42-26)12-15-31(43-36)30-7-3-6-29(35(30)38)28-5-2-4-27(34(28)37)23-10-8-22(9-11-23)18-39-20-25-13-16-32(44)41-25/h2-12,15,25-26,39-40H,13-14,16-21H2,1H3,(H,41,44)(H,42,45)/t25-,26-/m0/s1 LJSPNRSBNFWLLD-UIOOFZCWSA-N 479832 US10899735, No. 291 Programmed cell death 1 ligand 1/2 Human 523 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479832&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996180 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCO)c(Cl)c1 InChI=1S/C30H30Cl3N3O3/c1-39-30-21(18-35-13-15-38)10-11-27(36-30)25-7-3-6-24(29(25)33)23-5-2-4-22(28(23)32)19-8-9-20(26(31)16-19)17-34-12-14-37/h2-11,16,34-35,37-38H,12-15,17-18H2,1H3 IFVUIRILUNUXDG-UHFFFAOYSA-N 479833 US10899735, No. 292 Programmed cell death 1 ligand 1/2 Human 1047 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479833&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996181 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(Cl)c1 InChI=1S/C36H36Cl3N5O3/c1-47-36-23(18-41-20-25-12-15-33(46)43-25)10-13-31(44-36)29-7-3-6-28(35(29)39)27-5-2-4-26(34(27)38)21-8-9-22(30(37)16-21)17-40-19-24-11-14-32(45)42-24/h2-10,13,16,24-25,40-41H,11-12,14-15,17-20H2,1H3,(H,42,45)(H,43,46)/t24-,25-/m0/s1 HHQJUCOAZURJAT-DQEYMECFSA-N 479834 US10899735, No. 293 Programmed cell death 1 ligand 1/2 Human 973 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479834&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996182 COc1cc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCO)c(OC)n1 InChI=1S/C31H33Cl2N3O4/c1-39-28-17-20(9-10-21(28)18-34-13-15-37)23-5-3-6-24(29(23)32)25-7-4-8-26(30(25)33)27-12-11-22(19-35-14-16-38)31(36-27)40-2/h3-12,17,34-35,37-38H,13-16,18-19H2,1-2H3 WCJQQZPXAYLMHO-UHFFFAOYSA-N 479835 US10899735, No. 294 Programmed cell death 1 ligand 1/2 Human 382 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479835&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996183 COc1cc(CNCCO)ccc1-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCO)c(OC)n1 InChI=1S/C31H33Cl2N3O4/c1-39-28-17-20(18-34-13-15-37)9-11-22(28)23-5-3-6-24(29(23)32)25-7-4-8-26(30(25)33)27-12-10-21(19-35-14-16-38)31(36-27)40-2/h3-12,17,34-35,37-38H,13-16,18-19H2,1-2H3 NSRVFXMYEKAKIE-UHFFFAOYSA-N 479836 US10899735, No. 295 Programmed cell death 1 ligand 1/2 Human 918 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479836&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996184 COc1cc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C37H39Cl2N5O4/c1-47-32-17-22(9-10-23(32)18-40-20-25-12-15-33(45)42-25)27-5-3-6-28(35(27)38)29-7-4-8-30(36(29)39)31-14-11-24(37(44-31)48-2)19-41-21-26-13-16-34(46)43-26/h3-11,14,17,25-26,40-41H,12-13,15-16,18-21H2,1-2H3,(H,42,45)(H,43,46)/t25-,26-/m0/s1 ZNZYDWQBDXWBEM-UIOOFZCWSA-N 479837 US10899735, No. 296 Programmed cell death 1 ligand 1/2 Human 205 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479837&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996185 COc1cc(CNC[C@@H]2CCC(=O)N2)ccc1-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C37H39Cl2N5O4/c1-47-32-17-22(18-40-20-24-11-15-33(45)42-24)9-13-26(32)27-5-3-6-28(35(27)38)29-7-4-8-30(36(29)39)31-14-10-23(37(44-31)48-2)19-41-21-25-12-16-34(46)43-25/h3-10,13-14,17,24-25,40-41H,11-12,15-16,18-21H2,1-2H3,(H,42,45)(H,43,46)/t24-,25-/m0/s1 PPXBXJGLFUVCQO-DQEYMECFSA-N 479838 US10899735, No. 297 Programmed cell death 1 ligand 1/2 Human 700 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479838&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996186 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCO)c(F)c1 InChI=1S/C30H30Cl2FN3O3/c1-39-30-21(18-35-13-15-38)10-11-27(36-30)25-7-3-6-24(29(25)32)23-5-2-4-22(28(23)31)19-8-9-20(26(33)16-19)17-34-12-14-37/h2-11,16,34-35,37-38H,12-15,17-18H2,1H3 JMYBOQUWPPLHEP-UHFFFAOYSA-N 479839 US10899735, No. 298 Programmed cell death 1 ligand 1/2 Human 359 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479839&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996187 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCO)cc1Cl InChI=1S/C30H30Cl3N3O3/c1-39-30-20(18-35-13-15-38)9-11-27(36-30)25-7-3-6-24(29(25)33)23-5-2-4-22(28(23)32)21-10-8-19(16-26(21)31)17-34-12-14-37/h2-11,16,34-35,37-38H,12-15,17-18H2,1H3 QVWULXPBVQNVTR-UHFFFAOYSA-N 479840 US10899735, No. 299 Programmed cell death 1 ligand 1/2 Human 574 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479840&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996188 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCO)cc1F InChI=1S/C30H30Cl2FN3O3/c1-39-30-20(18-35-13-15-38)9-11-27(36-30)25-7-3-6-24(29(25)32)23-5-2-4-22(28(23)31)21-10-8-19(16-26(21)33)17-34-12-14-37/h2-11,16,34-35,37-38H,12-15,17-18H2,1H3 NFTRBEWNGXLVOJ-UHFFFAOYSA-N 479841 US10899735, No. 300 Programmed cell death 1 ligand 1/2 Human 379 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479841&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996189 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(F)c1 InChI=1S/C36H36Cl2FN5O3/c1-47-36-23(18-41-20-25-12-15-33(46)43-25)10-13-31(44-36)29-7-3-6-28(35(29)38)27-5-2-4-26(34(27)37)21-8-9-22(30(39)16-21)17-40-19-24-11-14-32(45)42-24/h2-10,13,16,24-25,40-41H,11-12,14-15,17-20H2,1H3,(H,42,45)(H,43,46)/t24-,25-/m0/s1 ZAZHTDXTOZHTGV-DQEYMECFSA-N 479842 US10899735, No. 301 Programmed cell death 1 ligand 1/2 Human 140 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479842&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996190 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)cc1Cl InChI=1S/C36H36Cl3N5O3/c1-47-36-22(18-41-20-24-11-15-33(46)43-24)9-13-31(44-36)29-7-3-6-28(35(29)39)27-5-2-4-26(34(27)38)25-12-8-21(16-30(25)37)17-40-19-23-10-14-32(45)42-23/h2-9,12-13,16,23-24,40-41H,10-11,14-15,17-20H2,1H3,(H,42,45)(H,43,46)/t23-,24-/m0/s1 NNWVEXHHGSKTIS-ZEQRLZLVSA-N 479843 US10899735, No. 302 Programmed cell death 1 ligand 1/2 Human 2169 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479843&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996191 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)cc1F InChI=1S/C36H36Cl2FN5O3/c1-47-36-22(18-41-20-24-11-15-33(46)43-24)9-13-31(44-36)29-7-3-6-28(35(29)38)27-5-2-4-26(34(27)37)25-12-8-21(16-30(25)39)17-40-19-23-10-14-32(45)42-23/h2-9,12-13,16,23-24,40-41H,10-11,14-15,17-20H2,1H3,(H,42,45)(H,43,46)/t23-,24-/m0/s1 LLQZJFOFPHVOAX-ZEQRLZLVSA-N 479844 US10899735, No. 303 Programmed cell death 1 ligand 1/2 Human 287 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479844&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996192 COc1nc(ccc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCC2COC(=O)N2)c(OC)n1 InChI=1S/C34H35Cl2N5O7/c1-46-32-19(14-37-16-21-18-48-34(45)39-21)9-11-27(40-32)25-7-3-5-23(30(25)35)24-6-4-8-26(31(24)36)28-12-10-20(33(41-28)47-2)15-38-17-22(42)13-29(43)44/h3-12,21-22,37-38,42H,13-18H2,1-2H3,(H,39,45)(H,43,44)/t21?,22-/m0/s1 IWZDWCJXQNLWOI-KEKNWZKVSA-N 479845 US10899735, No. 304 Programmed cell death 1 ligand 1/2 Human 110 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479845&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996193 COc1nc(ccc1CNC[C@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38Cl2N6O4/c1-47-35-21(17-39-19-23-11-15-31(45)41-23)9-13-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-20-24-12-16-32(46)42-24/h3-10,13-14,23-24,39-40H,11-12,15-20H2,1-2H3,(H,41,45)(H,42,46)/t23-,24+ CCQYZUWIGMDBQE-PSWAGMNNSA-N 479846 US10899735, No. 305 Programmed cell death 1 ligand 1/2 Human 118 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479846&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996194 COc1nc(ccc1CNC[C@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H38Cl2N6O4/c1-47-35-21(17-39-19-23-11-15-31(45)41-23)9-13-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-14-10-22(36(44-30)48-2)18-40-20-24-12-16-32(46)42-24/h3-10,13-14,23-24,39-40H,11-12,15-20H2,1-2H3,(H,41,45)(H,42,46)/t23-,24-/m1/s1 CCQYZUWIGMDBQE-DNQXCXABSA-N 479697 US10899735, No. 156::US10899735, No. 306 Programmed cell death 1 ligand 1/2 Human 86.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479697&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996195 COc1nc(ccc1CNC[C@H]1COC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2COC(=O)N2)c(OC)n1 InChI=1S/C34H34Cl2N6O6/c1-45-31-19(13-37-15-21-17-47-33(43)39-21)9-11-27(41-31)25-7-3-5-23(29(25)35)24-6-4-8-26(30(24)36)28-12-10-20(32(42-28)46-2)14-38-16-22-18-48-34(44)40-22/h3-12,21-22,37-38H,13-18H2,1-2H3,(H,39,43)(H,40,44)/t21-,22+ KBWRENFEOGBQIU-SZPZYZBQSA-N 479848 US10899735, No. 307 Programmed cell death 1 ligand 1/2 Human 526 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479848&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996196 COc1nc(ccc1CNC[C@H]1COC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@H]2COC(=O)N2)c(OC)n1 InChI=1S/C34H34Cl2N6O6/c1-45-31-19(13-37-15-21-17-47-33(43)39-21)9-11-27(41-31)25-7-3-5-23(29(25)35)24-6-4-8-26(30(24)36)28-12-10-20(32(42-28)46-2)14-38-16-22-18-48-34(44)40-22/h3-12,21-22,37-38H,13-18H2,1-2H3,(H,39,43)(H,40,44)/t21-,22-/m0/s1 KBWRENFEOGBQIU-VXKWHMMOSA-N 479849 US10899735, No. 308 Programmed cell death 1 ligand 1/2 Human 520 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479849&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996197 COc1nc(ccc1CN1CC2(C1)CN(C2)C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cccc(CN)n1 InChI=1S/C32H31Cl2N5O2/c1-20(40)39-18-32(19-39)16-38(17-32)15-21-12-13-28(37-31(21)41-2)26-10-5-8-24(30(26)34)23-7-4-9-25(29(23)33)27-11-3-6-22(14-35)36-27/h3-13H,14-19,35H2,1-2H3 HPYHULJKONUZPL-UHFFFAOYSA-N 479850 US10899735, No. 309 Programmed cell death 1 ligand 1/2 Human 608 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479850&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996198 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cccc(CN)n1 InChI=1S/C30H29Cl2N5O2/c1-39-30-18(16-34-17-20-12-14-27(38)36-20)11-13-26(37-30)24-9-4-7-22(29(24)32)21-6-3-8-23(28(21)31)25-10-2-5-19(15-33)35-25/h2-11,13,20,34H,12,14-17,33H2,1H3,(H,36,38)/t20-/m0/s1 YCJDIFGHESREJI-FQEVSTJZSA-N 479851 US10899735, No. 310 Programmed cell death 1 ligand 1/2 Human 574 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479851&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996199 COc1nc(ccc1CN1CC2(C1)CN(C2)C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN)c(CO)c1 InChI=1S/C34H34Cl2N4O3/c1-21(42)40-19-34(20-40)17-39(18-34)15-24-11-12-30(38-33(24)43-2)29-8-4-7-28(32(29)36)27-6-3-5-26(31(27)35)22-9-10-23(14-37)25(13-22)16-41/h3-13,41H,14-20,37H2,1-2H3 YOVOGDGXBHDCQP-UHFFFAOYSA-N 479852 US10899735, No. 311 Programmed cell death 1 ligand 1/2 Human 368 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479852&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996200 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN)c(CO)c1 InChI=1S/C33H32Cl2N4O3/c1-42-32-22(16-39-18-33(19-39)13-12-29(41)38-33)10-11-28(37-32)27-7-3-6-26(31(27)35)25-5-2-4-24(30(25)34)20-8-9-21(15-36)23(14-20)17-40/h2-11,14,40H,12-13,15-19,36H2,1H3,(H,38,41) WEEWJBXDXAQXSG-UHFFFAOYSA-N 479853 US10899735, No. 312 Programmed cell death 1 ligand 1/2 Human 715 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479853&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996201 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN)c(CO)c1 InChI=1S/C32H32Cl2N4O3/c1-41-32-21(16-36-17-23-11-13-29(40)37-23)10-12-28(38-32)27-7-3-6-26(31(27)34)25-5-2-4-24(30(25)33)19-8-9-20(15-35)22(14-19)18-39/h2-10,12,14,23,36,39H,11,13,15-18,35H2,1H3,(H,37,40)/t23-/m0/s1 HWYVRKYMEOFHCG-QHCPKHFHSA-N 479854 US10899735, No. 313 Programmed cell death 1 ligand 1/2 Human 649 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479854&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996202 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CN(C3)C(C)=O)c(CO)c1 InChI=1S/C39H41Cl2N5O4/c1-24(48)46-22-39(23-46)20-45(21-39)18-27-10-9-25(15-28(27)19-47)30-5-3-6-31(36(30)40)32-7-4-8-33(37(32)41)34-13-11-26(38(44-34)50-2)16-42-17-29-12-14-35(49)43-29/h3-11,13,15,29,42,47H,12,14,16-23H2,1-2H3,(H,43,49)/t29-/m0/s1 WCYKTRNDHMHFOF-LJAQVGFWSA-N 479855 US10899735, No. 314 Programmed cell death 1 ligand 1/2 Human 362 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479855&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996203 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(CO)c1 InChI=1S/C38H39Cl2N5O4/c1-49-37-24(17-41-18-27-11-13-33(47)42-27)10-12-32(43-37)31-7-3-6-30(36(31)40)29-5-2-4-28(35(29)39)23-8-9-25(26(16-23)20-46)19-45-21-38(22-45)15-14-34(48)44-38/h2-10,12,16,27,41,46H,11,13-15,17-22H2,1H3,(H,42,47)(H,44,48)/t27-/m0/s1 IHXNNQXIOHATHU-MHZLTWQESA-N 479856 US10899735, No. 315::US10899735, No. 318 Programmed cell death 1 ligand 1/2 Human 462 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479856&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996204 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(CO)c1 InChI=1S/C37H39Cl2N5O4/c1-48-37-24(18-41-20-27-12-15-34(47)43-27)10-13-32(44-37)31-7-3-6-30(36(31)39)29-5-2-4-28(35(29)38)22-8-9-23(25(16-22)21-45)17-40-19-26-11-14-33(46)42-26/h2-10,13,16,26-27,40-41,45H,11-12,14-15,17-21H2,1H3,(H,42,46)(H,43,47)/t26-,27-/m0/s1 UXEDUNFMJIIJOL-SVBPBHIXSA-N 479857 US10899735, No. 316 Programmed cell death 1 ligand 1/2 Human 499 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479857&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996205 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(CO)c1 InChI=1S/C39H39Cl2N5O4/c1-50-37-26(18-46-22-39(23-46)15-13-34(49)44-39)10-11-32(42-37)31-7-3-6-30(36(31)41)29-5-2-4-28(35(29)40)24-8-9-25(27(16-24)19-47)17-45-20-38(21-45)14-12-33(48)43-38/h2-11,16,47H,12-15,17-23H2,1H3,(H,43,48)(H,44,49) ZCBVJSXYAMVOKJ-UHFFFAOYSA-N 479858 US10899735, No. 317 Programmed cell death 1 ligand 1/2 Human 129 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479858&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996206 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(CO)c1 InChI=1S/C38H39Cl2N5O4/c1-49-37-24(17-41-18-27-11-13-33(47)42-27)10-12-32(43-37)31-7-3-6-30(36(31)40)29-5-2-4-28(35(29)39)23-8-9-25(26(16-23)20-46)19-45-21-38(22-45)15-14-34(48)44-38/h2-10,12,16,27,41,46H,11,13-15,17-22H2,1H3,(H,42,47)(H,44,48)/t27-/m0/s1 IHXNNQXIOHATHU-MHZLTWQESA-N 479856 US10899735, No. 315::US10899735, No. 318 Programmed cell death 1 ligand 1/2 Human 107 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479856&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996207 COc1nc(ccc1CN1CC[C@@H]2CC(=O)N[C@@H]2C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@H]3CC(=O)N[C@H]3C2)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-39-25(19-47-15-13-23-17-35(49)43-33(23)21-47)9-11-31(45-39)29-7-3-5-27(37(29)41)28-6-4-8-30(38(28)42)32-12-10-26(40(46-32)52-2)20-48-16-14-24-18-36(50)44-34(24)22-48/h3-12,23-24,33-34H,13-22H2,1-2H3,(H,43,49)(H,44,50)/t23-,24+,33-,34+ RXMSHKXNFOSMIA-AKQDJOCTSA-N 479860 US10899735, No. 319 Programmed cell death 1 ligand 1/2 Human 533 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479860&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996208 COc1nc(ccc1CN1C[C@@H]2CC(=O)N[C@@H]2C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2C[C@@H]3CC(=O)N[C@@H]3C2)c(OC)n1 InChI=1S/C38H38Cl2N6O4/c1-49-37-21(15-45-17-23-13-33(47)41-31(23)19-45)9-11-29(43-37)27-7-3-5-25(35(27)39)26-6-4-8-28(36(26)40)30-12-10-22(38(44-30)50-2)16-46-18-24-14-34(48)42-32(24)20-46/h3-12,23-24,31-32H,13-20H2,1-2H3,(H,41,47)(H,42,48)/t23-,24-,31+,32+/m0/s1 QFYNSTBVTQHQFX-NJKYLCJSSA-N 479861 US10899735, No. 320 Programmed cell death 1 ligand 1/2 Human 322 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479861&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996209 COc1nc(ccc1CNC[C@]12CC[C@H](C1)C(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@]23CC[C@H](C2)C(=O)N3)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-37-25(19-43-21-39-15-13-23(17-39)35(49)47-39)9-11-31(45-37)29-7-3-5-27(33(29)41)28-6-4-8-30(34(28)42)32-12-10-26(38(46-32)52-2)20-44-22-40-16-14-24(18-40)36(50)48-40/h3-12,23-24,43-44H,13-22H2,1-2H3,(H,47,49)(H,48,50)/t23-,24-,39+,40+/m1/s1 OQVOERCHIWSGMY-GQAPBGGVSA-N 479862 US10899735, No. 321 Programmed cell death 1 ligand 1/2 Human 520 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479862&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996210 COc1nc(ccc1CN1CCN2[C@@H](CCC2=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCN3[C@@H](CCC3=O)C2)c(OC)n1 InChI=1S/C40H42Cl2N6O4/c1-51-39-25(21-45-17-19-47-27(23-45)11-15-35(47)49)9-13-33(43-39)31-7-3-5-29(37(31)41)30-6-4-8-32(38(30)42)34-14-10-26(40(44-34)52-2)22-46-18-20-48-28(24-46)12-16-36(48)50/h3-10,13-14,27-28H,11-12,15-24H2,1-2H3/t27-,28-/m0/s1 PKFBEQKFOKBREE-NSOVKSMOSA-N 479863 US10899735, No. 322 Programmed cell death 1 ligand 1/2 Human 1915 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479863&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996211 COc1nc(ccc1CN1CC2(C1)NC(=O)NC2=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)NC(=O)NC3=O)c(OC)n1 InChI=1S/C36H32Cl2N8O6/c1-51-29-19(13-45-15-35(16-45)31(47)41-33(49)43-35)9-11-25(39-29)23-7-3-5-21(27(23)37)22-6-4-8-24(28(22)38)26-12-10-20(30(40-26)52-2)14-46-17-36(18-46)32(48)42-34(50)44-36/h3-12H,13-18H2,1-2H3,(H2,41,43,47,49)(H2,42,44,48,50) NUUDIVSQNRDJGA-UHFFFAOYSA-N 479864 US10899735, No. 323 Programmed cell death 1 ligand 1/2 Human 1278 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479864&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996212 COc1nc(ccc1CNCC1CCC(=O)N1C)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCC2CCC(=O)N2C)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-45-25(13-17-33(45)47)21-41-19-23-11-15-31(43-37(23)49-3)29-9-5-7-27(35(29)39)28-8-6-10-30(36(28)40)32-16-12-24(38(44-32)50-4)20-42-22-26-14-18-34(48)46(26)2/h5-12,15-16,25-26,41-42H,13-14,17-22H2,1-4H3 LSVGFZOFSWSGRG-UHFFFAOYSA-N 479865 US10899735, No. 324 Programmed cell death 1 ligand 1/2 Human 661 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479865&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996213 COc1nc(ccc1CNCC1CCCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCC2CCCC(=O)N2)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-49-37-23(19-41-21-25-7-3-13-33(47)43-25)15-17-31(45-37)29-11-5-9-27(35(29)39)28-10-6-12-30(36(28)40)32-18-16-24(38(46-32)50-2)20-42-22-26-8-4-14-34(48)44-26/h5-6,9-12,15-18,25-26,41-42H,3-4,7-8,13-14,19-22H2,1-2H3,(H,43,47)(H,44,48) RFRICFQSGQQGGN-UHFFFAOYSA-N 479866 US10899735, No. 325 Programmed cell death 1 ligand 1/2 Human 761 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479866&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996214 COc1nc(ccc1CNCC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-49-37-23(21-41-19-17-25-11-15-33(47)43-25)9-13-31(45-37)29-7-3-5-27(35(29)39)28-6-4-8-30(36(28)40)32-14-10-24(38(46-32)50-2)22-42-20-18-26-12-16-34(48)44-26/h3-10,13-14,25-26,41-42H,11-12,15-22H2,1-2H3,(H,43,47)(H,44,48)/t25-,26-/m0/s1 AYLLSVKFPNRLGP-UIOOFZCWSA-N 479867 US10899735, No. 326 Programmed cell death 1 ligand 1/2 Human 379 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479867&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996215 COc1nc(ccc1CNC(C)(C)CNC(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N)c(OC)n1 InChI=1S/C33H37Cl2N5O3/c1-19(36)22-14-16-28(40-32(22)43-6)26-12-8-10-24(30(26)35)23-9-7-11-25(29(23)34)27-15-13-21(31(39-27)42-5)17-38-33(3,4)18-37-20(2)41/h7-16,19,38H,17-18,36H2,1-6H3,(H,37,41)/t19-/m0/s1 ZNUHATAPJCVWJA-IBGZPJMESA-N 479868 US10899735, No. 327 Programmed cell death 1 ligand 1/2 Human 305 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479868&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996216 COc1nc(ccc1CN[C@@H]1CCC[C@@H]1O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N)c(OC)n1 InChI=1S/C32H34Cl2N4O3/c1-18(35)20-14-16-26(38-32(20)41-3)24-10-5-8-22(30(24)34)21-7-4-9-23(29(21)33)25-15-13-19(31(37-25)40-2)17-36-27-11-6-12-28(27)39/h4-5,7-10,13-16,18,27-28,36,39H,6,11-12,17,35H2,1-3H3/t18-,27+,28-/m0/s1 ZOLATEHDIRXSCV-GGQWNLSXSA-N 479869 US10899735, No. 328 Programmed cell death 1 ligand 1/2 Human 266 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479869&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996217 COc1nc(ccc1CNCC(C)(C)NC(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N)c(OC)n1 InChI=1S/C33H37Cl2N5O3/c1-19(36)22-14-16-28(39-32(22)43-6)26-12-8-10-24(30(26)35)23-9-7-11-25(29(23)34)27-15-13-21(31(38-27)42-5)17-37-18-33(3,4)40-20(2)41/h7-16,19,37H,17-18,36H2,1-6H3,(H,40,41)/t19-/m0/s1 IIQOJGPYMHTRMD-IBGZPJMESA-N 479870 US10899735, No. 329::US10899735, No. 330 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479870&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996218 COc1nc(ccc1CNCC(C)(C)NC(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N)c(OC)n1 InChI=1S/C33H37Cl2N5O3/c1-19(36)22-14-16-28(39-32(22)43-6)26-12-8-10-24(30(26)35)23-9-7-11-25(29(23)34)27-15-13-21(31(38-27)42-5)17-37-18-33(3,4)40-20(2)41/h7-16,19,37H,17-18,36H2,1-6H3,(H,40,41)/t19-/m0/s1 IIQOJGPYMHTRMD-IBGZPJMESA-N 479870 US10899735, No. 329::US10899735, No. 330 Programmed cell death 1 ligand 1/2 Human 395 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479870&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996219 COc1nc(ccc1CNC(C)(C)CNC(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC(C)(C)CNC(C)=O)c(OC)n1 InChI=1S/C38H46Cl2N6O4/c1-23(47)41-21-37(3,4)43-19-25-15-17-31(45-35(25)49-7)29-13-9-11-27(33(29)39)28-12-10-14-30(34(28)40)32-18-16-26(36(46-32)50-8)20-44-38(5,6)22-42-24(2)48/h9-18,43-44H,19-22H2,1-8H3,(H,41,47)(H,42,48) CAPOAOXEYDBXCO-UHFFFAOYSA-N 479872 US10899735, No. 331 Programmed cell death 1 ligand 1/2 Human 350 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479872&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996220 COc1nc(ccc1CNCc1cccc(=O)[nH]1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCc2cccc(=O)[nH]2)c(OC)n1 InChI=1S/C38H34Cl2N6O4/c1-49-37-23(19-41-21-25-7-3-13-33(47)43-25)15-17-31(45-37)29-11-5-9-27(35(29)39)28-10-6-12-30(36(28)40)32-18-16-24(38(46-32)50-2)20-42-22-26-8-4-14-34(48)44-26/h3-18,41-42H,19-22H2,1-2H3,(H,43,47)(H,44,48) FMEBKQZPHKJNAA-UHFFFAOYSA-N 479873 US10899735, No. 332 Programmed cell death 1 ligand 1/2 Human 1524 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479873&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996221 COc1nc(ccc1CNCCn1ccccc1=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCn2ccccc2=O)c(OC)n1 InChI=1S/C40H38Cl2N6O4/c1-51-39-27(25-43-19-23-47-21-5-3-13-35(47)49)15-17-33(45-39)31-11-7-9-29(37(31)41)30-10-8-12-32(38(30)42)34-18-16-28(40(46-34)52-2)26-44-20-24-48-22-6-4-14-36(48)50/h3-18,21-22,43-44H,19-20,23-26H2,1-2H3 NSQHEUXHVZRWMX-UHFFFAOYSA-N 479874 US10899735, No. 333 Programmed cell death 1 ligand 1/2 Human 342 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479874&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996222 COc1nc(ccc1CNC(C)(C)C)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC(C)(C)C)c(OC)n1 InChI=1S/C34H40Cl2N4O2/c1-33(2,3)37-19-21-15-17-27(39-31(21)41-7)25-13-9-11-23(29(25)35)24-12-10-14-26(30(24)36)28-18-16-22(32(40-28)42-8)20-38-34(4,5)6/h9-18,37-38H,19-20H2,1-8H3 IAVNIBINOAKCEM-UHFFFAOYSA-N 479875 US10899735, No. 334 Programmed cell death 1 ligand 1/2 Human 521 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479875&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996223 COc1nc(ccc1CNC(C)(C)CO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N)c(OC)n1 InChI=1S/C31H34Cl2N4O3/c1-18(34)20-13-15-26(37-30(20)40-5)24-11-7-9-22(28(24)33)21-8-6-10-23(27(21)32)25-14-12-19(29(36-25)39-4)16-35-31(2,3)17-38/h6-15,18,35,38H,16-17,34H2,1-5H3/t18-/m0/s1 VSYDBIFLDWFSNF-SFHVURJKSA-N 479876 US10899735, No. 335 Programmed cell death 1 ligand 1/2 Human 346 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479876&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996224 COc1nc(ccc1CNCC(C)(C)O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N)c(OC)n1 InChI=1S/C31H34Cl2N4O3/c1-18(34)20-13-15-26(37-30(20)40-5)24-11-7-9-22(28(24)33)21-8-6-10-23(27(21)32)25-14-12-19(29(36-25)39-4)16-35-17-31(2,3)38/h6-15,18,35,38H,16-17,34H2,1-5H3/t18-/m0/s1 BHSMKOQGVQLFCX-SFHVURJKSA-N 479877 US10899735, No. 336 Programmed cell death 1 ligand 1/2 Human 362 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479877&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996225 COc1nc(ccc1CNCC1(CO)CCC1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCC2(CO)CCC2)c(OC)n1 InChI=1S/C38H44Cl2N4O4/c1-47-35-25(19-41-21-37(23-45)15-5-16-37)11-13-31(43-35)29-9-3-7-27(33(29)39)28-8-4-10-30(34(28)40)32-14-12-26(36(44-32)48-2)20-42-22-38(24-46)17-6-18-38/h3-4,7-14,41-42,45-46H,5-6,15-24H2,1-2H3 ZFIXMQSNHAYOPS-UHFFFAOYSA-N 479878 US10899735, No. 337 Programmed cell death 1 ligand 1/2 Human 4939 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479878&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996226 COc1nc(ccc1CN1C[C@@H](O)C[C@@H](O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2C[C@@H](O)C[C@@H](O)C2)c(OC)n1 InChI=1S/C36H40Cl2N4O6/c1-47-35-21(15-41-17-23(43)13-24(44)18-41)9-11-31(39-35)29-7-3-5-27(33(29)37)28-6-4-8-30(34(28)38)32-12-10-22(36(40-32)48-2)16-42-19-25(45)14-26(46)20-42/h3-12,23-26,43-46H,13-20H2,1-2H3/t23-,24+,25-,26+ HMJJYLAWRKXCCW-POYMRFPPSA-N 479879 US10899735, No. 338 Programmed cell death 1 ligand 1/2 Human 829 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479879&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996227 COc1nc(ccc1CNCc1nc(C)cc(=O)[nH]1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCc2nc(C)cc(=O)[nH]2)c(OC)n1 InChI=1S/C38H36Cl2N8O4/c1-21-15-33(49)47-31(43-21)19-41-17-23-11-13-29(45-37(23)51-3)27-9-5-7-25(35(27)39)26-8-6-10-28(36(26)40)30-14-12-24(38(46-30)52-4)18-42-20-32-44-22(2)16-34(50)48-32/h5-16,41-42H,17-20H2,1-4H3,(H,43,47,49)(H,44,48,50) QAGSTUVLEMGTLV-UHFFFAOYSA-N 479880 US10899735, No. 339 Programmed cell death 1 ligand 1/2 Human 3236 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479880&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996228 COc1nc(ccc1CNCCN1CCCC1=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCN2CCCC2=O)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-49-37-25(23-41-17-21-45-19-5-11-33(45)47)13-15-31(43-37)29-9-3-7-27(35(29)39)28-8-4-10-30(36(28)40)32-16-14-26(38(44-32)50-2)24-42-18-22-46-20-6-12-34(46)48/h3-4,7-10,13-16,41-42H,5-6,11-12,17-24H2,1-2H3 XYXAEPFNLZEQEH-UHFFFAOYSA-N 479881 US10899735, No. 340 Programmed cell death 1 ligand 1/2 Human 173 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479881&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996229 COc1nc(ccc1CN1CC2(C1)CNC(=O)C2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N)c(OC)n1 InChI=1S/C33H33Cl2N5O3/c1-19(36)21-11-13-27(39-32(21)43-3)25-9-5-7-23(30(25)35)22-6-4-8-24(29(22)34)26-12-10-20(31(38-26)42-2)15-40-17-33(18-40)14-28(41)37-16-33/h4-13,19H,14-18,36H2,1-3H3,(H,37,41)/t19-/m0/s1 ABLNGAHLIVVTJC-IBGZPJMESA-N 479882 US10899735, No. 341 Programmed cell death 1 ligand 1/2 Human 682 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479882&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996230 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N)c(OC)n1 InChI=1S/C32H33Cl2N5O3/c1-18(35)21-12-14-27(39-32(21)42-3)25-9-5-7-23(30(25)34)22-6-4-8-24(29(22)33)26-13-10-19(31(38-26)41-2)16-36-17-20-11-15-28(40)37-20/h4-10,12-14,18,20,36H,11,15-17,35H2,1-3H3,(H,37,40)/t18-,20-/m0/s1 GKUIQDGQEYXOIX-ICSRJNTNSA-N 479883 US10899735, No. 342 Programmed cell death 1 ligand 1/2 Human 218 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479883&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996231 COc1nc(ccc1[C@H](C)N(C)C)-c1cccc(c1Cl)-c1cccc(-c2ccc([C@H](C)N(C)C)c(OC)n2)c1Cl InChI=1S/C32H36Cl2N4O2/c1-19(37(3)4)21-15-17-27(35-31(21)39-7)25-13-9-11-23(29(25)33)24-12-10-14-26(30(24)34)28-18-16-22(20(2)38(5)6)32(36-28)40-8/h9-20H,1-8H3/t19-,20-/m0/s1 BYKZOLIIMNMILZ-PMACEKPBSA-N 479884 US10899735, No. 343 Programmed cell death 1 ligand 1/2 Human 456 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479884&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996232 COc1nc(ccc1[C@@H](N)CO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H](N)CO)c(OC)n1 InChI=1S/C28H28Cl2N4O4/c1-37-27-17(21(31)13-35)9-11-23(33-27)19-7-3-5-15(25(19)29)16-6-4-8-20(26(16)30)24-12-10-18(22(32)14-36)28(34-24)38-2/h3-12,21-22,35-36H,13-14,31-32H2,1-2H3/t21-,22-/m0/s1 LDMNYAVUNWYFOJ-VXKWHMMOSA-N 479885 US10899735, No. 344 Programmed cell death 1 ligand 1/2 Human 950 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479885&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996233 COc1nc(ccc1CNC[C@]1(C)CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@]2(C)CCC(=O)N2)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-37(17-15-31(47)45-37)21-41-19-23-11-13-29(43-35(23)49-3)27-9-5-7-25(33(27)39)26-8-6-10-28(34(26)40)30-14-12-24(36(44-30)50-4)20-42-22-38(2)18-16-32(48)46-38/h5-14,41-42H,15-22H2,1-4H3,(H,45,47)(H,46,48)/t37-,38-/m0/s1 HWNLNEMQEUCCIT-UWXQCODUSA-N 479886 US10899735, No. 345 Programmed cell death 1 ligand 1/2 Human 323 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479886&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996234 COc1nc(ccc1CNC[C@@]1(C)CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@]2(C)CCC(=O)N2)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-37(17-15-31(47)45-37)21-41-19-23-11-13-29(43-35(23)49-3)27-9-5-7-25(33(27)39)26-8-6-10-28(34(26)40)30-14-12-24(36(44-30)50-4)20-42-22-38(2)18-16-32(48)46-38/h5-14,41-42H,15-22H2,1-4H3,(H,45,47)(H,46,48)/t37-,38-/m1/s1 HWNLNEMQEUCCIT-XPSQVAKYSA-N 479887 US10899735, No. 346 Programmed cell death 1 ligand 1/2 Human 289 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479887&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996235 COc1nc(ccc1CN1CC[C@@H](O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N)c(OC)n1 InChI=1S/C31H32Cl2N4O3/c1-18(34)21-11-13-27(36-31(21)40-3)25-9-5-7-23(29(25)33)22-6-4-8-24(28(22)32)26-12-10-19(30(35-26)39-2)16-37-15-14-20(38)17-37/h4-13,18,20,38H,14-17,34H2,1-3H3/t18-,20+/m0/s1 KWSPCGHCQQCYJE-AZUAARDMSA-N 479888 US10899735, No. 347 Programmed cell death 1 ligand 1/2 Human 365 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479888&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996236 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N)c(OC)n1 InChI=1S/C33H33Cl2N5O3/c1-19(36)21-11-13-27(38-32(21)43-3)25-9-5-7-23(30(25)35)22-6-4-8-24(29(22)34)26-12-10-20(31(37-26)42-2)16-40-17-33(18-40)15-14-28(41)39-33/h4-13,19H,14-18,36H2,1-3H3,(H,39,41)/t19-/m0/s1 VVIHASIRKHSQJB-IBGZPJMESA-N 479889 US10899735, No. 348 Programmed cell death 1 ligand 1/2 Human 142 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479889&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996237 COc1nc(ccc1[C@@H](N)CC(=O)N(C)C)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H](N)CC(=O)N(C)C)c(OC)n1 InChI=1S/C34H38Cl2N6O4/c1-41(2)29(43)17-25(37)21-13-15-27(39-33(21)45-5)23-11-7-9-19(31(23)35)20-10-8-12-24(32(20)36)28-16-14-22(34(40-28)46-6)26(38)18-30(44)42(3)4/h7-16,25-26H,17-18,37-38H2,1-6H3/t25-,26-/m0/s1 SXNXFLDROPIGFO-UIOOFZCWSA-N 479890 US10899735, No. 349 Programmed cell death 1 ligand 1/2 Human 701 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479890&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996238 CNC(=O)C[C@H](N)c1ccc(nc1OC)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H](N)CC(=O)NC)c(OC)n1 InChI=1S/C32H34Cl2N6O4/c1-37-27(41)15-23(35)19-11-13-25(39-31(19)43-3)21-9-5-7-17(29(21)33)18-8-6-10-22(30(18)34)26-14-12-20(32(40-26)44-4)24(36)16-28(42)38-2/h5-14,23-24H,15-16,35-36H2,1-4H3,(H,37,41)(H,38,42)/t23-,24-/m0/s1 KWBHMRUSKGMGQI-ZEQRLZLVSA-N 479891 US10899735, No. 350 Programmed cell death 1 ligand 1/2 Human 639 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479891&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996239 COc1nc(ccc1[C@@H](N)C1CC1)-c1cccc(c1Cl)-c1cccc(-c2ccc([C@@H](N)C3CC3)c(OC)n2)c1Cl InChI=1S/C32H32Cl2N4O2/c1-39-31-23(29(35)17-9-10-17)13-15-25(37-31)21-7-3-5-19(27(21)33)20-6-4-8-22(28(20)34)26-16-14-24(32(38-26)40-2)30(36)18-11-12-18/h3-8,13-18,29-30H,9-12,35-36H2,1-2H3/t29-,30-/m0/s1 OVITZXQPKUZWKE-KYJUHHDHSA-N 479892 US10899735, No. 351 Programmed cell death 1 ligand 1/2 Human 4235 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479892&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996240 COc1nc(ccc1CN1CCc2n[nH]cc2C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCc3n[nH]cc3C2)c(OC)n1 InChI=1S/C38H36Cl2N8O2/c1-49-37-23(19-47-15-13-31-25(21-47)17-41-45-31)9-11-33(43-37)29-7-3-5-27(35(29)39)28-6-4-8-30(36(28)40)34-12-10-24(38(44-34)50-2)20-48-16-14-32-26(22-48)18-42-46-32/h3-12,17-18H,13-16,19-22H2,1-2H3,(H,41,45)(H,42,46) JKUXMJFNODLLNG-UHFFFAOYSA-N 479893 US10899735, No. 352 Programmed cell death 1 ligand 1/2 Human 2509 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479893&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996241 COc1nc(ccc1CN[C@H](C)CO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN[C@H](C)CO)c(OC)n1 InChI=1S/C32H36Cl2N4O4/c1-19(17-39)35-15-21-11-13-27(37-31(21)41-3)25-9-5-7-23(29(25)33)24-8-6-10-26(30(24)34)28-14-12-22(32(38-28)42-4)16-36-20(2)18-40/h5-14,19-20,35-36,39-40H,15-18H2,1-4H3/t19-,20-/m1/s1 NABQFINQQAFDGY-WOJBJXKFSA-N 479894 US10899735, No. 353 Programmed cell death 1 ligand 1/2 Human 354 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479894&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996242 COc1nc(ccc1CN[C@@H](C)CO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN[C@@H](C)CO)c(OC)n1 InChI=1S/C32H36Cl2N4O4/c1-19(17-39)35-15-21-11-13-27(37-31(21)41-3)25-9-5-7-23(29(25)33)24-8-6-10-26(30(24)34)28-14-12-22(32(38-28)42-4)16-36-20(2)18-40/h5-14,19-20,35-36,39-40H,15-18H2,1-4H3/t19-,20-/m0/s1 NABQFINQQAFDGY-PMACEKPBSA-N 479895 US10899735, No. 354 Programmed cell death 1 ligand 1/2 Human 225 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479895&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996243 COc1nc(ccc1CNC[C@H](C)O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@H](C)O)c(OC)n1 InChI=1S/C32H36Cl2N4O4/c1-19(39)15-35-17-21-11-13-27(37-31(21)41-3)25-9-5-7-23(29(25)33)24-8-6-10-26(30(24)34)28-14-12-22(32(38-28)42-4)18-36-16-20(2)40/h5-14,19-20,35-36,39-40H,15-18H2,1-4H3/t19-,20-/m0/s1 DGCWGWWISDSKAT-PMACEKPBSA-N 479896 US10899735, No. 355 Programmed cell death 1 ligand 1/2 Human 747 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479896&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996244 COc1nc(ccc1CNC(C)(C)CO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC(C)(C)CO)c(OC)n1 InChI=1S/C34H40Cl2N4O4/c1-33(2,19-41)37-17-21-13-15-27(39-31(21)43-5)25-11-7-9-23(29(25)35)24-10-8-12-26(30(24)36)28-16-14-22(32(40-28)44-6)18-38-34(3,4)20-42/h7-16,37-38,41-42H,17-20H2,1-6H3 RFUFDVQGEDEMJL-UHFFFAOYSA-N 479897 US10899735, No. 356 Programmed cell death 1 ligand 1/2 Human 146 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479897&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996245 COc1nc(ccc1CNCC(C)(C)O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCC(C)(C)O)c(OC)n1 InChI=1S/C34H40Cl2N4O4/c1-33(2,41)19-37-17-21-13-15-27(39-31(21)43-5)25-11-7-9-23(29(25)35)24-10-8-12-26(30(24)36)28-16-14-22(32(40-28)44-6)18-38-20-34(3,4)42/h7-16,37-38,41-42H,17-20H2,1-6H3 BCRQGTIWGJHQRE-UHFFFAOYSA-N 479898 US10899735, No. 357 Programmed cell death 1 ligand 1/2 Human 273 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479898&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996246 COc1nc(ccc1CNC[C@@H](C)O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H](C)O)c(OC)n1 InChI=1S/C32H36Cl2N4O4/c1-19(39)15-35-17-21-11-13-27(37-31(21)41-3)25-9-5-7-23(29(25)33)24-8-6-10-26(30(24)34)28-14-12-22(32(38-28)42-4)18-36-16-20(2)40/h5-14,19-20,35-36,39-40H,15-18H2,1-4H3/t19-,20-/m1/s1 DGCWGWWISDSKAT-WOJBJXKFSA-N 479899 US10899735, No. 358 Programmed cell death 1 ligand 1/2 Human 297 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479899&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996247 COc1nc(ccc1C(=O)NC[C@H](C)N)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C(=O)NC[C@H](C)N)c(OC)n1 InChI=1S/C32H34Cl2N6O4/c1-17(35)15-37-29(41)23-11-13-25(39-31(23)43-3)21-9-5-7-19(27(21)33)20-8-6-10-22(28(20)34)26-14-12-24(32(40-26)44-4)30(42)38-16-18(2)36/h5-14,17-18H,15-16,35-36H2,1-4H3,(H,37,41)(H,38,42)/t17-,18-/m0/s1 LPTZTNVGJZBAPW-ROUUACIJSA-N 479900 US10899735, No. 359 Programmed cell death 1 ligand 1/2 Human 1005 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479900&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996248 COc1nc(ccc1C(=O)N1CC(N)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C(=O)N2CC(N)C2)c(OC)n1 InChI=1S/C32H30Cl2N6O4/c1-43-29-23(31(41)39-13-17(35)14-39)9-11-25(37-29)21-7-3-5-19(27(21)33)20-6-4-8-22(28(20)34)26-12-10-24(30(38-26)44-2)32(42)40-15-18(36)16-40/h3-12,17-18H,13-16,35-36H2,1-2H3 WUQFRRQQEDPWHR-UHFFFAOYSA-N 479901 US10899735, No. 360 Programmed cell death 1 ligand 1/2 Human 7673 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479901&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996249 COc1nc(ccc1C(=O)N[C@@H](C)CN)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C(=O)N[C@@H](C)CN)c(OC)n1 InChI=1S/C32H34Cl2N6O4/c1-17(15-35)37-29(41)23-11-13-25(39-31(23)43-3)21-9-5-7-19(27(21)33)20-8-6-10-22(28(20)34)26-14-12-24(32(40-26)44-4)30(42)38-18(2)16-36/h5-14,17-18H,15-16,35-36H2,1-4H3,(H,37,41)(H,38,42)/t17-,18-/m0/s1 RJVTUFIGKYUDKM-ROUUACIJSA-N 479902 US10899735, No. 361 Programmed cell death 1 ligand 1/2 Human 1342 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479902&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996250 COc1nc(ccc1C(=O)N[C@H](C)CN)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C(=O)N[C@H](C)CN)c(OC)n1 InChI=1S/C32H34Cl2N6O4/c1-17(15-35)37-29(41)23-11-13-25(39-31(23)43-3)21-9-5-7-19(27(21)33)20-8-6-10-22(28(20)34)26-14-12-24(32(40-26)44-4)30(42)38-18(2)16-36/h5-14,17-18H,15-16,35-36H2,1-4H3,(H,37,41)(H,38,42)/t17-,18-/m1/s1 RJVTUFIGKYUDKM-QZTJIDSGSA-N 479903 US10899735, No. 362 Programmed cell death 1 ligand 1/2 Human 6303 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479903&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996251 COc1nc(ccc1C(=O)NCC(C)(C)N)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C(=O)NCC(C)(C)N)c(OC)n1 InChI=1S/C34H38Cl2N6O4/c1-33(2,37)17-39-29(43)23-13-15-25(41-31(23)45-5)21-11-7-9-19(27(21)35)20-10-8-12-22(28(20)36)26-16-14-24(32(42-26)46-6)30(44)40-18-34(3,4)38/h7-16H,17-18,37-38H2,1-6H3,(H,39,43)(H,40,44) ZPXBJEIYGKYEII-UHFFFAOYSA-N 479904 US10899735, No. 363 Programmed cell death 1 ligand 1/2 Human 1119 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479904&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996252 COc1nc(ccc1C(=O)NC[C@@H](C)N)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C(=O)NC[C@@H](C)N)c(OC)n1 InChI=1S/C32H34Cl2N6O4/c1-17(35)15-37-29(41)23-11-13-25(39-31(23)43-3)21-9-5-7-19(27(21)33)20-8-6-10-22(28(20)34)26-14-12-24(32(40-26)44-4)30(42)38-16-18(2)36/h5-14,17-18H,15-16,35-36H2,1-4H3,(H,37,41)(H,38,42)/t17-,18-/m1/s1 LPTZTNVGJZBAPW-QZTJIDSGSA-N 479905 US10899735, No. 364 Programmed cell death 1 ligand 1/2 Human 1118 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479905&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996253 COc1nc(ccc1C(=O)NCCN)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C(=O)NCCN)c(OC)n1 InChI=1S/C30H30Cl2N6O4/c1-41-29-21(27(39)35-15-13-33)9-11-23(37-29)19-7-3-5-17(25(19)31)18-6-4-8-20(26(18)32)24-12-10-22(30(38-24)42-2)28(40)36-16-14-34/h3-12H,13-16,33-34H2,1-2H3,(H,35,39)(H,36,40) HTQKAUZXAQLOSQ-UHFFFAOYSA-N 479906 US10899735, No. 365 Programmed cell death 1 ligand 1/2 Human 1293 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479906&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996254 COc1nc(ccc1[C@@H](O)C1CCCN1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H](O)[C@H]2CCCN2)c(OC)n1 InChI=1S/C34H36Cl2N4O4/c1-43-33-23(31(41)27-11-5-17-37-27)13-15-25(39-33)21-9-3-7-19(29(21)35)20-8-4-10-22(30(20)36)26-16-14-24(34(40-26)44-2)32(42)28-12-6-18-38-28/h3-4,7-10,13-16,27-28,31-32,37-38,41-42H,5-6,11-12,17-18H2,1-2H3/t27-,28?,31-,32-/m1/s1 SDNBRORECCYKCM-VGVWILAUSA-N 479907 US10899735, No. 366 Programmed cell death 1 ligand 1/2 Human 8563 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479907&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996255 COc1nc(ccc1[C@H](O)C1CCCN1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](O)[C@@H]2CCCN2)c(OC)n1 InChI=1S/C34H36Cl2N4O4/c1-43-33-23(31(41)27-11-5-17-37-27)13-15-25(39-33)21-9-3-7-19(29(21)35)20-8-4-10-22(30(20)36)26-16-14-24(34(40-26)44-2)32(42)28-12-6-18-38-28/h3-4,7-10,13-16,27-28,31-32,37-38,41-42H,5-6,11-12,17-18H2,1-2H3/t27-,28?,31-,32-/m0/s1 SDNBRORECCYKCM-GNLVQPEFSA-N 479908 US10899735, No. 367 Programmed cell death 1 ligand 1/2 Human 8935 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479908&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996256 COc1nc(ccc1CN1CC[C@H]1CO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@H]2CO)c(OC)n1 InChI=1S/C34H36Cl2N4O4/c1-43-33-21(17-39-15-13-23(39)19-41)9-11-29(37-33)27-7-3-5-25(31(27)35)26-6-4-8-28(32(26)36)30-12-10-22(34(38-30)44-2)18-40-16-14-24(40)20-42/h3-12,23-24,41-42H,13-20H2,1-2H3/t23-,24-/m0/s1 JFQWPTXASVZYLZ-ZEQRLZLVSA-N 479909 US10899735, No. 368 Programmed cell death 1 ligand 1/2 Human 287 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479909&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996257 COc1nc(ccc1CN1CC[C@@H]1CO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@@H]2CO)c(OC)n1 InChI=1S/C34H36Cl2N4O4/c1-43-33-21(17-39-15-13-23(39)19-41)9-11-29(37-33)27-7-3-5-25(31(27)35)26-6-4-8-28(32(26)36)30-12-10-22(34(38-30)44-2)18-40-16-14-24(40)20-42/h3-12,23-24,41-42H,13-20H2,1-2H3/t23-,24-/m1/s1 JFQWPTXASVZYLZ-DNQXCXABSA-N 479910 US10899735, No. 369 Programmed cell death 1 ligand 1/2 Human 608 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479910&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996258 COc1nc(ccc1CN1CC(O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC(O)C2)c(OC)n1 InChI=1S/C32H32Cl2N4O4/c1-41-31-19(13-37-15-21(39)16-37)9-11-27(35-31)25-7-3-5-23(29(25)33)24-6-4-8-26(30(24)34)28-12-10-20(32(36-28)42-2)14-38-17-22(40)18-38/h3-12,21-22,39-40H,13-18H2,1-2H3 NLQNRFHYSJDNSV-UHFFFAOYSA-N 479911 US10899735, No. 370 Programmed cell death 1 ligand 1/2 Human 305 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479911&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996259 COc1nc(ccc1CN1CC[C@H](O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@H](O)C2)c(OC)n1 InChI=1S/C34H36Cl2N4O4/c1-43-33-21(17-39-15-13-23(41)19-39)9-11-29(37-33)27-7-3-5-25(31(27)35)26-6-4-8-28(32(26)36)30-12-10-22(34(38-30)44-2)18-40-16-14-24(42)20-40/h3-12,23-24,41-42H,13-20H2,1-2H3/t23-,24-/m0/s1 LYCQUDVNFPGQBY-ZEQRLZLVSA-N 479912 US10899735, No. 371 Programmed cell death 1 ligand 1/2 Human 357 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479912&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996260 COc1nc(ccc1CN1CC[C@@H](O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC[C@@H](O)C2)c(OC)n1 InChI=1S/C34H36Cl2N4O4/c1-43-33-21(17-39-15-13-23(41)19-39)9-11-29(37-33)27-7-3-5-25(31(27)35)26-6-4-8-28(32(26)36)30-12-10-22(34(38-30)44-2)18-40-16-14-24(42)20-40/h3-12,23-24,41-42H,13-20H2,1-2H3/t23-,24-/m1/s1 LYCQUDVNFPGQBY-DNQXCXABSA-N 479913 US10899735, No. 372 Programmed cell death 1 ligand 1/2 Human 142 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479913&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996261 COc1nc(ccc1CN1CCC[C@H]1CO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC[C@H]2CO)c(OC)n1 InChI=1S/C36H40Cl2N4O4/c1-45-35-23(19-41-17-5-7-25(41)21-43)13-15-31(39-35)29-11-3-9-27(33(29)37)28-10-4-12-30(34(28)38)32-16-14-24(36(40-32)46-2)20-42-18-6-8-26(42)22-44/h3-4,9-16,25-26,43-44H,5-8,17-22H2,1-2H3/t25-,26-/m0/s1 IQUROMPYJNPCRS-UIOOFZCWSA-N 479914 US10899735, No. 373 Programmed cell death 1 ligand 1/2 Human 166 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479914&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996262 COc1nc(ccc1CN1CCC[C@@H]1CO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC[C@@H]2CO)c(OC)n1 InChI=1S/C36H40Cl2N4O4/c1-45-35-23(19-41-17-5-7-25(41)21-43)13-15-31(39-35)29-11-3-9-27(33(29)37)28-10-4-12-30(34(28)38)32-16-14-24(36(40-32)46-2)20-42-18-6-8-26(42)22-44/h3-4,9-16,25-26,43-44H,5-8,17-22H2,1-2H3/t25-,26-/m1/s1 IQUROMPYJNPCRS-CLJLJLNGSA-N 479915 US10899735, No. 374 Programmed cell death 1 ligand 1/2 Human 281 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479915&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996263 COc1nc(ccc1[C@@H]1CCCN1CCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H]2CCCN2CCO)c(OC)n1 InChI=1S/C36H40Cl2N4O4/c1-45-35-27(31-11-5-17-41(31)19-21-43)13-15-29(39-35)25-9-3-7-23(33(25)37)24-8-4-10-26(34(24)38)30-16-14-28(36(40-30)46-2)32-12-6-18-42(32)20-22-44/h3-4,7-10,13-16,31-32,43-44H,5-6,11-12,17-22H2,1-2H3/t31-,32-/m0/s1 YIHVSBMZWJMSOR-ACHIHNKUSA-N 479916 US10899735, No. 375 Programmed cell death 1 ligand 1/2 Human 947 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479916&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996264 COc1nc(ccc1[C@@H](N)CCCN)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(C2CCCN2)c(OC)n1 InChI=1S/C32H35Cl2N5O2/c1-40-31-21(25(36)11-5-17-35)13-15-27(38-31)22-9-3-7-19(29(22)33)20-8-4-10-23(30(20)34)28-16-14-24(32(39-28)41-2)26-12-6-18-37-26/h3-4,7-10,13-16,25-26,37H,5-6,11-12,17-18,35-36H2,1-2H3/t25-,26?/m0/s1 PRVSYXUEDIINSK-PMCHYTPCSA-N 479917 US10899735, No. 376 Programmed cell death 1 ligand 1/2 Human 985 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479917&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996265 COc1nc(ccc1C1CCCN1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H]2CCCN2)c(OC)n1 InChI=1S/C32H32Cl2N4O2/c1-39-31-23(25-11-5-17-35-25)13-15-27(37-31)21-9-3-7-19(29(21)33)20-8-4-10-22(30(20)34)28-16-14-24(32(38-28)40-2)26-12-6-18-36-26/h3-4,7-10,13-16,25-26,35-36H,5-6,11-12,17-18H2,1-2H3/t25-,26?/m0/s1 MDCBPPTZLIPXJL-PMCHYTPCSA-N 479918 US10899735, No. 377::US10899735, No. 378 Programmed cell death 1 ligand 1/2 Human 626 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479918&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996266 COc1nc(ccc1C1CCCN1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H]2CCCN2)c(OC)n1 InChI=1S/C32H32Cl2N4O2/c1-39-31-23(25-11-5-17-35-25)13-15-27(37-31)21-9-3-7-19(29(21)33)20-8-4-10-22(30(20)34)28-16-14-24(32(38-28)40-2)26-12-6-18-36-26/h3-4,7-10,13-16,25-26,35-36H,5-6,11-12,17-18H2,1-2H3/t25-,26?/m0/s1 MDCBPPTZLIPXJL-PMCHYTPCSA-N 479918 US10899735, No. 377::US10899735, No. 378 Programmed cell death 1 ligand 1/2 Human 2191 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479918&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996267 COc1nc(ccc1[C@@H](N)CC=C)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H](N)CC=C)c(OC)n1 InChI=1S/C32H32Cl2N4O2/c1-5-9-25(35)21-15-17-27(37-31(21)39-3)23-13-7-11-19(29(23)33)20-12-8-14-24(30(20)34)28-18-16-22(26(36)10-6-2)32(38-28)40-4/h5-8,11-18,25-26H,1-2,9-10,35-36H2,3-4H3/t25-,26-/m0/s1 VBQGJOKMWBZYFA-UIOOFZCWSA-N 479920 US10899735, No. 379 Programmed cell death 1 ligand 1/2 Human 9865 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479920 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479920&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996268 COc1nc(ccc1[C@@H](N)CC=C)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](N)CC=C)c(OC)n1 InChI=1S/C32H32Cl2N4O2/c1-5-9-25(35)21-15-17-27(37-31(21)39-3)23-13-7-11-19(29(23)33)20-12-8-14-24(30(20)34)28-18-16-22(26(36)10-6-2)32(38-28)40-4/h5-8,11-18,25-26H,1-2,9-10,35-36H2,3-4H3/t25-,26+ VBQGJOKMWBZYFA-WMPKNSHKSA-N 479921 US10899735, No. 380 Programmed cell death 1 ligand 1/2 Human 7690 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479921&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996269 COc1nc(ccc1[C@H](C)NCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)NCCO)c(OC)n1 InChI=1S/C32H36Cl2N4O4/c1-19(35-15-17-39)21-11-13-27(37-31(21)41-3)25-9-5-7-23(29(25)33)24-8-6-10-26(30(24)34)28-14-12-22(32(38-28)42-4)20(2)36-16-18-40/h5-14,19-20,35-36,39-40H,15-18H2,1-4H3/t19-,20-/m0/s1 MKSADAHCJNHVJH-PMACEKPBSA-N 479922 US10899735, No. 381 Programmed cell death 1 ligand 1/2 Human 374 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479922&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996270 COc1nc(ccc1[C@@H](C)NCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)NCCO)c(OC)n1 InChI=1S/C32H36Cl2N4O4/c1-19(35-15-17-39)21-11-13-27(37-31(21)41-3)25-9-5-7-23(29(25)33)24-8-6-10-26(30(24)34)28-14-12-22(32(38-28)42-4)20(2)36-16-18-40/h5-14,19-20,35-36,39-40H,15-18H2,1-4H3/t19-,20+ MKSADAHCJNHVJH-BGYRXZFFSA-N 479923 US10899735, No. 382 Programmed cell death 1 ligand 1/2 Human 5807 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479923&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996271 COc1nc(ccc1[C@@H](C)NCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H](C)NCCO)c(OC)n1 InChI=1S/C32H36Cl2N4O4/c1-19(35-15-17-39)21-11-13-27(37-31(21)41-3)25-9-5-7-23(29(25)33)24-8-6-10-26(30(24)34)28-14-12-22(32(38-28)42-4)20(2)36-16-18-40/h5-14,19-20,35-36,39-40H,15-18H2,1-4H3/t19-,20-/m1/s1 MKSADAHCJNHVJH-WOJBJXKFSA-N 479924 US10899735, No. 383 Programmed cell death 1 ligand 1/2 Human 2566 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479924&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996272 COc1nc(ccc1[C@@H](C)N)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N)c(OC)n1 InChI=1S/C28H28Cl2N4O2/c1-15(31)17-11-13-23(33-27(17)35-3)21-9-5-7-19(25(21)29)20-8-6-10-22(26(20)30)24-14-12-18(16(2)32)28(34-24)36-4/h5-16H,31-32H2,1-4H3/t15-,16+ LZUPNOYLZARADD-IYBDPMFKSA-N 479925 US10899735, No. 384 Programmed cell death 1 ligand 1/2 Human 1149 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479925&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996273 COc1nc(ccc1[C@@H](C)N)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@@H](C)N)c(OC)n1 InChI=1S/C28H28Cl2N4O2/c1-15(31)17-11-13-23(33-27(17)35-3)21-9-5-7-19(25(21)29)20-8-6-10-22(26(20)30)24-14-12-18(16(2)32)28(34-24)36-4/h5-16H,31-32H2,1-4H3/t15-,16-/m1/s1 LZUPNOYLZARADD-HZPDHXFCSA-N 479926 US10899735, No. 385 Programmed cell death 1 ligand 1/2 Human 2837 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479926&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996274 COc1nc(ccc1[C@H](C)N)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc([C@H](C)N)c(OC)n1 InChI=1S/C28H28Cl2N4O2/c1-15(31)17-11-13-23(33-27(17)35-3)21-9-5-7-19(25(21)29)20-8-6-10-22(26(20)30)24-14-12-18(16(2)32)28(34-24)36-4/h5-16H,31-32H2,1-4H3/t15-,16-/m0/s1 LZUPNOYLZARADD-HOTGVXAUSA-N 479927 US10899735, No. 386 Programmed cell death 1 ligand 1/2 Human 185 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479927&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996275 COC1CN(Cc2ccc(nc2OC)-c2cccc(c2Cl)-c2cccc(c2Cl)-c2ccc(CN3CC(C3)OC)c(OC)n2)C1 InChI=1S/C34H36Cl2N4O4/c1-41-23-17-39(18-23)15-21-11-13-29(37-33(21)43-3)27-9-5-7-25(31(27)35)26-8-6-10-28(32(26)36)30-14-12-22(34(38-30)44-4)16-40-19-24(20-40)42-2/h5-14,23-24H,15-20H2,1-4H3 SLXOWAPLVYCMOA-UHFFFAOYSA-N 479928 US10899735, No. 387 Programmed cell death 1 ligand 1/2 Human 857 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479928&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996276 COc1nc(ccc1CN1CC(O)C1)-c1cccc(c1F)-c1cccc(-c2ccc(CN3CC(O)C3)c(OC)n2)c1C(F)(F)F InChI=1S/C33H32F4N4O4/c1-44-31-19(13-40-15-21(42)16-40)9-11-27(38-31)25-7-3-5-23(29(25)33(35,36)37)24-6-4-8-26(30(24)34)28-12-10-20(32(39-28)45-2)14-41-17-22(43)18-41/h3-12,21-22,42-43H,13-18H2,1-2H3 MMEIKUVSFRLKJS-UHFFFAOYSA-N 479929 US10899735, No. 388 Programmed cell death 1 ligand 1/2 Human 2909 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479929&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996277 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1F)-c1cccc(-c2ccc(CNC[C@@H]3CCC(=O)N3)c(OC)n2)c1C(F)(F)F InChI=1S/C37H38F4N6O4/c1-50-35-21(17-42-19-23-11-15-31(48)44-23)9-13-29(46-35)27-7-3-5-25(33(27)37(39,40)41)26-6-4-8-28(34(26)38)30-14-10-22(36(47-30)51-2)18-43-20-24-12-16-32(49)45-24/h3-10,13-14,23-24,42-43H,11-12,15-20H2,1-2H3,(H,44,48)(H,45,49)/t23-,24-/m0/s1 WYPVUSKENCXBES-ZEQRLZLVSA-N 479930 US10899735, No. 389 Programmed cell death 1 ligand 1/2 Human 3271 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479930&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996278 COc1nc(ccc1CNCC1CC(=O)NC1=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCC2CC(=O)NC2=O)c(OC)n1 InChI=1S/C36H34Cl2N6O6/c1-49-35-19(15-39-17-21-13-29(45)43-33(21)47)9-11-27(41-35)25-7-3-5-23(31(25)37)24-6-4-8-26(32(24)38)28-12-10-20(36(42-28)50-2)16-40-18-22-14-30(46)44-34(22)48/h3-12,21-22,39-40H,13-18H2,1-2H3,(H,43,45,47)(H,44,46,48) RCBPZDAYAVNRJO-UHFFFAOYSA-N 479931 US10899735, No. 390 Programmed cell death 1 ligand 1/2 Human 487 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479931&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996279 COc1nc(ccc1CN1CCC(C1)c1cnccn1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC(C2)c2cnccn2)c(OC)n1 InChI=1S/C42H40Cl2N8O2/c1-53-41-29(25-51-19-13-27(23-51)37-21-45-15-17-47-37)9-11-35(49-41)33-7-3-5-31(39(33)43)32-6-4-8-34(40(32)44)36-12-10-30(42(50-36)54-2)26-52-20-14-28(24-52)38-22-46-16-18-48-38/h3-12,15-18,21-22,27-28H,13-14,19-20,23-26H2,1-2H3 BYADAYCHGATPIT-UHFFFAOYSA-N 479932 US10899735, No. 391 Programmed cell death 1 ligand 1/2 Human 1837 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479932&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996280 COc1nc(ccc1CN1CCC(C1)c1cccnc1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC(C2)c2cccnc2)c(OC)n1 InChI=1S/C44H42Cl2N6O2/c1-53-43-33(27-51-21-17-31(25-51)29-7-5-19-47-23-29)13-15-39(49-43)37-11-3-9-35(41(37)45)36-10-4-12-38(42(36)46)40-16-14-34(44(50-40)54-2)28-52-22-18-32(26-52)30-8-6-20-48-24-30/h3-16,19-20,23-24,31-32H,17-18,21-22,25-28H2,1-2H3 RBRZVPAOMMXUCS-UHFFFAOYSA-N 479933 US10899735, No. 392 Programmed cell death 1 ligand 1/2 Human 7899 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479933&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996281 COc1nc(ccc1CN1CCC(C1)c1ccccn1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC(C2)c2ccccn2)c(OC)n1 InChI=1S/C44H42Cl2N6O2/c1-53-43-31(27-51-23-19-29(25-51)37-13-3-5-21-47-37)15-17-39(49-43)35-11-7-9-33(41(35)45)34-10-8-12-36(42(34)46)40-18-16-32(44(50-40)54-2)28-52-24-20-30(26-52)38-14-4-6-22-48-38/h3-18,21-22,29-30H,19-20,23-28H2,1-2H3 KPFAKLJUBRKERB-UHFFFAOYSA-N 479934 US10899735, No. 393 Programmed cell death 1 ligand 1/2 Human 7659 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479934&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996282 COc1nc(ccc1CN1CCC(O)(CC#N)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC(O)(CC#N)C2)c(OC)n1 InChI=1S/C38H38Cl2N6O4/c1-49-35-25(21-45-19-15-37(47,23-45)13-17-41)9-11-31(43-35)29-7-3-5-27(33(29)39)28-6-4-8-30(34(28)40)32-12-10-26(36(44-32)50-2)22-46-20-16-38(48,24-46)14-18-42/h3-12,47-48H,13-16,19-24H2,1-2H3 YVOBTAPNPQMPFC-UHFFFAOYSA-N 479935 US10899735, No. 394 Programmed cell death 1 ligand 1/2 Human 797 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479935&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996283 COc1nc(ccc1CN1CCC(C1)c1ncccn1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC(C2)c2ncccn2)c(OC)n1 InChI=1S/C42H40Cl2N8O2/c1-53-41-29(25-51-21-15-27(23-51)39-45-17-5-18-46-39)11-13-35(49-41)33-9-3-7-31(37(33)43)32-8-4-10-34(38(32)44)36-14-12-30(42(50-36)54-2)26-52-22-16-28(24-52)40-47-19-6-20-48-40/h3-14,17-20,27-28H,15-16,21-26H2,1-2H3 NAZUMAWJOLZRGC-UHFFFAOYSA-N 479936 US10899735, No. 395 Programmed cell death 1 ligand 1/2 Human 922 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479936&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996284 COc1nc(ccc1CN1CCC(C1)C1CCCO1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC(C2)C2CCCO2)c(OC)n1 InChI=1S/C42H48Cl2N4O4/c1-49-41-29(25-47-19-17-27(23-47)37-11-5-21-51-37)13-15-35(45-41)33-9-3-7-31(39(33)43)32-8-4-10-34(40(32)44)36-16-14-30(42(46-36)50-2)26-48-20-18-28(24-48)38-12-6-22-52-38/h3-4,7-10,13-16,27-28,37-38H,5-6,11-12,17-26H2,1-2H3 AGOZSDVNFOQIRN-UHFFFAOYSA-N 479937 US10899735, No. 396 Programmed cell death 1 ligand 1/2 Human 1452 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479937&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996285 COc1nc(ccc1CN1CCC(C1)C1CCOC1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCC(C2)C2CCOC2)c(OC)n1 InChI=1S/C42H48Cl2N4O4/c1-49-41-29(23-47-17-13-27(21-47)31-15-19-51-25-31)9-11-37(45-41)35-7-3-5-33(39(35)43)34-6-4-8-36(40(34)44)38-12-10-30(42(46-38)50-2)24-48-18-14-28(22-48)32-16-20-52-26-32/h3-12,27-28,31-32H,13-26H2,1-2H3 WCPUGWLGLVFMKP-UHFFFAOYSA-N 479938 US10899735, No. 397 Programmed cell death 1 ligand 1/2 Human 906 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479938&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996286 COc1nc(ccc1CNCCc1cncc(O)c1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCc2cncc(O)c2)c(OC)n1 InChI=1S/C40H38Cl2N6O4/c1-51-39-27(21-43-15-13-25-17-29(49)23-45-19-25)9-11-35(47-39)33-7-3-5-31(37(33)41)32-6-4-8-34(38(32)42)36-12-10-28(40(48-36)52-2)22-44-16-14-26-18-30(50)24-46-20-26/h3-12,17-20,23-24,43-44,49-50H,13-16,21-22H2,1-2H3 NMSOHXKCPAXSOM-UHFFFAOYSA-N 479939 US10899735, No. 398 Programmed cell death 1 ligand 1/2 Human 3092 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479939&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996287 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(-c2ccc(CNC[C@@H]3CCC(=O)N3)c(OC)n2)c1OC(F)F InChI=1S/C37H39ClF2N6O5/c1-49-35-21(17-41-19-23-11-15-31(47)43-23)9-13-29(45-35)27-7-3-5-25(33(27)38)26-6-4-8-28(34(26)51-37(39)40)30-14-10-22(36(46-30)50-2)18-42-20-24-12-16-32(48)44-24/h3-10,13-14,23-24,37,41-42H,11-12,15-20H2,1-2H3,(H,43,47)(H,44,48)/t23-,24-/m0/s1 ABLPORRFCKDAAY-ZEQRLZLVSA-N 479940 US10899735, No. 399 Programmed cell death 1 ligand 1/2 Human 630 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479940&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996288 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(C)c(CN2CC3(C2)CCC(=O)N3)c(OC)n1 InChI=1S/C39H40Cl2N6O4/c1-23-16-31(43-37(51-3)29(23)18-47-21-39(22-47)15-13-33(49)45-39)28-9-5-7-26(35(28)41)25-6-4-8-27(34(25)40)30-11-10-24(36(42-30)50-2)17-46-19-38(20-46)14-12-32(48)44-38/h4-11,16H,12-15,17-22H2,1-3H3,(H,44,48)(H,45,49) GOFTYGCNURKIEO-UHFFFAOYSA-N 479941 US10899735, No. 400 Programmed cell death 1 ligand 1/2 Human 162 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479941&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996289 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1F)-c1cccc(-c2ccc(CNC[C@@H]3CCC(=O)N3)c(OC)n2)c1OC InChI=1S/C37H41FN6O5/c1-47-35-27(7-5-9-29(35)31-15-11-23(37(44-31)49-3)19-40-21-25-13-17-33(46)42-25)26-6-4-8-28(34(26)38)30-14-10-22(36(43-30)48-2)18-39-20-24-12-16-32(45)41-24/h4-11,14-15,24-25,39-40H,12-13,16-21H2,1-3H3,(H,41,45)(H,42,46)/t24-,25-/m0/s1 CQJIBUQOESECQD-DQEYMECFSA-N 479942 US10899735, No. 401 Programmed cell death 1 ligand 1/2 Human 255 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479942&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996290 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(C)c(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C37H40Cl2N6O4/c1-21-16-31(45-37(49-3)29(21)20-41-19-24-12-15-33(47)43-24)28-9-5-7-26(35(28)39)25-6-4-8-27(34(25)38)30-13-10-22(36(44-30)48-2)17-40-18-23-11-14-32(46)42-23/h4-10,13,16,23-24,40-41H,11-12,14-15,17-20H2,1-3H3,(H,42,46)(H,43,47)/t23-,24-/m0/s1 VTAAOWZLJRYVPK-ZEQRLZLVSA-N 479943 US10899735, No. 402 Programmed cell death 1 ligand 1/2 Human 108 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479943&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996291 COc1nc(ccc1CN1CC2(C1)CN(C2)C(C)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(C)c(CN2CC3(C2)CN(C3)C(C)=O)c(OC)n1 InChI=1S/C41H44Cl2N6O4/c1-25-14-35(45-39(53-5)33(25)16-47-19-41(20-47)23-49(24-41)27(3)51)32-11-7-9-30(37(32)43)29-8-6-10-31(36(29)42)34-13-12-28(38(44-34)52-4)15-46-17-40(18-46)21-48(22-40)26(2)50/h6-14H,15-24H2,1-5H3 IJRZPYQAZMJEKE-UHFFFAOYSA-N 479944 US10899735, No. 403 Programmed cell death 1 ligand 1/2 Human 198 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479944&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996292 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(C)c(CNCCO)c(OC)n1 InChI=1S/C31H34Cl2N4O4/c1-19-16-27(37-31(41-3)25(19)18-35-13-15-39)24-9-5-7-22(29(24)33)21-6-4-8-23(28(21)32)26-11-10-20(17-34-12-14-38)30(36-26)40-2/h4-11,16,34-35,38-39H,12-15,17-18H2,1-3H3 MCFMMOPRBCLEET-UHFFFAOYSA-N 479945 US10899735, No. 404 Programmed cell death 1 ligand 1/2 Human 474 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479945&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996293 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(-c2ccc(CNC[C@@H]3CCC(=O)N3)c(OC)n2)c1C#N InChI=1S/C37H38ClN7O4/c1-48-36-22(18-40-20-24-11-15-33(46)42-24)9-13-31(44-36)27-6-3-5-26(30(27)17-39)28-7-4-8-29(35(28)38)32-14-10-23(37(45-32)49-2)19-41-21-25-12-16-34(47)43-25/h3-10,13-14,24-25,40-41H,11-12,15-16,18-21H2,1-2H3,(H,42,46)(H,43,47)/t24-,25-/m0/s1 GWAYLQYARFPIAZ-DQEYMECFSA-N 479946 US10899735, No. 405 Programmed cell death 1 ligand 1/2 Human 242 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479946&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996294 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(-c2ccc(CNC[C@@H]3CCC(=O)N3)c(OC)n2)c1OC InChI=1S/C37H41ClN6O5/c1-47-35-27(7-5-9-29(35)31-15-11-23(37(44-31)49-3)19-40-21-25-13-17-33(46)42-25)26-6-4-8-28(34(26)38)30-14-10-22(36(43-30)48-2)18-39-20-24-12-16-32(45)41-24/h4-11,14-15,24-25,39-40H,12-13,16-21H2,1-3H3,(H,41,45)(H,42,46)/t24-,25-/m0/s1 UCNCEEKNMHVWKY-DQEYMECFSA-N 479947 US10899735, No. 406 Programmed cell death 1 ligand 1/2 Human 154 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479947&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996295 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cc(C)cc(c1C)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C38H43ClN6O4/c1-22-16-30(23(2)31(17-22)33-13-9-25(38(45-33)49-4)19-41-21-27-11-15-35(47)43-27)28-6-5-7-29(36(28)39)32-12-8-24(37(44-32)48-3)18-40-20-26-10-14-34(46)42-26/h5-9,12-13,16-17,26-27,40-41H,10-11,14-15,18-21H2,1-4H3,(H,42,46)(H,43,47)/t26-,27-/m0/s1 DACNUWOZUDGPTB-SVBPBHIXSA-N 479948 US10899735, No. 407::US10899735, No. 408 Programmed cell death 1 ligand 1/2 Human 910 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479948&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996296 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cc(C)cc(c1C)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C38H43ClN6O4/c1-22-16-30(23(2)31(17-22)33-13-9-25(38(45-33)49-4)19-41-21-27-11-15-35(47)43-27)28-6-5-7-29(36(28)39)32-12-8-24(37(44-32)48-3)18-40-20-26-10-14-34(46)42-26/h5-9,12-13,16-17,26-27,40-41H,10-11,14-15,18-21H2,1-4H3,(H,42,46)(H,43,47)/t26-,27-/m0/s1 DACNUWOZUDGPTB-SVBPBHIXSA-N 479948 US10899735, No. 407::US10899735, No. 408 Programmed cell death 1 ligand 1/2 Human 323 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479948&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996297 COc1cc(nc(Cl)c1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H37Cl3N6O4/c1-48-30-15-29(44-35(39)27(30)19-41-18-22-11-14-32(47)43-22)26-8-4-6-24(34(26)38)23-5-3-7-25(33(23)37)28-12-9-20(36(45-28)49-2)16-40-17-21-10-13-31(46)42-21/h3-9,12,15,21-22,40-41H,10-11,13-14,16-19H2,1-2H3,(H,42,46)(H,43,47)/t21-,22-/m0/s1 UKZBAMKXOHEYTI-VXKWHMMOSA-N 479950 US10899735, No. 409 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479950&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996298 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(C)c(CNC[C@@H]2CCC(=O)N2)c(Cl)n1 InChI=1S/C36H37Cl3N6O3/c1-20-15-30(44-35(39)28(20)19-41-18-23-11-14-32(47)43-23)27-8-4-6-25(34(27)38)24-5-3-7-26(33(24)37)29-12-9-21(36(45-29)48-2)16-40-17-22-10-13-31(46)42-22/h3-9,12,15,22-23,40-41H,10-11,13-14,16-19H2,1-2H3,(H,42,46)(H,43,47)/t22-,23-/m0/s1 LXMVPMUBDHYZFH-GOTSBHOMSA-N 479951 US10899735, No. 410 Programmed cell death 1 ligand 1/2 Human 335 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479951&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996299 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cc(Cl)cc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H37Cl3N6O4/c1-48-35-20(16-40-18-23-8-12-31(46)42-23)6-10-29(44-35)26-5-3-4-25(33(26)38)27-14-22(37)15-28(34(27)39)30-11-7-21(36(45-30)49-2)17-41-19-24-9-13-32(47)43-24/h3-7,10-11,14-15,23-24,40-41H,8-9,12-13,16-19H2,1-2H3,(H,42,46)(H,43,47)/t23-,24-/m0/s1 KJWUBHCLLZRWBH-ZEQRLZLVSA-N 479952 US10899735, No. 411 Programmed cell death 1 ligand 1/2 Human 194 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479952&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996300 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(Cl)c(CNC[C@@H]2CCC(=O)N2)cn1 InChI=1S/C35H35Cl3N6O3/c1-47-35-20(15-39-18-22-9-12-31(45)42-22)8-11-29(44-35)26-6-2-4-24(33(26)37)25-5-3-7-27(34(25)38)30-14-28(36)21(17-41-30)16-40-19-23-10-13-32(46)43-23/h2-8,11,14,17,22-23,39-40H,9-10,12-13,15-16,18-19H2,1H3,(H,42,45)(H,43,46)/t22-,23-/m0/s1 PCIHICQZEYRFQX-GOTSBHOMSA-N 479953 US10899735, No. 412 Programmed cell death 1 ligand 1/2 Human 865 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479953&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996301 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cc(F)cc(c1Cl)-c1cc(F)cc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H36Cl2F2N6O4/c1-49-35-19(15-41-17-23-5-9-31(47)43-23)3-7-29(45-35)27-13-21(39)11-25(33(27)37)26-12-22(40)14-28(34(26)38)30-8-4-20(36(46-30)50-2)16-42-18-24-6-10-32(48)44-24/h3-4,7-8,11-14,23-24,41-42H,5-6,9-10,15-18H2,1-2H3,(H,43,47)(H,44,48)/t23-,24-/m0/s1 VOBPJIVJQKPFEW-ZEQRLZLVSA-N 479954 US10899735, No. 413 Programmed cell death 1 ligand 1/2 Human 387 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479954&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996302 Clc1c(cccc1-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OCC#N)n1)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OCC#N)n1 InChI=1S/C40H36Cl2N8O4/c41-35-27(3-1-5-29(35)31-9-7-25(37(45-31)53-17-15-43)19-49-21-39(22-49)13-11-33(51)47-39)28-4-2-6-30(36(28)42)32-10-8-26(38(46-32)54-18-16-44)20-50-23-40(24-50)14-12-34(52)48-40/h1-10H,11-14,17-24H2,(H,47,51)(H,48,52) CRLNZDMTGKGWES-UHFFFAOYSA-N 479955 US10899735, No. 414 Programmed cell death 1 ligand 1/2 Human 664 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479955&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996303 Clc1c(cccc1-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OCC#N)n1)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OCC#N)n1 InChI=1S/C38H36Cl2N8O4/c39-35-27(3-1-5-29(35)31-11-7-23(37(47-31)51-17-15-41)19-43-21-25-9-13-33(49)45-25)28-4-2-6-30(36(28)40)32-12-8-24(38(48-32)52-18-16-42)20-44-22-26-10-14-34(50)46-26/h1-8,11-12,25-26,43-44H,9-10,13-14,17-22H2,(H,45,49)(H,46,50)/t25-,26-/m0/s1 JOJYVRPEISDCNE-UIOOFZCWSA-N 479956 US10899735, No. 415 Programmed cell death 1 ligand 1/2 Human 298 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479956&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996304 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CC3(C2)CCC(=O)N3)c(OCC#N)n1 InChI=1S/C39H37Cl2N7O4/c1-51-36-24(18-47-20-38(21-47)14-12-32(49)45-38)8-10-30(43-36)28-6-2-4-26(34(28)40)27-5-3-7-29(35(27)41)31-11-9-25(37(44-31)52-17-16-42)19-48-22-39(23-48)15-13-33(50)46-39/h2-11H,12-15,17-23H2,1H3,(H,45,49)(H,46,50) USLUNMGAIOKZBC-UHFFFAOYSA-N 479957 US10899735, No. 416 Programmed cell death 1 ligand 1/2 Human 132 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479957&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996305 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OCC#N)n1 InChI=1S/C37H37Cl2N7O4/c1-49-36-22(18-41-20-24-10-14-32(47)43-24)8-12-30(45-36)28-6-2-4-26(34(28)38)27-5-3-7-29(35(27)39)31-13-9-23(37(46-31)50-17-16-40)19-42-21-25-11-15-33(48)44-25/h2-9,12-13,24-25,41-42H,10-11,14-15,17-21H2,1H3,(H,43,47)(H,44,48)/t24-,25-/m0/s1 QPJOABQGZRSFHQ-DQEYMECFSA-N 479958 US10899735, No. 417 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479958&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996306 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cc(F)cc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C36H37Cl2FN6O4/c1-48-35-20(16-40-18-23-8-12-31(46)42-23)6-10-29(44-35)26-5-3-4-25(33(26)37)27-14-22(39)15-28(34(27)38)30-11-7-21(36(45-30)49-2)17-41-19-24-9-13-32(47)43-24/h3-7,10-11,14-15,23-24,40-41H,8-9,12-13,16-19H2,1-2H3,(H,42,46)(H,43,47)/t23-,24-/m0/s1 OYXLDXYBBZNNCR-ZEQRLZLVSA-N 479959 US10899735, No. 418 Programmed cell death 1 ligand 1/2 Human 126 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479959&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996307 COc1nc(ccc1CN1CCN(CC1)C1COC1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CN2CCN(CC2)C2COC2)c(OC)n1 InChI=1S/C40H46Cl2N6O4/c1-49-39-27(21-45-13-17-47(18-14-45)29-23-51-24-29)9-11-35(43-39)33-7-3-5-31(37(33)41)32-6-4-8-34(38(32)42)36-12-10-28(40(44-36)50-2)22-46-15-19-48(20-16-46)30-25-52-26-30/h3-12,29-30H,13-26H2,1-2H3 UITOQAWHLDGZBR-UHFFFAOYSA-N 479960 US10899735, No. 419 Programmed cell death 1 ligand 1/2 Human 774 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479960&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996308 COc1nc(ccc1CNC[C@H]1CNC(=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@H]2CNC(=O)C2)c(OC)n1 InChI=1S/C36H38Cl2N6O4/c1-47-35-23(19-39-15-21-13-31(45)41-17-21)9-11-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-12-10-24(36(44-30)48-2)20-40-16-22-14-32(46)42-18-22/h3-12,21-22,39-40H,13-20H2,1-2H3,(H,41,45)(H,42,46)/t21-,22-/m0/s1 CGHOXEHQYUBLSN-VXKWHMMOSA-N 479961 US10899735, No. 420 Programmed cell death 1 ligand 1/2 Human 283 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479961&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996309 COc1nc(ccc1CNCCOCC(N)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCCOCC(N)=O)c(OC)n1 InChI=1S/C34H38Cl2N6O6/c1-45-33-21(17-39-13-15-47-19-29(37)43)9-11-27(41-33)25-7-3-5-23(31(25)35)24-6-4-8-26(32(24)36)28-12-10-22(34(42-28)46-2)18-40-14-16-48-20-30(38)44/h3-12,39-40H,13-20H2,1-2H3,(H2,37,43)(H2,38,44) KSZCBNKWFVHDQA-UHFFFAOYSA-N 479962 US10899735, No. 421 Programmed cell death 1 ligand 1/2 Human 228 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479962&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996310 COc1nc(ccc1CNC[C@@H]1CNC(=O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CNC(=O)C2)c(OC)n1 InChI=1S/C36H38Cl2N6O4/c1-47-35-23(19-39-15-21-13-31(45)41-17-21)9-11-29(43-35)27-7-3-5-25(33(27)37)26-6-4-8-28(34(26)38)30-12-10-24(36(44-30)48-2)20-40-16-22-14-32(46)42-18-22/h3-12,21-22,39-40H,13-20H2,1-2H3,(H,41,45)(H,42,46)/t21-,22-/m1/s1 CGHOXEHQYUBLSN-FGZHOGPDSA-N 479963 US10899735, No. 422 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479963&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996311 COc1nc(ccc1CNCc1cn[nH]c1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCc2cn[nH]c2)c(OC)n1 InChI=1S/C34H32Cl2N8O2/c1-45-33-23(19-37-13-21-15-39-40-16-21)9-11-29(43-33)27-7-3-5-25(31(27)35)26-6-4-8-28(32(26)36)30-12-10-24(34(44-30)46-2)20-38-14-22-17-41-42-18-22/h3-12,15-18,37-38H,13-14,19-20H2,1-2H3,(H,39,40)(H,41,42) ZOYBPCTZDGCNLE-UHFFFAOYSA-N 479964 US10899735, No. 423 Programmed cell death 1 ligand 1/2 Human 841 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479964&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996312 COc1cc(cc(F)c1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C37H38Cl2FN5O4/c1-48-32-16-22(15-30(40)29(32)20-42-19-24-11-14-34(47)44-24)25-5-3-6-26(35(25)38)27-7-4-8-28(36(27)39)31-12-9-21(37(45-31)49-2)17-41-18-23-10-13-33(46)43-23/h3-9,12,15-16,23-24,41-42H,10-11,13-14,17-20H2,1-2H3,(H,43,46)(H,44,47)/t23-,24-/m0/s1 SWMRLVGFNFGHJL-ZEQRLZLVSA-N 479965 US10899735, No. 424 Programmed cell death 1 ligand 1/2 Human 242 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479965&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996313 COc1nc(ccc1CNC[C@@H](O)CC(O)=O)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1ccc(CNCC2CCC(=O)N2)c(OC)n1 InChI=1S/C35H37Cl2N5O6/c1-47-34-20(16-38-18-22-11-14-30(44)40-22)9-12-28(41-34)26-7-3-5-24(32(26)36)25-6-4-8-27(33(25)37)29-13-10-21(35(42-29)48-2)17-39-19-23(43)15-31(45)46/h3-10,12-13,22-23,38-39,43H,11,14-19H2,1-2H3,(H,40,44)(H,45,46)/t22?,23-/m0/s1 TWPOKEJJITXALU-WCSIJFPASA-N 479966 US10899735, No. 425 Programmed cell death 1 ligand 1/2 Human 64.0 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479966&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search C03834 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996314 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(c(CNC[C@@H]2CCC(=O)N2)c(Cl)n1)C(F)(F)F InChI=1S/C36H34Cl3F3N6O3/c1-51-35-19(15-43-16-20-9-12-30(49)45-20)8-11-28(48-35)24-6-2-4-22(32(24)37)23-5-3-7-25(33(23)38)29-14-27(36(40,41)42)26(34(39)47-29)18-44-17-21-10-13-31(50)46-21/h2-8,11,14,20-21,43-44H,9-10,12-13,15-18H2,1H3,(H,45,49)(H,46,50)/t20-,21-/m0/s1 SARHIGKVFGUSME-SFTDATJTSA-N 479967 US10899735, No. 426 Programmed cell death 1 ligand 1/2 Human 191 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479967&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996315 COc1nc(cc(C)c1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(C)c(CNC[C@@H]2CCC(=O)N2)c(OC)n1 InChI=1S/C38H42Cl2N6O4/c1-21-15-31(45-37(49-3)29(21)19-41-17-23-11-13-33(47)43-23)27-9-5-7-25(35(27)39)26-8-6-10-28(36(26)40)32-16-22(2)30(38(46-32)50-4)20-42-18-24-12-14-34(48)44-24/h5-10,15-16,23-24,41-42H,11-14,17-20H2,1-4H3,(H,43,47)(H,44,48)/t23-,24-/m0/s1 UDNRLQNQSZJWBK-ZEQRLZLVSA-N 479968 US10899735, No. 427 Programmed cell death 1 ligand 1/2 Human 173 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479968&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996316 COc1nc(ccc1CN1CC(O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(C)c(CN2CC(O)C2)c(Cl)n1 InChI=1S/C32H31Cl3N4O3/c1-18-11-28(36-31(35)26(18)17-39-15-21(41)16-39)25-8-4-6-23(30(25)34)22-5-3-7-24(29(22)33)27-10-9-19(32(37-27)42-2)12-38-13-20(40)14-38/h3-11,20-21,40-41H,12-17H2,1-2H3 AKZQBJLFNTXYEZ-UHFFFAOYSA-N 479969 US10899735, No. 428 Programmed cell death 1 ligand 1/2 Human 290 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479969&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996317 COc1nc(ccc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(Cl)c(CNC[C@@H]2CCC(=O)N2)c(Cl)n1 InChI=1S/C35H34Cl4N6O3/c1-48-35-19(15-40-16-20-9-12-30(46)42-20)8-11-28(45-35)24-6-2-4-22(32(24)37)23-5-3-7-25(33(23)38)29-14-27(36)26(34(39)44-29)18-41-17-21-10-13-31(47)43-21/h2-8,11,14,20-21,40-41H,9-10,12-13,15-18H2,1H3,(H,42,46)(H,43,47)/t20-,21-/m0/s1 JJIGXIMIVDKCIB-SFTDATJTSA-N 479970 US10899735, No. 429 Programmed cell death 1 ligand 1/2 Human 221 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479970&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996318 COc1nc(ccc1CNCCO)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(C)c(CNCCO)c(Cl)n1 InChI=1S/C30H31Cl3N4O3/c1-18-15-26(36-29(33)24(18)17-35-12-14-39)23-8-4-6-21(28(23)32)20-5-3-7-22(27(20)31)25-10-9-19(16-34-11-13-38)30(37-25)40-2/h3-10,15,34-35,38-39H,11-14,16-17H2,1-2H3 MVLQQJCTMBSZAO-UHFFFAOYSA-N 479971 US10899735, No. 430 Programmed cell death 1 ligand 1/2 Human 153 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479971&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996319 COc1nc(ccc1CN1CC2(C1)CCC(=O)N2)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(C)c(CN2CC3(C2)CCC(=O)N3)c(Cl)n1 InChI=1S/C38H37Cl3N6O3/c1-22-15-30(42-35(41)28(22)17-47-20-38(21-47)14-12-32(49)45-38)27-8-4-6-25(34(27)40)24-5-3-7-26(33(24)39)29-10-9-23(36(43-29)50-2)16-46-18-37(19-46)13-11-31(48)44-37/h3-10,15H,11-14,16-21H2,1-2H3,(H,44,48)(H,45,49) CMBJSSUUTMBGHX-UHFFFAOYSA-N 479972 US10899735, No. 431 Programmed cell death 1 ligand 1/2 Human 444 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479972&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 996320 COc1nc(ccc1CN1CC(O)C1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cc(Cl)c(CN2CC(O)C2)c(Cl)n1 InChI=1S/C31H28Cl4N4O3/c1-42-31-17(11-38-12-18(40)13-38)8-9-26(37-31)22-6-2-4-20(28(22)33)21-5-3-7-23(29(21)34)27-10-25(32)24(30(35)36-27)16-39-14-19(41)15-39/h2-10,18-19,40-41H,11-16H2,1H3 MQRCBRWEMOPOCB-UHFFFAOYSA-N 479973 US10899735, No. 432 Programmed cell death 1 ligand 1/2 Human 131 US Patent 10.7270/Q2DB84Z1 aid1805207 US10899735 Aktoudianakis, E; Cho, A; Du, Z; Graupe, M; Lad, LT; Machicao Tello, PA; Medley, JW; Metobo, SE; Mukherjee, PK; Naduthambi, D; Parkhill, EQ; Phillips, BW; Simonovich, SP; Squires, NH; Wang, P; Watkins, WJ; Xu, J; Yang, KS; Ziebenhaus, CA 1/26/2021 8/15/2021 Gilead Sciences, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=479973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=322&target=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=479973&enzyme=Programmed+cell+death+1+ligand+1%2F2&column=ki&startPg=0&Increment=50&submit=Search 2 MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI 6UMT Programmed cell death 1 ligand 2 PD1L2_HUMAN Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5